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CHAPTER 
1 
INTRODUCTION 

INTRODUCTION 
''If the Ilumber of victims which a disease claims is the measure of its significance, then 
all diseases, particularly the most dreaded infictiolls diseases, ... mllst runk/ar behind 
(uberculosis." Robert Koch (1882) quoted by Waksman (1) 
General Introduction 
Tuberculosis (IB) is a good example of a disease that is easy to cure with modern 
chemotherapy but yet continues to ravage entire communities leaving in its wake a trail 
of human suffering. Since time immemorial, hlberculosis has reaped untold suffering in 
human society and continues to do so with near impunity in some countries. In the latter 
part of the nineteenth century, Robert Koch proved that tuberculosis was due to a 
specific organism, the JvJycohacteriu11l tuberculosis (2). The introduction of effective 
anti-tuberculosis dmgs, started in the 1940s with the discovelY of streptomycin by 
Selman \Vaksman (1) in the US, heralded a new optimistic stage in the control of 
tuberculosis. Brightman and Hilleboe best summed this optimism in 1962 (3): ' 
"The white plague, tuberculosis - is retreating ... 11,e decade ahead of 
us, the sixties, will be decisive. We are determined ... that the retreat oj 
the tubercle bacillus shall inflict asfew casualties upon our human 
resources as possible. Today tuberculosis workers have found it 
increasingly more difficult to find the persons who have active 
tuberculosis and control work requires case-finding methods that have 
the accuracy oJhigh-powered rifles ... Ifwe lFork hard in the decade 
ahead, tuberculosis is one disease that we can relegate to a position oj 
minor importance in public health ... " 
It is now more than three decades ago since Brightman and Hilleboe wrote and yet 
tuberculosis remains a major public health problem. Estimates of the global tuberculosis 
problem portray a gloomy and bleak prospect. According to the World Health Organisa-
tion (\VHO) and the International Union Against Tuberculosis and Lung Disease 
(IUATLD) onc-third of the world's population, that is about 1.7 billion people, is 
infected with A-l tuberculosis. These are, therefore, carriers of live bacilli and can re-
activatc and disseminate it (4). WHO and IUATLD further estimate that: 
a) about 20 million of these have active tuberculosis; 
b) of these tuberculosis patients at least 2.5 million die every year - making 
tuberculosis the leading single calise of death world-wide from an infectious disease; 
c) every year there are about 8 million new cases of tuberculosis - of which 3 million 
are contagious (4). 
Before 1985 the industrialised nations of the world had experienced a steady decline in 
tuberculosis, but this changed when the downward trend in the United States was 
reversed. More countries in the industrialised world began reporting similar findings. 
From 1985 through to 1991, the United States reported an 18% increase in the number 
of tuberculosis cases notified (5). Tllis sudden resurgence of tuberculosis in industrial-
ised nations during the era of modern chemotherapy is multifaceted. Dramatic cutbacks 
in public funding and in facilities to control and treat TB, increasing POVCliy, homeless-
ness, overcrowded housing, and drug abuse all conspired to rekindle tuberculosis which 
was a dying epidemic in industrialised countries (6). The human immunodeficiency 
virus (mV) infection epidemic has also had a profound effect on the resurgence of 
tuberculosis (7,8). More ominously is the emergence ofmultiple-dmg-resistant (MDR) 
lvfycobacteriumtuberculosis. MDR tuberculosis shows resistance to at least isoniazid 
and rifampicin which are key components oftherapeutic regimens in the treatment of 
tuberculosis. The emergence of MDR tuberculosis has been attributed to a number of 
factors. Jacobs (9) has best summed them up. He highlighted iuadequate trailling of 
health care workers in treatment and control of tuberculosis; inadequate knowledge in 
epidemiology of tuberculosis; unmonitored outpatient tuberculosis treatment; 
deterioration of infrastructure for public~health-services and the onset of human 
immunodeficiency virus (HIV) infections. 
Tuberculosis control in the Royal Netherlands Army has been a prominent feature of the 
Army Health Services since the eud of World War II. The Army has used over the years 
different tuberculosis control tools in minimising the TB problem in the Service. Data 
which have been accumulated by the Army especially on tuberculin skin testing 
initiated in 1956 is of particular interest. Tuberculin skin testing is to this day the only 
method available to screen and identify persons infected with A1. tuberculosis and to 
assess the risk of tuberculosis in a defined group of persons. Information from the Royal 
Netherlands Army (RNLA) tuberculin skin testing programme has been used by Styblo 
to provide insight into the annual risk of infection (ARl) for the Dutch population (10). 
By calculating the ARl based on this screening method, useful epidemiological 
information has been generated not only for the military but also for civilian public 
health. The Army populations llsed in the tuberculin skin testing programme thus 
provide a unique insight into epidemiological changes and trends, which reflect the 
general tuberculosis epidemiology in the country. 
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The tuberculin skin testing programme is also the basis for isoniazid prophylactic 
treatment (lPT) of persons infected withA1. tuberculosis. The tuberculin skin testing, 
however, is not a straightforward clear-cut qualitative "positive" or "negative"(lO). 
Much attention has been paid to standardising the test and adopting the same 
methodological approaches while administering the test. Since the beginning of 
tuberculin skin testing in the Army, for the tuberculin skin test (Mantoux) a 
concentration of I TU of Purified Protein Derivative (PPD) RT 23 has been used as 
recommended by the World Health Organisation in 1963 (II). To make the results 
comparable to those from past surveys, the Army has continued to use this dosage of 
PPD. However PPD is far from a standard to diagnose tuberculosis infections. PPD even 
in its purest form is a mosaic of multiple antigen (12). These antigens partially cross-
react with non-tuberculous mycobacteria (NTM) and therefore do not elicit a 
monospecific response (13). Most of these NTMs are not or are only facultatively 
pathogenic for humans. Tills cross-reactivity might result in NTM infected persons 
reacting with a positive result in response to a tuberculin skin test. Such persons will 
therefore be erroneously classified as having tuberculosis infection. This has important 
implications for individual patient care and for epidemiological shldies. Examples are 
the overestimation of the annual tuberculin index in the general population by including 
false-positive PPD RT 23 reactions and the UtUleCessary prescription of isoniazid 
prophylaxis in Army personnel. The prevalence ofNTM sensitivity limits the usefulness 
of the tuberculin skin test as a diagnostic and epidemiological tool in tuberculosis 
control. Tuberculosis control programmes dependent on a policy of tuberculin skin 
testing would need to identify A1. tuberculosis infected persons with a high degree of 
specificity. Edwards and Palmer (14) used dual skin testing to separate infections due to 
1\1. tuberculosis from those resulting from NTM by supposing that subjects with a 
stronger reaction to tuberculin prepared from M tuberculosis than to sensitin prepared 
from NTMs could be considered as infected with the tubercle bacilli. Earlier 
experiments proved that infection with a single mycobacterial species provided a degree 
of tuberculin sensitivity that was definitely greater to the homologous antigen than to 
the heterologous mycobacterial antigen (15). During recmitment, the Army performs 
mandatory tuberculin skin testing on the recruits. The limitation that NTMs might pose 
on the interpretation of the tuberculin skin testing results are therefore of concern and 
increasing the specificity of the skin test is of major importance. 
Concern about the specificity and sensitivity of the tuberculin skin test lies in the fact 
that the army recommends isoniazid prophylaxis for persons with a positive test. In the 
early 60s, the effectiveness of prophylactic isoniazid administration in reduction of 
tuberculosis morbidity was first reported by Ferebee and Mount (16). In 1967, the 
American Thoracic Society recommended the use of isoniazid prophylaxis therapy for 
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all persons with a positive tuberculin skin test (17). Unfortunately since the 1950s and 
19608 the use of isoniazid prophylaxis for persons infected with M tuberculosis has 
been associated with numerous reports of undesirable side-effects, mostly hepatitis (18-
21), at a time when the drug gained importance in tuberculosis control. Because these 
early studies were based on only a limited number of patients who were in most cases 
also receiving other dmgs, it was difficult to implicate isoniazid as cause of the side 
effects. However Scharer and Smith in 1969 proved that isoniazid was responsible for 
hepatitis among Ai tuberculosis infected persons who took the drug for prophylaxis 
(22). Since then a number of studies have reported many persons with hepatitis that are 
linked to isoniazid prophylaxis (23-27). Whether or not to use isoniazid prophylaxis, in 
view of the potential side effects, has become a big question in tuberculosis control 
programmes in which an IPT strategy is applied. Despite more upbeat reports that have 
documented an efficiency of93% in treatment of latent hlberculosis with isoniazid (28, 
29), the decision on its use has been marred by much controversy. The use of isoniazid 
in persons with a positive tuberculin skin reaction with a normal chest x-ray has cnded 
with conflicting opinions for or against its use (26, 27, 30-37). On the other hand 
persons with untreated healed fibrotic lesions on chest x-rays are given up to 70% 
protection from reactivation of disease by isoniazid prophylaxis (38, 39). Amidst all 
these controversies, the Royal Netherlands Army has continued to use isoniazid 
prophylaxis therapy for Army recnlits with a positive tuberculin skin reaction. Recmits 
into the Army are on average 20 years of age. Studies have demonstrated that in 
younger age groups, such as those of recruits into the Dutch Army, isoniazid 
prophylaxis has a clear advantage (27,37). However, age in relationship to isoniazid 
prophylaxis has not been devoid of conflicting results and opinions. Stead et a1. (40) 
demonstrated that isoniazid prophylaxis had a clear benefit among elderly persons who 
show evidence of new tuberculosis infection. 
In this thesis a historical review of the Royal Netherlands Army tuberculosis control 
programme is outlined in chapter two. An overview is provided of the tools that have 
been used by the army to control tuberculosis. Through the years, the changes in trends 
in tuberculosis have been monitored and this has often resulted in reviewing and 
adapting control strategy to reflect on the epidemiological situation or level of current 
scientific knowledge. This historical review discusses issues of policy and practices 
over the years and their scientific basis. 
The Army isoniazid prophylaxis programme in the period 1984-1995 is presented in 
chapter three. Particular attention is given to the documentation of side effects. The 
incidence of these side effects therefore forms a basis on which decisions regarding the 
use of isoniazid prophylaxis in the Army can be made. Different popUlation groups 
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often respond differently to medicaments and it is therefore of scientific importance to 
provide finn data on isoniazid prophylaxis as arising in programme conditions. 
The prevalence of non-tuberculous mycobacteria sensitivity in the army recruit 
population through the years is presented in chapter four. This data provides information 
on the prevalence ofNTM in the general Dutch population and - as mentioned earlier -
NTM sensitivity does affect the specificity of the tuberculin skin test, which forms the 
cornerstone of the isoniazid prophylaxis programme in the Royal Netherlands Army. 
Taking into consideration the presence ofNTM also in the Army population, chapter 
five presents the results of an investigation that uses a double skin testing procedure to 
distinguish M tuberculosis from NTM infections. It is the opinion of this investigator 
that this method minimises the unnecessary administration of isoniazid and is an 
imp0l1ant method to improve the tools available to control tuberculosis. 
In chapter six as an example, a case study on the usefulness of tuberculin skin testing to 
identify infection with a suspected MDR strain is presented. The army has had 
increasing international deployments. In recent years, servicemen have been deployed in 
fields as far apart and diverse as from Cambodia to Eastern Zaire. The Army is 
increasingly mobile and so is the general population in much of the world. International 
migration and increased travel have brought persons in areas previously considered 
relatively at low TB risk in contact with tuberculosis. In the era ofMDR tuberculosis, 
the usefulness of isoniazid - an important tool in the Royal Netherlands Army 
tuberculosis control - threatens to become obsolete. In chapter six, the need to control 
the global tuberculosis problem is stressed. 
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CHAPTER 
2 
TUBERCULOSIS CONTROL IN THE ROYAL 
NETHERLANDS ARMY 
Historical Perspective 

Tuberculosis Control in the Royal Netherlands Army: 
Historical Perspective 
"Het gevaar vall de ziekte word! nog altijd ontiel'sc/zat en tuberculose is etgenlijk 
hef best Ie vergelijken met een heidebl'and. Hel vuw' sluimert, maar laait af ell toe 
weer op. En dam'in SCllllillllll jutsl het gevaar", HA van Geuns (1) 
Tuberculosis continues to be of great concern worldwide inspite of significant positive 
developments in the last decades in its treatment and control. At the beginning of the 
19605, there was great optimism that eliminating tuberculosis - now defined as a case of 
one per million population - was a goal that could soon be attained. TIllS up-beat mood 
resulted from recently proven efficacy of antituberculosis chemotherapy and the 
prospect of isoniazid prophylaxis therapy (IPT) to prevent the advance of tuberculous 
infection to disease (2). 
Today, the goal of eradicating tuberculosis and achieving "zero tuberculosis" still 
remains elusive inspite of the giant strides made in elucidating the epidemiology of this 
ancient scourge. The emergence of multiple-drug-resistant (MDR) Mycobacterium 
tuberculosis and tuberculosis associated with human immunodeficiency virus (HIV) 
infection threaten or have even reversed the gains achieved in TB control realised in the 
last decades. The problems in many technologically less advanced countries may be of 
exploding numbers of sputum positive tuberculosis cases and the burden therein of 
providing reliable and sustainable control measures (3). In teclmologically advanced 
countries there is a come-back of tuberculosis. The first evidence of tlus reversal in the 
later occurred in the USA (4). In the Netherlands, the number of notified tuberculosis 
patients has been rising since 1987 (5). An increase in notifications has indeed been 
registered in other countries such as Ireland, Italy, Denmark, Norway and Switzerland 
(6). With the resurgence of tuberculosis, a number of controversial policies that had 
been ignored or subject to little research, given the declining trends in technologically 
advanced countries, need to be re-evaluated. Notable among these problems are the use 
and interpretation of the tuberculin skin test, isoniazid prophylaxis therapy (lPT) and the 
use of BCG vaccination. Studies investigating the use of IPT among persons who have a 
positive tuberculin skin reaction with a normal chest radiograph have ended with 
conflicting opinions on its use (7-10). The use ofBCO vaccination on the other hand 
has shown great variation in protection ranging from 80% in some populations and nil 
in others (11). 
II 
It is over a century ago that Robert Koch atmounced at the Tenth International Congress 
of Medicine in Berlin a breakthrough in the treatment of tuberculosis (12). Koch's 
curative agent was described as a "brownish transparent fluid" and many referred to it as 
Koch's lymph or Koch's remedy. TIllS fluid was a culture filtrate of MycobacteriulII 
tuberculosis to which the name tuberculin was given by Bluwid (13). However the 
enthusiasm ofthis curative agent £1.iled the tests ofthe critical scientific conununity. 
Tuberculin was found to lack the curative prope11ies that Koch had claimed and the 
euphoria of Koch's method of treatment of tuberculosis was soon lost. The end of 
tuberculin as a mode of treatment however did not spell the end of Koch's "brownish 
transparent fluid ". 
Tuberculin found a new use as a diagnostic agent - what Koch himself had observed 
(14). Koch employed a method of subcutaneous inoculation oftuberculin to make a 
diagnosis of tuberculosis. Persons with tuberculosis, when inoculated with tuberculin 
subcutaneously, had a sharp rise in body temperature lasting several hours. This test was 
not widely used by the medical profession in the early years of this century as it was 
considered that practically everybody reacted to tuberculin. Veterinarians on the other 
hand saw the potential of the tuberculin test to control tuberculosis in cattle. The test 
was used to identify diseased cattle to be disposed of. In the Netherlands, Mouton in 
1897 found that tuberculin was useful to control tuberculosis in herds but was dangerous 
and unreliable in man (15). Thus Mouton was among the first persons in the 
Netherlands who registered scepticism on the use of the tuberculin test to control 
tuberculosis in man. 
In spite of doubts about the use ofthe tuberculin test, attempts to improve it for the 
diagnosis of tuberculosis continued in different countries. In particular new methods of 
administering tuberculin were developed. Griep, among others, outlined in 1957 the 
different methods of tuberculin administration (13). These included a percutaneous test 
(Moro), a conjuctival test (Calmette), a modified Koch subcutaneous test (Hamburger), 
a cutaneous test (Von Pirquet). Other methods of administering tuberculin have 
included the Heaf test, Trambutsi test, the patch test of Vollmer and a host of others. In 
1908 an intracutaneous test was described independently by three scientists: Mantoux in 
France, Mendel in Germany and Van Balen in the Netherlands (13). The latter is 
credited as the first to use adrenaline in an attempt to make the tuberculin reaction better 
defined. In spite of attempts by proponents of Van Balen, such as Cornelia de Lange 
(13) to honour this Dutch achievement by referring to the Balen-Mantoux test, the 
intracutaneous test is now globally known as the Mantoux reaction. In almost all areas 
of the world, it is the Mantoux test that has survived as the standard means to administer 
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tuberculin. The primary advantage of the Mantoux test in comparison to all the above 
tests is its ability to provide a quantitative assessment of the tuberculin response. 
In the first half of this century, the Von Pirquet method was popular in the Netherlands. 
The earliest Dutch records on tuberculin skin testing were between 1925 - 1948 
performed by the Amsterdam Municipality clinic. These surveys employed the Von 
Ph'quet method to test children aged up to 14 years and who were not in contact with 
tuberculosis patients (16). The results demonstrated that there was a steady decline in 
the prevalence of infection at all ages during the 23 years. In 1954, Duit and Vreeling 
employed (I 7) for the first time a tuberculin skin test (Von Pirquet) as an epide-
miological tool within the Royal Netherlands Army. They skin-tested 131 soldiers 
following the detection of a sputum positive tuberculosis case in the anny barracks at 
Assen. Twenty one (21%) percent of the soldiers investigated showed a positive Pirquet 
test. It is notewOlthy that Duit and Vreeling hinted that ifthey had used the Mantoux 
method possibly more positives might have been found among the soldiers. One of their 
conclusions was that the tuberculin skin test was a necessity for tlie anny in her 
tuberculosis control program, which at the time relied primarily on radiography for 
screening and diagnostic test. Indeed the following year witnessed the use of the 
tuberculin skin test on a routine basis with the Mantoux skin test as the standard method 
for tuberculin administration. The limitations regarding the sensitivity of the tuberculin 
skin test method as pointed out by Duit and Vreeling in the aforegoing were just one of 
the several problems that would and have continued to generate controversy with the 
tuberculin skin test. These shortcomings of the tuberculin skin test are best sunmlarised 
by Edwards and Edwards who wrote in 1960 (14): 
"Indeed, the st01Y ojthe tuberculin test is punctuated with the 
unexpected, with periods of high hopes broken by periods of doubt and 
disillusion about its lIsejitiness as a diagnostic test. " 
This could also be said about the entire evolution of the tools available to understand the 
epidemiology of tuberculosis and therefore to institute effective intervention methods. 
The following methods have been available to control of tuberculosis: 
• the chest X-ray 
• the tuberculin test 
• sputum investigations (such as Ziehl-Neelsen staining and culture) 
• chemotherapy 
• chemoprophylaxis 
• BeG vaccination 
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It is noteworthy that even before the introduction of the above tools, tuberculosis 
already seemed to be declining in the Netherlands. This decline has been attributed to 
general improvements in the socio-economic conditions (18). In the Netherlands, 
tuberculosis mortality decreased from 146.1 per 100,000 in 1920 to 43.7 per 100,000 in 
1940, with the risk oftuberculous infection declining from 6.7% in 1920 to 2.1 % in 
1940. Styblo (18) has reffered to tlus as the "natural" decline of tuberculosis. These 
trends in mortality and the risk of tuberculous infection are shown in figure 1. 
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Figure I. The risk ojtubercu/os infection in The Netherlands, and death rates ill the 
Netherlands: 1920-1940 (Adaptedfi'olll Slyblo (18)) 
The crowded living conditions usually found in military barracks are ideal for the spread 
of infectious respiratory diseases (19). In such crowded settings persons are also at an 
increased risk of acquiring tuberculosis if there is an infected person in the crowd. 
Therefore during the immediate post-war period (1945) the army tuberculosis control 
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program placed emphasis on screening and identifying persons who had been in contact 
with a known or unknown source of tuberculous infection especially among recruits. 
Recmits with X-ray evidence of tuberculosis were not enrolled into the army. In this 
way it was hoped that outbreaks of tuberculosis in barracks' would be minimised. 
The present chapter gives insight into the different screening methods that have been 
used by the Netherlands army in the past five decades. Particular reference is made to 
the chest X-ray and the tuberculin skin test. In the light of changing epidemiological 
trends, the suitability of these strategies is also discussed. 
Tuberculosis problem in the army before World War /I 
Accurate records on tuberculosis prevalence in the Netherlands army during the 
beginning of tills century are hard to come by. Existing reports indicate that tuberculosis 
was indeed a problem within the army. A clear indication of the severity of the problem 
is described in a 1913 letter from the Tuberculosis Commission (S.taatscommissie inzake 
tuberculose-bestrijding) addressed to the Minister of \Var. In tIus letter the commission 
was concerned about the high tuberculosis morbidity and mortality within the Dutch 
military compared to that in the French and German military. In the Netherlands army, 
the tuberculosis incidence was 4 per 1000 soldiers in 1913. Reacting to this letter, the 
Surgeon General wrote: 
1I1n response to the statement by the Tuberculosis Commission, I wish to 
c1arw' tltat claims to tlte effect tltat tlte Netherlands arm)' Itas a higher 
tuberculosis problem than other countries are erroneOllS and 
unfollnded". 
The Surgeon General pointed to two factors as being responsible for this seemingly high 
tuberculosis figure within the Dutch military: 
1. The short conscription period (82 months). In other European countries, recmits 
were obliged to serve for longer periods, usually years. Therefore, the Dutch 
conscription practice meant that about three cohorts of recruits were inducted 
while other countries were still dealing with one cohort of recruits. The chances 
of finding new tuberculosis cases was, therefore, much higher in the Netherlands 
military. 
2. Absence of proper record keeping which resulted in many double registries. 
\Vith such irregularities taken into account, the Surgeon General argued, the 
tuberculosis incidence would be 2.86 per 1000 soldiers. This latter figure would then not 
be much different from what was being observed in Germany and France. According to 
the Surgeon General, record keeping was an area of immense weakness. It was with tIus 
in mind that the Minister of \Var and the Surgeon General resolved that begiIming with 
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1919, the statistics on health matters would be handled by the Central Bureau of 
Statistics (CBS), a civil organisation. Statistical data processed by the CBS for the year 
1919,1920 and 1921 showed respectively 121,83 and 76 army recruits admitted to 
sanatoria for tuberculosis treatment. In 1919, Heynsius van den Berg, in a report to the 
Surgeon General (20) called for more measures to treat and control tuberculosis in the 
army. He justified this to the Ministry of War on a cOlmnunity health perspective and 
for the well being of the military. He recommended five measures, which laid the 
foundations of tuberculosis control program in the army: 
I. Early diagnosis of tuberculosis 
2. Notification of all cases of tuberculosis to the CBS 
3. Early treatment in sanatoriullls and hospitals 
4. Discharge from the army and provision of social support 
5. Aftercare and cooperation with civilian organisations working to control 
tuberculosis. 
During this period the only diagnostic test which was used routinely to identify cases of 
active disease was the bacteriological examination of sputum. Other nonspecific tests 
included measuring the erythrocyte sedimentation rate - which is usually high in cases 
of active tuberculosis. These tests were unsuitable to screen large populations such as of 
recmits. It was, therefore, a giant step fonvard when chest X-rays could be used as a 
screening tool. 
Beginnings of Rontgenography in the RNLA 
In the period before 1955, the Netherlands military relied almost exclusively on physical 
examination supplemented with X-ray examination oftlle chest to identify cases of 
active pulmonary tuberculosis. During this period chest X-ray screening of all recruits 
into the army became part of the routine medical examination at induction and it was 
"methode de choix lt to detect cases of active and latent disease in this group. 
From the time of Rontgen Discovery to World War 1/ 
Rontgen rays were discovered in 1895 by Wilhelm Conrad Rontgen (21). A few years 
later, in 190 I, Gillard in France conducted possibly the first chest radiographic 
investigation in a military setting (22). Another French study conducted in the years 
1922 and 1934 by Sieur (22) involved 106070 military servicemen who underwent chest 
X-ray examination. Active tuberculosis was found in 0.17% of those screened. The 
value of routine chest X-ray examination to identifY recmits with tuberculous was soon 
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apparent to military establishments in other countries. From a military point of view, the 
exclusion of tuberculous recruits could provide the following advantages: 
• The spread of tuberculosis within the army could be limited by isolating infectious 
sources. 
• The time lost due to disease could be minimised. 
• The economic burden of providing care in later years would be minimised, even 
though prior to World War II this was not the case in the Netherlands. The Dutch 
army treated all persons found with tuberculosis at induction. Tlus practice was in 
sharp contrast to the system in other countries where persons with tuberculosis at 
induction were not recruited but were passed on to civilian organisations for 
treatment. 
In 1931 a compulsory chest X-ray of all members of the armed forces was initiated in in 
Germany 1931 (22). In that year, out of the 106070 persons examined radiologically, 
1.68% had active pulmonary tuberculosis and 1.75% had the inactive form. In the 
Netherlands it was Burger (23) who recommended that chest X-rays form part of the 
routine medical check-up of all those enrolling into the RNLA. Burger had at the time 
completed a mass chest X-ray screening program for employees of the Philips factory in 
Eindhoven. He was quick to recogluse the importance of chest radiology in a military 
setting. In this period, le. Diehl was the Surgeon General and he too appreciated the 
immense potential of radiology as a tool to identify asymptomatic tuberculosis cases 
within the army. He encouraged and fhcilitated efforts to adapt this form of tuberculosis 
screening for recmits into the RNLA. Subsequently, the first trial with X-ray screening 
was initiated in 1933. It took nearly four decades after Rontgenrs discovery of the X-
rays before the RNLA supplemented physical examination and history with radiography 
in to improve the chances of identifying active pulmonary tuberculosis cases to 
minimise the induction of tuberculous recruits. Tlus first trial involved 1001 recntits 
who were reporting for military duty. The results were viewed with gratification since 
six cases of active tuberculosis were found, which otherwise would not have been 
identified through physical examination alone (23). Studies elsewhere had also shown 
that chest X-rays identified some persons with advanced tuberculosis with minimal or 
no symptoms (24-26). Thus the chest X-ray became an indispensable tool to identify not 
only early but even extensive tuberculous lesions that could be present without 
symptoms. 
By 1936, S. W. Praag had SllCceded Diehl as Surgeon General. Just like his predecessor, 
Praag also was convinced of the value of radiography. In 1936 the RNLA officially 
incorporated chest radiology as part of the routine screening ofrecntits. Between March 
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1936 and June 1937, 86033 recruits to the RNLA underwent chest radiographic 
examination (23). The yield from tIus mass chest radiography was 44 cases of open 
tuberculosis (about 0.5%), 262 cases of Itactive lung processes rt and 16 cases of pleuritis. 
During the general mobilisation of 1939, X-ray screening was extended beyond the 
conscripts to include military personnel already in active service. 
However the chest X-ray at the time was not devoid of problems. A major bottleneck 
was the cumbersome radiographic equipment available before 1936. This made it 
difficult to radiograph every newly inducted conscript on recmitment into the Anny. 
Botenga (27) pointed out that another major frustration with the equipment at the time 
was its inability to record the fluoroscopic image. To overcome this deficiency, Botenga 
conducted studies at the Military hospital in Utrecht in collaboration with a private firm 
- they investigated possibilities to develop a practical way of photographing the 
fluoroscopic image (22). These attempts were abmptly and prematurely ended whcn the 
Germans occupied the Netherlands in 1940. But also by this time (1940) the idea of 
photographing a fluoroscopic image had already been developed by the Brazilian 
radiologist Manoel de Abreu in 1936 (28). De Abreu conducted mass X-ray surveys in a 
number of South American countries. This improvement of the radiographic teclmique 
and equipment revolutionised radiography and made it possible to screen hundreds of 
persons within a short period using Mass radiography (Mass Miniature Radiography -
MMR). TillS approach was considered as the most effective method to detect 
tuberculosis and the technique was extensively employed in many surveys of military 
populations. MMR was not a Ilnew" diagnostic technique in the sense of providing 
better identification of tuberculous cases. It was a faster and efficient screening method 
well adapted for mass surveys. The switch over to use MMR was looked at with 
suscipicion in certain circles. Some considered the use of small sized films in the 
diagnosis of tuberculosis as an oversimplification of Case finding and doubted its 
usefulness in tuberculosis control (29). Eventually the wider appreciation of the 
advantages of MMR as a screening method prevailed over such criticisms. 
In 1938, Germany began using the new techniques of Abreu to conduct chest 
radiographs of military servicemen (30). In Britain and the United States the first 
MMRs for examitllng recruits was started in 1941 by the Royal Navy and US Navy 
respectively (31-34). The policy of radiographing all new US army recruits followed a 
year later (35). These new techniques were not to be adapted in the Netherlands until 
after the end of World War II. 
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Figure 2. The TVatsoll radiographic equipment used during a chest x-ray session of 
young lIIilitmy recruits, ca. 1952. (Photograph DMGZ archive) 
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Tuberculosis control between 1945 - 1955 
In the period 1944-1945,just before the liberation, the incidence and mortality due to 
tuberculosis in the Netherlands was reported to be high (36). War conditions had 
brought about great deprivations and in the winter of 1944 - 1945, there was famine in 
large parts of the country. These factors, coupled with the breakdown of social services 
resulted in increases in tuberculosis cases, It was therefore a necessity to reactivate the 
tuberculosis control measures crippled during the war. \Vith the end of the war, the 
recommendations of Burger to carry out routine chest X-ray screening of all army 
recmits could now he followed. It was S.L Fransman, an army physician who initiated 
steps to establish the llDicllSt Rontgenoiogisch Borstonderzoek - ROBO n - the militaty 
X-ray screening department. It is also due to him that in 1945 the new technology of 
MMR was used for the first time in the Netherlands (37). 
Fransman recognised the importance of identifYing cases of hlberculosis through this 
method to safeguard the health of other recruits during the period of their induction into 
the military. By August 1945, the first photofluorographic unit, a lIWatsonl1 , was 
installed in Amsterdam (27). It was three years later that MMR was used for the 
indiscriminate screening of the gencral Dutch population (37). The lIWatsonli was a 
major advancement - it facilitated radiographing many recruits and enabled the ROBO 
to X-ray this group of persons within a short stay in the barracks compared to the pre-
war average of three weeks (figure 2 is a picture of an RNLA clinic with the \Vatson in 
action). This was an important step forward as the army recruits had to stay in quarters 
where close contact was inevitable while awaiting medical examinations. In this kind of 
setting, a conscript with open tuberculosis could be a source of infection to a large 
group, hcnce the emphasis on shortening the duration between induction and the first 
chest X-ray. The average duration of stay of recruits with chest X-ray evidence of 
tuberculosis from time of first day in the barracks to radiographic investigation in the 
year 1951 - 1960 was studied by van Alten and his results are reproduced in table I (22). 
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Table 1. The average time interval between first day in barracks and whelll'ecl'uits 
underwent chest X-ray examinatiol1-for recruits who were found to have active disease 
Year Average interval (days) 
1951 6.8 
1952 5.8 
1953 6.9 
1954 6.9 
1955 6.8 
1956 6.8 
1957 8.2 
1958 5.9 
1959 3.7 
1960 3.0 
These results show a shortening of the interval in 1960 by 56% over the 1951 average of 
6.8 days. This was made possible through a policy of having mobile units that X-rayed 
recmits at different sites of induction. Figure 3 shows a mobile x-ray unit that was used 
by the army tuberculosis programme. This specially designed bus traversed the country 
radiographing army recruits at different induction centers. \Vith the development of 
better technology, it was possible by 1967 to X-ray all recruits on theirfirsl day at an 
induction centre (38). Limiting time that recruits took before the chest X-ray 
examination did not mean that radiography was the ideal means to identify cases of 
hlberculosis disease. Infact a hitherto unrecognised problem presented itself after \Vorld 
\Var II in civilian and military populations. This was the finding of variability in the 
intelvretation of chest X-rays even by experienced radiologists (39-41). Discrepancy 
was also noted in the same radiologist when examining the same films after a short 
interval of time (intra-observer disagreement). To minimise this problem, Birkelo et al. 
(39) recommended that all survey films be read by at least two independent persons 
("double reading"). In the Netherlands, Griep reviewed over 3,000 films that had earlier 
been examined and reported upon during a mass survey. In that study, all the films were 
studied and reported upon by six persons experienced in interpreting chest X-rays. It 
was found that 27.8% of the films with tuberculous lesions had been misinterpreted in 
the earlier reading. 
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Figure 3. The ROSO bus at a mililmy complex, ca. 1959. (Photograph DMGZ archive). 
In another investigation, Griep demonstrated that double reading of chest films 
identified 91% of all films with tuberculous lesions (42, 43). From the results of this 
Dutch study and of other studies conducted elsewhere, the ROBO depalimcnt 
incorporated the policy of double reading in 1953. The ability to conduct chest X-rays in 
large populations with relative ease set the pace for epidemiological studies of 
tuberculosis as it oeeured in the Netherlands Army. In their study which consisted of 
123,902 soldiers, Bangma and Aulbers (44) found that there were 22 times more recmits 
professional soldiers with active tuberculosis. Tllis was surprising especially since 
barracks' with their close living conditions are considered places in which infectious 
respiratory diseases could spread easily. They thought it most likely that the difference 
was related to the extent the two groups interacted with the general popUlation. 
Professional soldiers were confined to batTacks' and only went home on the weekends 
whereas the recruits were directly coming from the general population where the degree 
of exposure to hlberculosis was higher. Also, the professional soldiers underwent 
frequent chest X-ray examinations so persons with active disease could be identified and 
isolated. Recruits coming directly out of the general population lacked this regular 
controL In the study by Tuinstra and Van der Linde (19) it was observed, however, that 
tuberculosis among recruits was 1.3 times higher than among similar age groups in the 
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general population. Since the films in both groups were not read by the same 
radiologists, these differences are possibly largely methodological. Tuinstra and van der 
Linde also observed that the cases of active tuberculosis in the army were showing a 
downward trend, and that there was a seasonal pattern in the case finding with most 
active tuberculosis being in spring. This downward trend in the cases of active 
tuberculosis has continued to be observed within the military to this present day. 
The first chest X~ray screening in 1933 was directed at recruits with the intention of 
preventing tuberculous cases from entering the army. \Vith the formation of ROBO in 
1945, the X-ray program was expanded beyond the recmit population to involve 
professional soldiers and civilians working for the RNLA. The ROBO tuberculosis 
control program provided the following measures: 
1. Recruits into the RNLA had to undergo a chest X~ray as part of the medical 
examination at induction. Persons found to have an abnormal chest X~ray would 
therefore not be enrolled into the army, but charnleled to the ciyilian health services 
for further management. Those found eligible for the army were expected to report 
for duty in a period of 12 months. 
2. Recruits rep0l1illg for duty had to undergo a second chest X-ray within a short 
period after reporting. Cases of tuberculosis missed out between induction and the 
start of active service were usually found. Such persons were also discharged from 
the army. 
3. R6ntgenographic examination of the chest of all recruits after six weeks of stay in 
the service. TIllS examination at the time was thought to be useful to identify cases 
of viral pneumonia which were common in such crowded conditions during the first 
six weeks. An occassional case of tuberculosis was also found during this 
examination. 
4. Annual chest radiological examination of all military personnel and civilians in 
military service who were 40 years of age or younger. 
5. Persons older than 40 years (both civilian and professional soldiers) had to undergo 
a chest X-ray twice a year. This examination was influenced by the fact that persons 
in this group had a more increased risk of developing lung malignancies and it was 
in that period found desirable to screen these at an early stage. 
6. All military persons being deployed to foreign countries had to undergo a 
radiological examination of the chest. Persons found with abnormalities were not 
deployed. 
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7. AU military personnel being discharged or released from active service also 
underwent a radiological chest examination. 
8. A chest radiograph for all reserve military personnel who report for active military 
duty. 
9. Persons showing abnormalities suspected of tuberculosis were referred to a military 
pulmonologist for further assessment to verify such a diagnosis. 
It is therefore evident that the ROBO not only aimed at controlling tuberculosis but also 
at a strategy providing comprehensive health care for persons employed by the military. 
In 1955 the army incorporated the tuberculin skin test (Mantoux) as an extra tool into 
her armament to fight against tuberculosis. 
Tuberculin Skin Testing in the RNLA: 1954-1995 
Although it were Duit and Vreeling in 1954 who first employed a tuberculin skin test as 
an epidemiological tool iu the RNLA, the tuberculin skin test was made part of the 
routine physical examination for military recruits in 1955. This followed the 
recommendations of a study group UDe Adviesconunissie T.N.O. inZ:1.ke het BCO 
vraagstukU which was a collabora-tive work between T.N.O and the Military Health 
Service (22). This study group was originally set up to study the suitability ofBCO 
vaccinatiou in the Netherlands on request of the Health Council (Oezondheids Raad). 
The army as a group represented a suitable and reliable population for investigations on 
this subject. I-fence the recOlmncndation for tuberculin skin testing in the army was 
based on the need to: 
1_ Provide information on the tuberculin sensitivity in the Netherlands of males with an 
average age of 19 years. 
2. Investigate at a later stage the value ofBCO in tuberculine negative recruits. 
It is impOliant to note here that this study group was the fore-runner of the International 
Tuberculosis Surveillauce Center (ITSC), a collaborative body bringing together 
tuberculosis experts from the International Uuion Against Tuberculosis (IUAT), WHO, 
TNO, KNCV and the Department of Military Health Care (DMOZ). 
From 1955, the RNLA tuberculosis program had an additional diagnostic method 
supplementing the chest X-ray in identifying persons infected with tuberculosis_ The 
late implementation of tuberculin skin testing in the RNLA is in contrast to the policy in 
other countries. In the United States Navy, routine testing of recruits became a reality in 
1948. The recruits were skin tested with intennediate strength purified protein 
derivative (PPD) by the Mantoux method (45). 
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The late introduction of the tuberculin test to control tuberculosis in the RNLA is 
possibly due to the controversies surrounding tuberculin as such and the epidemio-
logical situation in the Netherlands. Before \Vorld \Var II negative tuberculin reactions 
among persons with radiographic evidence of pulmonary calcifications were observed in 
the United States (46-49). Then, such calcifications were synonymous with unequivocal 
evidence of healed tuberculosis. Therefore the findings of these naIl-reactors led to 
serious doubts and controversies on the use of tuberculin. A common argument at the 
time was on the erroneous assumption that tuberculin sensitivity dissappearcd with 
complete healing of the tuberculous focus (14). Later confidence was restored in the 
hlberculin test when it was found that many of these calcifications were due to histo-
plasmosis (SO, SI). Another factor that influenced the late introduction of skin testing in 
the army was to be found in the distribution of tuberculin sensitivity in the population. 
In the early part of this century, the usefulness of the tuberculin test was limited as a 
large percentage of the Netherlands population was infected with lvfycobactel'ium 
tuberculosis or }vfycobacterium bovis. The presence of infection with At/. bovis therefore 
would result in a large population of persons with positive results to the tuberculin skin 
test. In 1946 Green (S2) published his classic chart (reproduced here in table 2). The 
chart indicated existence of cross-reactions with all six PPDs. Only small differences 
existed in the specificity of the human, bovine and BeG PPDs. As a result, the 
tuberculin skin test would not have been a helpful tool to identify cases of active 
tuberculosis then since many persons were believed to harbour At/. bovis infection. 
However in the 1950s the incidence of Ni bovis infections had substantially decreased 
after bovine hlberculosis had been eliminated in 1956. It is only then that the 
epidemiological potential of tuberculin became apparent. 
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Table 2 Specificity factors' of PPD antigens preparedji-om different organisms, and 
used to test guinea pigs sensitized by infection with the homologous and heterologous 
organisllls (52). 
Type of Type of PPD Antigen 
Sensitization human bovine BCG johne aviul11 phlei 
human 2 2 30 20 150 
bovine 2 30 40 150 
BCG 2 30 20 150 
johne 10 10 10 3 50 
avium 20 40 40 3 100 
phlei 150 150 150 50 100 
• The number of weight units of heterologous PPD required to 
elicit the same intensity of skin reaction as one unit of 
homologous PPD. 
Before the work of Florence Seibert of the Henry Phipps Institute, Philadelphia, in the 
1930s (53), there had been little attempt to standardise tuberculin - then not a simple 
unit but a complex substance. Green (54) has referred to this old tuberculin (O.T) as: 
fl •••• any witches' bre'w derived by evaporation of any unspecified fluid 
medium in which any unspecified strain afmammalian. .1.\1. tuberculosis 
had been grown, provided its potency matched that of another witches' 
brew kept ill Copenhagen and called international standard, or any 
allegedly equivalent sub-standard thereof, when tested 011 an 
unspecified number 0/ guinea-pigs without wonying too much about 
statistical analysis o/results. " 
Florence Seibert prepared precipitates ofO.T. which she called purified protein 
derivative (PPD). In 1941, Seibert and Glenn made a single large lot for deposit as the 
standard reference material in the United States (55). This lot known as PPD-S (the "sn 
after Seibert) was established as the International Standard for Purified Protein 
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Derivative of Mammalian Tuberculin by the \VHO Expert Committee on Biological 
Standardization in 1951 (56). In addition, it remained unclear what dosage ofPPD 
would be suitable for use. The practice of using a series of skin tests with graduated 
doses of tuberculin was clearly inappropriate for large groups of persons. It was 
Furcolow and collaborators in 1941 (57) who showed that 5 TU ofPPD tuberculin was 
the limit dosage that would detect tuberculous infected persons and minimised the 
number of nonspecific reactions. Palmer et al (58) and Goddard et al (59) later found 
that in the USA, 5 TU dose ofPPD-S was highly efficient in identifying persons with 
pulmonary infilitrates and calcifications who did not react to histoplasmin. 
It was also known even before 1955, that most of the strong-dose tuberculin sensitivity 
was not caused by tuberculous infection and doubts also began emerging about the 
small reactions to 5 TU (14). It is now generally believed that these reactions are caused 
by sensitisation with nontuberculous mycobacteria (NTM) (18). Through such cross-
reactions as a result of shared antigens between PPD and NTIvls, false positive results 
would be common in geographical areas with a high prevalence ofNTM. This kind of 
sensitivity to tuberculin as a result of cross-reactions with NTM has been referred to as 
"aspecific" or NTM sensitivity. In his study of school children in different countries 
published in 1967 and 1968, Blciker found that the Netherlands with a prevalence of 4 
percent was among the countries with a high prevalence ofNTM sensitivity (60,61). 
From 1955 to 1958, recruits were skin tested using the Mantoux technique with 5 
tuberculin units (TU) ofPPD RT 22 (Staten Serum institut, Copenhagen, Denmark) 
following the TNO recommendations (22). Before 1955, 10 TU ofPPD-S was in regular 
use in most countries but was observed to cause many untoward reactions such as 
blistering at the injection site, fever,joint pains. In addition a dose of 10 TU elicited 
nonspecific reactions. The TNO BeG work group collected information on recruits 
inducted in the years 1955 and 1956 and an attempt made to find if a regional difference 
in the prevalence of tuberculin sensitivity existed (13). Figure 4 presents this 
distribution by districts of the tuberculosis control program in the Dutch population. 
This figure showed that the tuberculin sensitivity ranged from 14 to 30%. The lowest 
percentage of tuberculin sensitive persons were observed in the northern provinces. The 
Illost important factor influencing this distribution was the rate at which bovine 
tuberculosis had been controlled in the south and north. The northern part eradicated 
tuberculosis in herds long before the same results were realised in the south. These 
regional differences in controlling tuberculosis in herds was influenced largely by 
economic reasons. After the World \Var II United States troops stationed in western 
Germany made a decision to buy their beef and milk supplies from the northern parts of 
the Netherlands. However beef would only be accepted if the meat was free from bovine 
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tuberculosis. This led to increased efforts to control tuberculosis in the northern herds 
(Bleiker, personal conmlllllication). It has also been suggested that the population 
density had an influence on this distribution, as the northern parts are less populated in 
comparison to the south: therefore the chance of coming into contact with an infectious 
case of tuberculosis was greater in the south (13). 
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Figure 4: The percellfagejrequency tuberculin sensitivity among recruits 1955 -1956 
based on their places of origiJl ill the Netherlands. 
A Search for the Best Tuberculin Concentration 
In 1956 Guld and colleagues observed that PPD was unstable, and that this instability 
affected the potency of the tuberculin (62). This instability was observed with 
hlberculins RT 19,20, and 21. They did not observe tlIis effect with other hlberculin 
concentrations. The possibility that tuberculin was being adsorbed on the glass 
ampoules was suggested. Since the army was using PPD RT 22, there was concern as to 
whether this preparation was subject to the same effect as that seen by Guld and 
collaborators. Studies by Bleiker and the Tuberculosis Research Office in Copenhagen 
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showed a similar instability which rcsulted from the adsorption ofPPD RT 22 on the 
glasswalls of the ampoules (63). The Tuberculosis Research Office in Copenhagen 
solved the problem by adding a small quanty of a detergent called Tween 80. This 
product stabilised PPD and its addition made it possible to diminish the strength of the 
tuberculin test liquid to 1 unit. From January 1959, recruits into the army were skin 
tested with I TU ofPPD RT 23 + Tween 80 by the Mantoux method. Bleiker showed 
that 5TU PPD RT 22 and I TU ofPPD RT 23 + Tween 80 had a similar biological 
activity (64). Thus the tuberculin sensitivity results of the period 1955 to end of 1958 
could be £:1irly compared with those that would be found llsing the new concentration of 
I TU. By 1963, the World Health Organization (WHO) had adapted 1 TU ofPPD RT 
23 as the recommended dosage for the tuberculin test (65). 
To coordinate the activities of tuberculosis control within the army, a special "Mantoux" 
group, combined RNLAfTNO teams, was established in 1958. Nurses were trained how 
to properly apply the Mantoux skin test. To obtain comparable results it was essential 
that attention was paid to how the technique was perfonned. The ROBO and the 
Mantoux group were finally brought under one organization, the Department of Military 
Health Care (Dienst Militaire Gezondheidszorg - DMGZ) under Branger. The DMGZ 
emphasised preventive health care and a close collaboration was established with other 
institutes designing strategies to reduce disease burden through prevention. These 
included The TNO, present RIVM and NIPG. These civil organisations co-operated 
with the army in conducting a number of disease preventive measures such as 
inoculations against smallpox, tetanus, polio, diphtheria, and BeG vaccination (when 
indicated). This relationship between these organisations and the military has flourished 
till this day. The ROBO and the Mantoux departments of the DMGZ embarked on a 
large scale program of screening the military population for tuberculosis. The results 
from these activities were used to give an insight into the changing epidemiology of 
tuberculosis in the Netherlands in general. 
In spite of all these reorganisations, there was still room for improvement. In the period 
between the end of the war and 1960, Van Alten (22) assi'sted in shaping policy on 
tuberculosis control. He extensively used the Mantoux skin test in contact tracing of 
recruits in barracks'. His work underscored the importance of using tuberculin skin 
testing in conjuction with the chest X-ray in order to arrive at optimal tuberculosis 
control. He reconullended the following measures to minimise the risk of recntits with 
infectious tuberculosis spreading the infection in a barracks setting: 
1. Apart from the obligatory dual reading of chest X-rays of recruits, a third reading is 
necessary for those with a positive tuberculin skin reaction at entry into the military 
service. 
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2. Recruits with a positive skin reaction or those with a positive history of tuberculosis 
in their immediate family should regularly be controlled by a chest physician. 
3. All recmits with a positive skin test should undergo a chest radiograph at three 
months interval during their stay in the Army. 
4. A central administrative and supervisory body is indispensable in maintaining a 
registry on tuberculosis control activities. 
5. Persons entering the military service should undergo a chest X-rayon the very day 
of enrollement and this should under no circumstances be postponed. 
6. If the number of Mantoux conversions amounts to over 10 per cent in case of 
contact tracing in a group of exposed persons, the scope of the contact examination 
should be broadened. 
These recommendations were to a large extent incorporated into the hlberculosis control 
policy of the army. Although appreciated, some were found difficult to implement. A 
third chest X-ray reading of all those with a positive Mantoux and the three monthly 
chest X-ray proved a difficult organizational problem. The latter measure was modified 
to twice yearly chest radiography but was later abandoned because of the small number 
of recruits found with active hlberculosis during such subsequent chest X-rays. In his 
fourth recommendation, Van Alten recognised the importance of a tuberculosis registry 
in keeping track of the epidemiological trends of disease. Over the years this registry 
has provided a unique set of data on tuberculosis control. Sutherland and collaborators 
(66) stated the following in regard to this unique set of tuberculosis control data: 
"The series a/tuberculin surveys afmale army recruits in the 
Netherlands, ... is almost certainly the best and most btjormative 
material of this type. " 
Walig (67) examined the change in the tuberculin sensitivity (prevalence of M. 
tuberculosis infection) patterns of army recruits during the period 1956 to 1969. His 
results showed a downward trend in prevalence. Indeed this downward trend has 
continued to be observed since the start of the Mantoux skin testing. Figure 5 shows this 
downward trend among army recruits over a span of 4 decades. 
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Figllre 5. Prevalence ojlllberelliolls ilifeelion among army recruits 1956 -1995 (11ze y-
axis is a semilog scale). 
During the period 1956 to 1969, the percentage ofrecmits reacting with a positive 
Mantoux, that is more than 9mlll diameter, decreased from 19.2% to 4.4%. In 1995, the 
percentage of recmits with a positive Mantoux test was 0.42. The downward trend in the 
prevalence of tuberculosis infection among recruits reflected the declining trend within 
the general Dutch population from which the group of recruits is drawn. Unlike in the 
general population, in the army active tuberculosis cases have consistently continued to 
decline. In the general population, tuberculosis cases showed a decline from 145 cases 
per 100,000 persons in 1950 to 10 per 100,000 persons in 1980 with the lowest number 
of registered cases being in 1987 (68). Since then, the number of tuberculosis cases has 
increased as pointed out earlier. Figure 6 shows the trend of active tuberculosis cases 
within the army in a period of 40 years. 
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Figure 6. Notifications of allforlils of tuberculosis in the army, 1955 -1995. 
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The increase in tuberculosis in the general population has been attributed to risk factors 
such as: 
• immigration from countries where tuberculosis is widespread 
• drug addiction and or other associated social problems such as homelessness 
• mv infection, 
\Vhereas these factors are notable in the general population, they are not prominent in 
the Dutch army. Their insignificance in the army may therefore explain the observed 
downward trend of active tuberculosis within the military. For example in 1995, 
foreign-born persons accounted for only about 0.02% of the conscript population. To 
what extent these factors will be of importance within the military will depend largely 
on the interaction between the militalY and these risk groups on the one hand and the 
intensity and effectiveness of the civil tuberculosis control efforts on the other. 
Recruits into the army account annually for about 50% of each male population cohort 
in the Netherlands, therefore information gathered from tuberculin testing provides a 
rare chance to examine the epidemiological trends of tuberculosis over time. Using this 
Army data, Bleiker has applied Styblds calculations to give an insight into the age 
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prevalence of tuberculosis infection in the indigenous population of the Netherlands for 
the year 1945, 1975, and 2005 (69). These are illustrated in figure 7. 
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Figure 7. Estimated prevale11ce of tuberculous infection by age: The Netherlands, 1945, 
1975,2005 (Bleikel', 1984) 
Another important measure of the epidemiology oftuberculosis is the annual rate of 
infection with tubercle bacilli, also known as the annual risk of infection (ARl). This is 
defined as the percentage of the population that is infected or reinfected during a 
calendar year. The ARl is the best single indicator for evaluating the tuberculosis 
problem and its trend in both developed and developing countries. The data from army 
recruits has been of extreme value to calculate the ARI for the Netherlands population. 
Styblo (18) has pointed out that the ARl, unlike disease notification rates, is not linked 
directly to the case-finding and treatment measures of the tuberculosis program. The 
rates of the ARi have been derived since 1956 from the data on recmits. The decrease in 
the ARl was 13.7% annually between 1956 and 1965, 10.4% annually between 1966 
and 1979 (66) and about 8% between 1980 and 1990 (70). The changing ARl is shown 
in Figure 8. 
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Policy on BeG Vaccination 
In the early 19008, Calmette and Guerin working at the Pasteur Institute in Lille, France, 
during many years attenuated a strain of lvi hovis (BeG). The first administration of the 
vaccine in humans took place in Paris in 1921. Since then, BeG has become one the 
worlds most used and also most controversial vaccines. A worldwide assessment of its 
protective value has indicated greatly divergenl results - from 0 10 80% (II). These 
conflicting issues regarding BeG are underscored best by Rouillon and Waaler (71): 
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"JVhen and where is it indicated to undertake, to pursue or to 
discontinue BCG vaccination? This is the question which today ... gives 
rise to burning controversies, often strongly loaded with emotion, as is 
Ihe whole slDlY of BeG. " 
A look at different practices in other national Armies clearly show these confusing 
aspects of BeG. In France, it has been compulsory for all soldiers to undergo a BeG 
vaccination since 1952, if this was not given in childhood. The overlap between national 
public health policy and military health care meant that all incoming recruits in some 
countries are already vaccinated and if not, BeG is administered. One of the largest 
study to examine the prophylactic effects of BeG in a military popUlation was the series 
of ovcr 60,000 Swedish national servicemen conducted by Dahlstrom and Difs (72) 
duringI941-1946. This Swedish retrospective study found that BeG appeared to confer 
protection against primary tuberculosis only after two months from vaccination, or 
against other forms of tuberculosis only after six months. In the Netherlands, Bergsma 
studied the potential protective effect of BeG against primary tuberculosis by studying 
a group of student nurses working in the sanatorium IISOlmevanckft. His findings 
confirmed the observations of Dahlstrom and Difs (22). Muller and Edens had similar 
findings (22). Other studies using oral BeG in children did not find much optimism. 
This study conducted in the cities ofHilversum and Schiedam registered a high 
incidence of otitis media complicating oral BeG vaccination (Bleiker, personal 
communication). Such complications, some directly linked to BeG, discouarage the use 
of this vaccine. 
Within the military, there were people who advocated for a policy of BeG vaccination 
as a result of these studies. For example, Duit and Vreeling (17) in 1955 wrote: 
IINam' aanleiding van de tuberculose-epidemie in de Noordeli}ke 
garnizoenen kome1l wi} tot de conelusie, dat tengevolge van het grote 
aan/al anergischen onder de militairen de mogeli}kheid geschapen was, 
daf eell soldaat met open tuberculose een epidemie deed ontstaan, die 
ons inziens voorkomen had kwmen worden door algehele BCG 
vaccillatie van he/ legeI'll 
The above argument by Duit and Vreeling advocating BeG vaccination for the entire 
army was expressed in financial terms by Tuinstra and Van der Linde (19). Using data 
based on the number of active tuberculosis cases seen in the army during 1951-1955. 
They applied the findings of Dahlstrom and Difs to calculate the number oftuberculosis 
cases that would have been prevented by early BeG vaccination. Their findings showed 
that during the five years period, the BeG protective effect would have saved the 
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military over five million Dutch guilders in treatment costs. However as early as 1952, 
the Health Committee advised the Minister of Health to limit the use of BCG to the 
following groups (22). 
a) Persons exposed to a known infectious case of pulmonary tuberculosis. 
b) Persons for whom it was unclear if there had been any exposure to a given infectious 
case of tuberculosis, or persons who through their nature of work or circumstances 
are at increased risk of exposure to tuberculosis. 
Subsequently, BeG has not been used on a large scale in the Netherlands and has only 
been limited to selected groups. Despite all the arguments for its use within the Dutch 
army, the positive tuberculin reaction caused by BeG vaccination was considered a 
major drawback in the use of the tuberculin test as an epidemiological and clinical tool. 
However the use ofBCG was not summarily rejected by the military. By 1956, its use 
was confined to the following groups (22): 
a) All military health-care workers (including the sub-department IIMilva ll which 
consisted almost entirely of females working in the military Health sector). 
b) Military personnel exposed to a known infectious case of tuberculosis. 
BeG would only be administered if persons in any of the above groups were found who 
had a negative tuberculin reaction and the chest X-ray results showed no evidence of 
tuberculosis. With the observation in 1959, that the decline in tuberculosis morbidity 
among military persons was not as rapid as that seen in the general population (table 3), 
the Ministry of Health and Soical Affairs recommended BeG vaccination on a 
voluntary basis within the military. Tllis came into force within the military in 1960. 
Table 3. A comparison o/tuberculosis morbidity among recruits and the general 
population (13) 
Year Recruits General population 
per 10,000 per 10,000 
1951 24.4 25.7 
1952 25.1 23.1 
1953 20.9 19.5 
1954 18.4 15.6 
1955 15.6 12.7 
1956 13.8 10.3 
1957 7.9 9.5 
1958 10.3 6.5 
1959 16.4 4.9 
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There are no exact figures on the number of persons who undenvent BCG vaccination 
voluntarily following the above reconunendations. Tuinstra and Van der Linde (19) in 
1955 had already shown that tuberculosis in the group of recruits was much higher than 
in the general population. The difference between military persOlmel (by and large 
recruits) and the general population regarding tuberculosis morbidity might be a result 
of increased risk to infection and disease within the confines of a military barracks. This 
argument however directly contradicts the findings of Bangs rna and Aulbers (44) who 
showed that professional soldiers had less tuberculosis than recruits, suggesting that the 
argument of living conditions within the close confines of a military barracks was not a 
big factor, at least in the Netherlands. It should however be pointed out that the living 
conditions of professional soldiers were relatively much better than those of recruits and 
that this might have strongly influenced the results of Bangsma and Aulbers. It is also 
possible that through its intensive tuberculosis program the army could detect more 
cases of tuberculosis than their counterparts in the civil tuberculosis program. Tllis 
would therefore be reflected in higher numbers of tuberculosis being recorded in the 
army tuberculosis register. 
In 1966, the military broadened the group of persons to be vaccinated with BeG. This 
included persons being deployed to areas considered as with a high risk of tuberculosis 
infection. Military personnel deployed as part of a United Nations unit in areas of 
conflict were also to have a BCG vaccination. These recommendations were similar to 
those already in civil practice. The number of persons coming into the army with a 
history of BeG vaccination has continued to decline. In 1956, 11.7% of the recruits 
already had BeG before joining the army. This percentage was 0.4% in 1993 and 
0.017% in 1995. With the dynamic nature of the Dutch society, more army recruits who 
immigrated from countries with a policy of childhood BeG are being enrolled in the 
army. In 1995, the Mantoux department registered a total of 306 recmits with evidence 
of past BeG vaccination of whom 74% were foreign born. 
Isoniazid Prophylactic Therapy (IPT) 
Ferebee and Palmer set the pace for isoniazid chemoprophylaxis following their 
experiments with animals (73). In 1956, Debr" (74) described the use of isoniazid to 
prevent the development of progressive tuberculous disease in cases of primary 
tuberculosis. In 1960, the army started with the isoniazid prophylactic therapy (IPT) 
program for persons showing a conversion of the Mantoux reaction. This was referred to 
as secondary INH chemoprophy-laxis.1n his study begun in 1960, Holscher (75) 
investigated the protective effect of INH in Dutch marines showing a positive Mantoux 
reaction. This was a double-blind study involving 261 with a positive Mantoux. Of 
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these persons, 133 received INH and 128 were given placebo. The results showed that 
after seven years offollow-up, 9.5% of the persons treated on placebo developed 
pulmonary lesions suspicious of tuberculosis compared with only 0.8% in the INH 
group. However, as Walig (67) pointed out, the application of secondary INH 
prophylaxis was difficult in many cases - as symptoms of disease were already present 
when the positive Mantoux reaction was detected. For morc effective interventions 
Walig recommended the use of the primary INH prophylaxis which was defined as 
giving INH to possibly very recently infected persons with a still negative Mantoux 
reaction. INH as an intervention tool in the army tuberculosis control program is 
presented in chapter three. 
Epidemiology and Changes in Control Measures 
The policies of the army tuberculosis program have changed over time. As results there 
are many important changes affecting the tools used to control tuberculosis over the 
years. Many of these changes are mainly results of the declining importance of 
tuberculosis within the army and the general population. 
It has already been pointed out that the number of tuberculosis cases and the prevalence 
of positive tuberculin sensitivity has consistently shown a downward trend in the 
military. Subsequently the screening methods, largely the chest X-ray were increasingly 
not identifYing tuberculous cases at a rate that would justifY their application. Many 
other disease conditions over time had gained more importance and therefore arc being 
paid more attention than a IIsearchlt for tuberculosis. At induction, the medical 
examination is aimed at detecting persons with health impairements that would pose 
limitations on their military senrice and or who might he a source of health risk for 
others. In the period after the war, tuberculosis was an important factor for not enrolling 
persons into the military service. \Valig (67) studied the number of persons who were 
not inducted into the service between 1956 to 1969. He showed that persons not 
inducted as a result of tuberculosis declined from 8.9% in 1956 to 0.4% in 1969. Other 
diseases such as sarcoidosis were becoming more important than tuberculosis. In 1956, 
1.4% persons were not inducted due to sarcoidosis, and this percentage was 1.1 % in 
1969. Hence the interest in tuberculosis as an important disease began declining - a 
direct result of the changing epidemiological pattern. 
Nearly twenty years after the establishement ofROBO, the military in 1964 began 
examining whether the returns from the chest X-ray justified the cost. Other aspects that 
were seriously considered were the risks of radiographic screening. Subsequently, in 
1964, the annual chest X-ray for all conscripts was discontinued. These changes in the 
ROBO program are shown in chronological order in table 4. 
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Table 4 The chronology of evenls inlhe ROBO policy 
1964 Annual chest X-ray among conscripts discontinued 
1971 Chest X-ray at 6 weeks after recruits have reported for active 
service is discontinued. The effect of overcrowding which had 
been responsible for the viral pneumonias during this period had 
been overcome by establishing more recruitment centers 
1973 Half yearly chest X-rays for those above the age of 40 was no 
longer compulsory 
1974 The chest X-ray as a routine medical examination for recruits at 
induction is discontinued. 
1983 Annual chest X-rays for professional soldiers was discontinued as 
was the chest X-ray at demobilisation. 
1986 Chest radiology for reservists reporting for active service 
discontinued 
1988 Chest X-ray for recruits reporting for active service discontinued 
1989 All compulsory chest X-rays discontinued 
The army ROBO department definitely contributed to the decline of tuberculosis in the 
army. 
Currently the tuberculin skin test is the only method available for diagnosing 
tuberculosis infection in recruits. However the sensitivity of the test is limited, 
especially with a lessening of tuberculosis prevalence. The tuberculin antigen is not a 
single protein but consists of multiple antigens. Partial cross-reactivity of purified 
protein derivative (PPD) products with non-tuberculous mycobacteria means that a 
monospecific response that separates M tuberculosis infected from non-infected 
persons is precluded. This has implications for recommending isoniazid 
chemoprophylaxis in view of a positive Mantoux test and may result in an overestimate 
of the arumai tuberculin index. The future use of the Mantoux skin test in the military 
will therefore have to reckon with the NTM factor. Perhaps advances in molecular 
biology will result in the possibility of using molecularly defined tuberculins based on 
antigens which are predominantly or exclusively expressed by the tubercle bacilli and 
not by NTMs. Such a development would remove many of the uncertainities of using 
the tuberculin skin test in a low prevalence country. 
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THE ISONIAZID PROPHYLAXIS PROGRAMME IN THE 
ROYAL NETHERLANDS ARMY: 1984 -1995. 
Introduction 
To effectively control tuberculosis the following aspects have to be addressed: 
- Preve11liOl1 of tuberculolls injection by: 
a) case-finding and treatment of sputum positive patients. Sputum examination 
and the chest X-ray are the important tools in this aspect. 
b) isolation of infectious tuberculous patients. Isolation in sanatoriums was a 
popular tool before the advent of effective chemotherapy. With modern 
chemotherapy, this practice is no longer necessary as long as persons are not 
infected with multiple dmg resistant tuberculosis. 
c) minimising the opportunities of infection from an unknown case of open 
tuberculosis through better ventilation and avoidance of overcrowding at 
home, at work, places of entertainment and public transport such as 
aeroplanes. There is increasingly more information documenting infections 
acquired in such circumstances especially in the aircraft envirollllents (l) 2). 
- Increasing host defences through: 
a) increasing the standard of living. This creates an environment not conducive 
to infectious diseases that might weaken host immunity. 
b) specific vaccination. BeG has been used extensively in many countries for 
tillS purpose.- Prevention of disease in infected persons: an important tool in 
identifying this group of persons is the tuberculin skin test. Persons 
classified as reacting positively to this test can be given iSOlllazid 
prophylaxis. 
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Figure 1. Interrupting the chain of tuberculosis transmission. 
These measures if appropriately applied will intemlpt the chain of transmission of 
tuberculous disease among persons. figure 1 (adapted from reference 3) illustrates the 
points at which the various intervention tools can be applied to interrupt the chain of 
tuberculosis transmission in man. This model is based on our understanding of the 
progression of tuberculosis from the time of infection. Prevention of disease in infected 
persons is by administering isonicotinic acid hydrazine (INH) commonly referred to as 
isoniazid. Isoniazid is an important bactericidal drug in the treatment of active 
tuberculosis. Its use as a prophylactic medicament in preventing tuberculosis followed 
the elaborate animal experiments of Ferebee and Palmer conducted in the 1950s (4). The 
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use of dnlg prophylaxis in preventing development of progressive tuberculous disease in 
cases of primary tuberculosis was subsequently demonstrated by Debre in 1956 (5). 
Since then isoniazid prophylaxis has found a place as an intergral component in 
tuberculosis control, albeit the conflicting medical opinions (6). The efficacy of 
isoniazid prophylaxis in preventing tuberculosis reactivation has been shown to range 
from 60 - 80 % (7). The rationale of isoniazid prophylaxis for persons without active 
disease was stated by Ferebee and Mount (8) as: ufor the recently infected, to prevent 
progression to clinical disease; for those with dormant infections, to prevent future 
activation of diseases. Among persons with subclinical tuberculosis infection 
mycobacteria are present in small numbers and can easily be reduced using isoniazid 
(6). The small number of bacteria in subclinically infected persons permits the use of 
monotherapy without being limited by concerns about development of isoniazid 
resistance. However as early as 1966, a case report on the development of dmg resistant 
tubercle bacilli in a person with inactive disease in an isoniazid prophylactic program 
was reported (9). Therefore the exclusion of active disease before iniation of isoniazid 
prophylaxis becomes of paramount importance. This is mainly done by taking a chest 
X-ray before initiation of therapy and if found abnormal, a sputum specimen is collected 
and both Ziehl-Nielsen staining and culture performed. 
Initiating isoniazid prophylaxis for infected persons has been mainly hampered by 
reports of its untoward effects, more especially hepatitis, sometimes fatal, in persons 
older than 35 years of age. The largest study to monitor the effects of isoniazid 
prophylaxis conducted by the US Public Health Service (USPHS) indicated that death 
rates in those older than 35 years and receiving isoniazid was 0.1 % (l0). Salpeter has re-
evaluated the USPHS study and concluded that many of the deaths that occurred would 
have been prevented if current guidelines, such as excluding patients with acute liver 
disease and detecting early signs of toxicity with routine laboratory monitoring had been 
practiced (II). Given its apparent effectiveness in preventing active clinical disease on 
one hand and the potential of fatal hepatitis on the other, many studies have been 
conducted to establish the cost-effectiveness of this intervention. The results of these 
studies have come to conflicting results (12-21). These studies of isoniazid intervention 
to control tuberculosis have not been conducted by the Royal Netherlands Army. 
Only few of the persons who are infected only develop clinically active tuberculosis. 
Progression from infection to active disease depends largely on cell-mediated 
immullocom-petence. It is estimated that progression from infection to disease is 
approximately 10 per cent over a lifetime for a newly infected inununocompetent child 
(22). However half of this 10 per cent lifetime risk occurs in the first 2 years following 
infection (23). Persons with a normal chest x-ray whose tuberculin reaction has been 
positive tor all unknown duration of time are generally believed to have a risk 0[0.08% 
51 
per year for progression to disease (20). A very potent factor influencing the shift from 
tuberculosis infection to disease is infection with the human immunodeficiency virus 
(HIV). The cumulative incidence of tuberculosis in persons infected with HIV and 
having concomitant tuberculosis is estimated at 2 per cent year, for a relative risk of 100 
to 500 times average (24,25). The incidence of active tuberculosis is also increased by 
as much as 5 per cent among persons with a chest X-ray consistent with old healed 
tuberculosis (26). Therefore certain factors clearly increase the risk of developing 
tuberculosis among the infected. 
The tuberculin skin test is the only tool for detecting subclinical infection with 1\1. 
tuberculosis. Infected persons show a "positive test" which is produced by a delayed 
hypersensitivity (DHS) reaction characterised by an induration which is read at 48 or 72 
hours after tuberculin administration. The interpretation ofthe test has very imp0l1ant 
implications especially in decisions to give isoniazid. In the United States, the Centers 
for Disease Control and Prevention (CDC) has re-defined a diagnostic criteria for a 
positive reaction aimed at maximising the predictive value of the tuberculin skin test 
(23). These guidelines have been prompted by an increase in the incidence of new cases 
of active tuberculosis especially among immunocompromised patients. Table I shows 
the CDC criteria of determining the need for preventive therapy for persons with 
positive tuberculin reactions by category. The size of the tuberculin induration that 
eventually influences choice of chemoprophylaxis not only varies with risk category, 
but also takes into account the age of patients. Although isoniazid preventive therapy is 
recommended for all ages in patients with risk factors, some are not keen on prescribing 
isoniazid for those older than 35 years due to fcars of isoniazid-induced hepatitis in this 
age group (14). Because of the current resurgence of tuberculosis, the A TS recommends 
that persons with previous BCG vaccination should be screened and treated as if they 
were never vaccinated (27). 
In spite of these recommendations, isoniazid prophylaxis therapy is still an issue that is 
marred by controversy and conflicting opinion. Some authors have stopped short of 
calling a total-ban on IPT accusing the practice as being dangerous and unrewarding 
(28). In a study of patients receiving chemoprophylaxis at a US Air Force Medical 
Center, Byrd and collaborators showed that routine clinical and liver function evaluation 
of patients should avoid serious liver damage (29). In their series of 1,000 patients. none 
of the persons died of hepatitis although 6.4% of the group 011 isoniazid had therapy 
discontinued due to abnormal liver functions. It might be argued that routine liver 
function monitoring might be impracticable in some IPT programmes due to financial 
and organizational constraints. However if an equilbrium in the controversial isoniazid 
prophylaxis equation is to be sought, there is a strong temptation to opt for an approach 
of frequent liver function monitoring to avoid a possible fatal outcome. Although the 
52 
Table 1. Risk groups/or which variolls-sized indurations 011 tuberculin skin testing are 
considered as a positive result. 
Induration of 5 ml11 or more 
• Persons with known or suspected HIV infection 
• Persons who have had close contact with someone with infectious 
tuberculosis 
• Persons with a chest radiography showing fibrotic lesions likely to 
represent healed tuberculosis 
• Intravenous drug abusers with unknown HIV status 
Induration of 10 nun or more 
• Persons with medical conditions or undergoing therapies known to 
substantially increase the risk of tuberculosis 
• Silicosis 
• Diabetes mellitus 
• Haematologic or reticuloendothelial disease 
• End-stage renal disease 
• Chronic malabsorption syndrome 
• Carcinoma of the oropharynx or upper gastrointestinal tract 
• Body weight 10% or more below ideal 
• Dialysis 
• History of intestinal bypass surgery 
• History of gastrectomy 
• Prolonged immunosuppressive therapy 
• Prolonged corticosteroid therapy 
• Foreign-born persons from areas where prevalence of tuberculosis is 
high (eg, Asia, Africa, Latin America) 
• Medically underserved, low-income populations, including high-
risk minorities (blacks, Hispanics, native Americans) 
• Persons who are alcoholic, homeless, or intravenous drug abusers 
and are HIV -negative 
• Residents of long-term-carc facilities (eg, correctional institutions, 
nursing homes) 
• Hcalthcare workers 
Induration of 15 mill or more 
• Persons with no risk factors (ie, all others) 
Adapted from reference (31) 
Although the American Thoracic Society guidelines of 1983 reconunended obtaining 
baseline and periodic liver function tests for persons older than 35 years and 
discontinuing treatment if aminotransferase levels exceeded three to five times normal 
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(30), these recommenda-tions were not extended to younger age-groups as the risk of 
isoniazid-induced hepatotoxicity was less in these younger age-groups (26). 
Isoniazid prophylactic therapy (IPT) for treating tuberculous infection has been 
extensively used in the Dutch army since the inception of the programe in 1960. The 
army policy has been to administer isoniazid to all personnel who reacted with a 
positive Mantoux induration to tuberculin. This study describes the army isoniazid 
chemoprophylaxis in the period 1984 - 1995. The characteristics of persons enrolling 
into the IPT programme are presented including the frequency of side-effects that were 
possibly isoniazid-associated. The usefulness of isoniazid prophylaxis within the Dutch 
army and regular assessment of liver functions are discussed. 
Materials and Methods 
The Dutch army tuberculosis screening programme in the period 1984 -1995 conducted 
tuberculin skin tests on all persons recmited into the army as part of a routine medical 
evaluation aimed at identifying candidates for isoniazid prophylaxis. Besides the routine 
skin testing of army recmits, tuberculin skin testing of army personnel was carried out 
in the event of contact with a known case of tuberculosis or when personnel returned 
from overseas deployement in areas designated as highly endemic for tuberculosis. 
Screening of servicemen for tuberculosis infection is perfomed by nurses of the 
Department of Military Health Care (DMGZ). A Mantoux skin test with 1 TU ofPPD 
RT 23 + Tween 80 is administered and the amount of induration determined after 72 
hours. Persons with a positive skin test were defined as having an induration diameter of 
at least 10 mm to I TV ofPPD. Since 1989, all persons reacting with an induration 
diameter of 10 - 15 mill to PPD undergo a second test with an 1\11 scrolulacel/Ill sensitin 
(32). This means that persons reacting with an induration in this range are considered as 
infected with tuberculosis when the indurations to PPD surpass those by M. 
scrofulaceum sensitin by at least 3 mm. 
All persons with a positive skin test are then referred to the Chest Clinic of the Central 
Military Hospital (CMH), Utrecht, where a chest X-ray is performed to exclude the 
presence of active tuberculosis. In addition a detailed history to establish if persons 
have risk factors for tuberculosis activation is conducted. Chest physicians at the CMH 
make the decision of placing tuberculin positive persons on isoniazid prophylaxis. 
Isoniazid is administered as an adult dose of 300 mg daily for a period of 6 months. The 
6 months regimen has been preferred over the more beneficial 12-months isoniazid 
regimen because it gives better compliance (33). Vitamin B, or pyridoxine (10 mg/day) 
is also prescribed along with the isoniazid. Pyridoxine has been shown to prevent 
occurrence of peripheral neuropathy which might happen among persons taking 
isoniazid (26). Persons placed on isoniazid are informed of the possibility of untoward 
54 
side-effects that might develop while on the drug. In the event of such a side-effect 
happening, they are advised to report inmlediately to their doctor. The doctor asesses 
their condition and only refers them to the Chest Clinic if his findings suggest that the 
untoward symptoms could be associated with isoniazid therapy. 
Before initiation of isoniazid chemoprophylaxis, baseline liver function tests are 
performed at the CMH laboratories. The lcvels of ASAT (normal range 10-34 lUll), 
ALAT (normal range 6-37 IU/I) arc measured in addition to total bilirubin (normal 
range 1-17 rmoUI). Subsequent follow-up after initiation of isoniazid is done through 
the Chest Clinic of the CMH. After the initial visit, patients are seen after six weeks 
during which period liver function tests are performed. Thereafter persons are seen 
every two months at the CMH where the chest physicians question patients on any 
unusual symptoms that might be attributed to the medicaments being used. During these 
visits, the pretreatment liver function tests are repeated. In between visits to the Chest 
Clinic, persons can also consult their doctor in case of problems with isoniazid. In the 
event of such cases, the patient is referrred to the Chest Clinic and a decision to continue 
or discontinue with the drug is made by the chest physician. Persons with complaints 
attributed to isoniazid but in whom the chest physicians find no reason to discontinue 
the drug are then seen at more frequent intervals. If there is evidence of liver damage 
during follow-up persons undergo additional tests which include serology for hepatitis 
B (HbsAg and anti Hbc) and heterophile antibodies for Epstein-Barr infections. 
Records all all persons on isoniazid and the progress of their treatment are submitted to 
the Depaltment ofMilitaty Health Care (DMGZ) for entry into a data-base specifically 
kept for monitoring the tuberculin screening programme of the anny. This information 
provides the following: 
I. Patients demographic characteristics - name, military registration number, sex, age. 
2. Risk f..1ctors for tuberculosis - these are classified as; 
I) contact with an infectious case of tuberculosis. 
b) recent conversion of Mantoux - defined as a 10 nun increase within two years. 
c) fibrotic lesions on chest X-ray 
d) foreign-born 
e) positive mantoux of unknown duration (low-risk tuberculin reactors) - these are 
reactors in whom time of infection is not known and lacking any established 
risk factor for tuberculosis activation. 
3. History of travel to areas designated as having a serious tuberculosis problem. 
4. BCG vaccination status. 
5. Date of start of treatment. 
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6. Presence, nature and severity of sideeffects - the severity of sideeffects is defined as 
severe when such untoward symptomatology or signs lead to discontinue treatment. 
In addition when these sideeffects appeared is also noted. 
A study number was given to each person on isoniazid prophylaxis, by arranging all the 
military registration numbers in ascending order which meant that the person with the 
earliest birthday was given study number 1 and the one with the latest birthday was 
given the last study number. 
Statistical Analysis 
All data were entered in a computerised database and analysed using statistical software in 
public domain (Epi info Version 5, CDC, Atlanta). Students t test and Fisher's 2-tailed exact 
test were used for univariate analysis oftlIe significance of association. The Mantel-Haenszel 
test was lIsed for stratified analysis. 
Results 
Between January 1984 to December 1995, a total of739 persons were enrolled into the 
army isoniazid prophylaxis programme, being followed up until completion of 
treatment or until therapy was discontinued. The mean age of the population was 22 
years (range 18 to 54 years) with only II (1.5%) persons being above the age of35. 
Most of the group (98.8%) was male. Evidence ofBCG vaccination through a positive 
history of childhood immunisation or presence of a characteristic scar was obtained only 
in three male patients. In these three cases, the Mantoux induration diameter was 
> 15mm. One of the persons was foreign-born and the other two persons did not have 
any history or evidence of factors associated with tuberculosis activation. 
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Figure 2. Number of persons 011 isoniazid prophylaxis, 1984 - 1995. 
The trend in the number of persons placed on isoniazid chemoprophylactic therapy from 
1984 to 1995 is shown in figure 2. In 1984, 20 persons were placed on isoniazid chemo-
therapy and this number did not fluctuate considerably till 1987, when the number more 
than doubled to 55 persons. This represents an increase of 175% over the 1984 figure. 
This increase continued to show a moderate rise in the subsequent years peaking to 108 
persons on isoniazid in 1993. After 1993, the number of persons on isoniazid took on a 
downward trend, with only 42 persons placed on chemoprophylaxis during 1995. 
Tuberculin Test Results 
The fvfantoux skin induration (mm) was recorded in 729 out of739 persons. Ten 
persons were recorded "positive". The mean Mantoux induration in the 729 persons 
was 16.7 111m (95% CI; 16.4-17.0). There were 239 (32.8%) persons (out of 729) with 
induration diameter <15mm. The mean induration diameters in the different age groups 
are shown in table 2. These means arc not statistically different. Two persons with an 
induration diameter of 8 mm and 9 nml respectively were placed on isoniazid chemo-
prophylaxis. These two persons had risk factors for activation of tuberculosis. In one, 
there was a history of contact with an infectious case oftuherculosis and the other with 
an induration diameter of 8 mm showed a Mantollx conversion in 6 months. 
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Table 2. lvleml Mailloux indurations and age 
Age group No. of persons Mean 95% CI for mean 
Induration 
(mm) 
#19 158 16.3 15.7-16.8 
20-24 468 17.1 16.6-17.5 
25-29 79 15.8 14.8-16.7 
30-34 II 18.6 14.7-22.4 
:0-35 13 14.5 12.1-17.0 
Total 729' 16.7 16.4-17.1 
* Excluding 10 persons whose Mantoux result was only indicated as "positive". 
Risk-factors of Tuberculosis Activation 
Most of the persons receiving isoniazid chemoprophylaxis in the period 1984-1995 had 
no recognizable risk factor for tuberculosis activation. These low-risk tuberculin 
reactors (Mantoux of unknown duration) formed 72.7% of the population on isoniazid. 
Among the remaining 202 persons in whom a risk factor was identified, most (47%) 
were classified as recent tuberculin converters. Persons with a positive Mantoux and 
having been in contact with an infectious hlberculous case accounted for 25.2% while 
15.8% were foreign-born. Fibrotic lesions on chest x-ray were seen in only 24 persons, 
representing 11.9% of persons in the group with a known risk factor. Table 3 shows the 
mean Mantoux indurations classified according to risk factors. The mean indurations 
were only significantly lower in persons with recent Mantoux conversion when 
compared to those who were foreign-born (p~O.044). 
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Table 3. Alecm 1\lantoux indurations in d(ffol'e11/ risk groups/or TB activation. 
Risk factor for TB activation Mean Mantollx No. of 95%CI 
induration (mm) persons 
Unknown I6.9 529 I6.5-I7.2 
Foreign~born I8.I 32 16.4-19.7 
Fibrotic lesion on chest x~ray 17.0 24 15.1-19.0 
Contact with infectiolls TB 16.6 49 15.2-17.9 
Recent Mantoux cOllversion 15.6 95 14.7-16.5 
*Excludes the 10 persons whose Mantoux result were only indicated as "positive". 
Between 1984-1986, out of the 80 persons placed on isoniazid chemoprophylaxis, 
63.8% had an identifiable risk factor for tuberculosis activation. From 1987-1995, there 
was a reversal in the relationship between those on isoniazid with a known risk factor 
and the low-risk tuberculin converter. In that period, persons with a known risk factor 
accounted for 22.9% of those placed on isoniazid. This is a significant difference when 
compared to the period 1984 -1986 (p < 0.005). 
Figure 3. shows the number of persons on isoniazid according to presence or absence of 
a known risk factor tor tuberculosis activation. It is shown that the absolute numbers of 
persons with a known risk £:1ctor who were placed on isoninzid did 110t show great 
fluctuations over the years. In contrast among the low risk tuberculin converters, a steep 
rise was registered in 1986 peaking in 1993. Low risk tuberculin converters accounted 
tor much of the increase in the number of persons on isoniazid chemoprophylaxis from 
1986 to 1995. TillS increase was remarkable in those with a Mantoux induration greater 
than 15 nun (figure 3). Overall, a total of 490 (66%) persons with an induration 
diameter 2':15 111m were placed on isoniazid during the entire study period. 
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The general trend in isoniazid prescription over the entire period 1984 M 1986 in 
relationship to the presence of the different risk factors for tuberculosis activation are 
shown in figure 4. The figure shows a steep rise in the number of low risk tuberculin 
reactors - those prescribed isoniazid over the years - with the peak in 1993. 
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Figure 4. Riskfactors for enrol/llle1ll into the isoniazid programme, 1984-1995. 
Side-effects in study group 
Table 4 shows the frequency of adverse reactions reported during 1984-1995. In this 
period 79 (10.6%) out of739 persons on IPT had adverse effects suspected to result 
from isoniazid chemoprophylaxis. The most frequently encountered adverse reaction 
was an abnormal liver function test (elevated AST or AL T) which was recorded in 40 
persons. If liver injury is defined by the international standard of an increase in AST of 
> two times the upper limit of normal (ULN) (34), then of these persons only 10 (25%) 
developed AST levels of> 2 times ULN. Only one person had an AST level greater 
than 5x ULN. Among the 10 persons with liver damage, 6 (60%) were low risk 
tuberculin converters (three with a Mantoux < 15 nml and two with a Mantoux of ~ 15 
mm) and the rest had a known risk factor for tuberculosis activation. Mantoux 
indurations of < 15 mm were recorded in four of these persons and the other six had 
induration diameters of~ 15 HUll. Two persons had elevated transminase levels that 
were explained by other factors that were more likely to have caused the liver injury 
than isoniazid. One of these patients had an infection with Epstein-Ban virus (Pfeiffer 
disease) at the time of liver function test elevations (AST > 3.6 X ULN) while the other 
was 011 pamcetamol (self-prescribed following a festive evening) to which he had 
reacted with cutaneous symptoms. In the latter transaminase levels were the highest 
recorded in this study (14 X ULN). In both cases isoniazid prophylaxis was 
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discontinued. Remarkable in all these cases of elevation in the liver function tests was 
the absence of clinical hepatitis. 
Six persons were found to have mild transaminase elevations before initiation of 
isoniazid therapy. One of these persons had an increase in the transaminase levels 
during treatment, although the AST remained less than two times ULN. Three persons 
in this group developed sideeffects that were isoniazid-associated. Treatment was not 
discontinued in any of the six persons. It is remarkable that four persons with initial 
elevated transaminase levels developed sideeffects to isoniazid. However given the 
small numbers no conclusions can be drawn from tIus observation. 
In the one person who developed neurological symptoms these were characterised by a 
tingling sensation in the face with a feeling of numbness in the left half of his body. I-Ie 
noticed these symptoms four days after commencement ofINH therapy. The symptoms 
got worse with continued INH use, forcing discontinuation after one week of treatment. 
Seventy-seven per cent of the adverse effects were registered within the first three 
months of isoniazid therapy. Isoniazid adverse reactions were deemed serious and 
leading to discontinuation of therapy in 19 persons. This represented 24% of all those 
persons who developed adverse reactions attributed to isoniazid therapy. Reasons for 
discontinuing isoniazid chemoprophylaxis are shown ill table 5. Nine persons with 
elevated transaminase levels had treatment discontinued with all but one being 
asymptomatic. One person with elevated liver function tests also reported fatigue. 
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Table 4. Frequency of suspected INH-related side effects 
Adverse Reaction No. 
Abnormal LFTs 40 
Fatigue 31 
Dizziness 10 
orT symptoms 9 
Loss of concentration 3 
Headache 3 
Depression 
Neurological 
To association between the risk, diameter of induration or age and the development of 
isoniazid-related side effects were assessed using univariate analyses. Among the 537 
persons in whom the risk of tuberculous activation was unknown, sideeffects were 
reported by 56. Tlus compares with 23 persons out of a total 0[202 in the group with 
known risk factors for tuberculous activation. The differences between these two groups 
arc not significant (OR~ 0.91; 95% CI~ 0.53 - 1.57). 
Fifty persons with an induration of at least 15 mIll developed side effects compared to 
27 with an induration diameter ofless than 15 nun (these differences are not significant 
OR~1.l2; 95%CI~ 0.66 - 1.89). Similarly age (older than 35 years or 35 years and 
younger) was not associated with occurrence of side effects, although these data are not 
conclusive given that only 13 people were at least 35 years. However side effects were 
reported by 76 persons out of a total of 726 persons younger than 35 years, while 3 out 
of the 13 persons who were at least 35 years of age reported side effects (OR~0.39; 
95%CI~ 0.10 - 2.26). 
In the 56 persons developing isoniazid-associated side effects but in whom the risk of 
tuberculous activation is unknown, 38 (67.9%) had an induration of at least 15 mm and 
17 (30.4%) had an induration of less than 15 nun. In one person, the Mantoux result was 
recorded as "positive". 
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Table 5. Adverse reactions among persons ill whom IPT was discontinued 
Age 
Sex GIT Neuro- Rash Fatigue Dizziness Loss of Head- ALAT AST Onset' 
logical Concentra- ache 
tion 
46 M 2 
yes 
35 M 92 39 5 
27 M 
yes Yes yes 
26 M 
yes 
24 M 140 103 3 
25 M 265 97 2 
yes 
22 M 2 
yes 
22 M 253 160 3 
24 M yes yes yes yes 2 
23 M 172 50 4 
24 M 214 107 2 
21 M yes 3 
23 M 236 93 2 
23 M yes 
22 M 234 81 
23 M 224 185 2 
21 F yes yes 
19 M 2 
yes 
20 M yes 
* months of therapy before onset of symptoms 
Other Findings 
One person was found with an elevated bilirubin level (25.3 411101/1 Total) before 
iniation of isoniazid therapy. Isoniazid was administered and a rise in total bilirubin to 
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32.3 ljlUolfl happened during month 5 of treatment. The levels went back to near 
pretreatment bilirubin at end of treatment. Tlils person did not develop any rise in 
transaminase levels. 
Discussion 
The adequate control of tuberculosis involves treatment of active disease and provision 
of isoniazid prophylaxis to the pool of infected persons. Over a 12-year period, 739 
persons infected with tuberculosis, mostly young males with a mean age of22 years, 
were enrolled into the army iSOlilazid prophylaxis programme. This shIdy found that 
isoniazid-associated adverse effects were present in 10.6% of the study population. In a 
univariate analysis, the development of iSOlilazid-related side effects were not related to 
risk factors for activation of hlberculosis. There was also no association between the 
indurations and development of side effects when a cut-off point of 15 nun was 
considered. Therefore these two factors (presence of risk fhctors or size of induration) 
could not be used to predict the risk of side effects. 
Isoniazid has been associated with a number of sideeffects, most of wlilch are mild. 
Byrd et af. described II different symptoms occurring among 120 subjects at a United 
States Airfarce Medical facility who were placed on isoniazid prophylactic therapy (35). 
However these symptoms did not occur at a significantly increased frequency among 
isoniazid recepients when compared to subjects taking placebo. In the current study 
persons presented with eight adverse effects which were attributed to isoniazid intake 
(see table 4). Of all adverse effects associated with isoniazid intake, liver damage is the 
most feared. In a few persons on isolilazid, toxic hepatitis may result in a fatal outcome 
(36). Experimental evidence in the early 1950s had shown that lethal doses of isoniazid 
resulted in liver damage (37). It was Randolph and Joseph who in 1953 reported the first 
case of possible isoniazid-associated hepatitis in clinical practice (38). However their 
patient had also reacted adversely to p-aminosalicylic acid and was also receiving 
streptomycin. A liver biopsy of the patient showed a moderate degree of cirrhosis which 
could not be explained by the short period of isoniazid intake. It was thus not possible to 
entirely attribute the liver abnormalities to isoniazid as other potentially hepatotoxic 
drugs were being given. More isolated case reports of hepatitis possibly resulting from 
isoniazid therapy continue to appear in the medical literature (39- 43). 
In spite of all these reports, it was not until 1969 when Scharer and Smith convincingly 
demonstrated the role of isoniazid as a hepatotoxic agent (44). In that study 90 persons 
were placed on isoniazid chemoprophylaxis and elevations in transaminase levels were 
seen in 12.2 percent with the majority being asymptomatic. In the CUlTent Shldy, 
elevated transaminase levels were seen in 5,4 per cent of the study group with evidence 
of hepatic damage according to international definition (34) being found in 1.4%. 
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Hepatic damage being defined as an increase in AST of greater than two times upper 
limit of normal. The majority ofthe transaminase level elevations were less than two 
times ULN. It is estimated that approximately 15 percent of persons on isoniazid have 
minor asymptomatic elevations in senun aspartate aminotransferase which normalise 
spontaneously even with continued treatment (45). In the United States Air Force study, 
Byrd et al (29) found a much higher percentage of22% who developed elevated trans-
aminase levels while on isoniazid prophylaxis. They give no independent data on 
number of persons with transaminase levels greater than two times ULN. The reasons 
for the wide discrepancy between the findings of Scharer and Smith (44), and Byrd et al 
(29) on the one hand and this study on the other hand is possibly related to the age of the 
patients. In the isoniazid prophylaxis study described by Scharer and Smith the mean 
age of the group was 29 years, while 72% of persons enrolled into the Byrd et al study 
were at least 30 years. The persons in the current study were generally much younger 
with 96.8% younger than 30 years of age and a mean age of22 years. Isoniazid 
hepatotoxicity has been shown to occur with increased incidence with increasing age 
(35). The current study could not conclusively evaluate if those aged <': 35 years were at 
increased risk of developing hepatitis due to the small nUIll.bers. However the data 
seemed to show no particular risk for those aged :::::35 years in comparison to those less 
than 35 years (OR~0.39; 95% CI~O.IO - 2.26). In the USPHS study the risk for hepatitis 
was approximately three times greater among patients aged::::: 35 years than among those 
aged < 35 years (l0). These findings led to recommendations that limited the use of 
isoniazid to reactors at high-risk of developing active tuberculosis and those under 35 
years of age and recommended monthly monitoring for adverse effects (46). 
The Dutch army isoniazid prophylaxis program prescribes isoniazid for persons found 
to have a positive Mantoux induration defined as::::: 10 mm. Most of these persons are 
seen at conscription into the army with the result that isoniazid will be prescribed to 
mainly young male adults. However the last years have seen an increasing role of the 
army in peacekeeping and disaster relief operations overseas. These overseas deploy-
ments have led the army to pursue a policy of tuberculin testing servicemen upon return 
from deployments especially in areas of high tuberculosis endemicity. This might 
explain the increase in the number of persons on isoniazid which began showing a rise 
in 1987 as more persons were being tuberculin tested. However this is unlikely to be the 
entire reason. Another explanation for the increase might be related to the general trend 
of tuberculosis infection in the Netherlands. This trend which had been showing a 
decline witnessed a reversal after 1987 (47). Factors that have been attributed for this 
increase after 1987 have included an increase in the number of persons immigrating 
from high endemic countries. However in this present study, the number of foreign-born 
persons on isoniazid prophylaxis accounted for only 4.3% of the study popUlation. It 
should be noted that before 1987 more emphasis was placed on the side effects of 
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isoniazid as had appeared in the literature (10) and hence a more selective approach 
based on giving isoniazid to persons with a known risk factor. However with the 
increase in tuberculosis cases being notified in the Netherlands after 1987, emphasis in 
the army tuberculosis programme focused on the need to prevent tuberculosis re-
surgence, hence a rise in the number of persons with low-risk for tuberculosis activation 
being enrolled for isoniazid. The majority of persons (71.6%) on isoniazid in this study 
were young males, < 35 years, with a positive Mantoux and without a known risk for 
tuberculosis activation. If the practices of isoniazid prescription in the army are 
therefore compared to guidelines from CDC (table I) with age and risk-factor being 
taken into account, then isoniazid therapy would be indicated in 70 % of those with no 
known risk factors for tuberculosis activation. The remaining 30 % would not be given 
isoniazid prophylaxis because of concerns for hepatitis. Among persons with evidence 
of liver damage while 011 isoniazid, 33% were persons with no known risk factor for 
tuberculosis activation and an induration diameter of less than 15 mrn. If the CDC 
guidelines were to be followed, hepatic damage would be avoided in these three 
persons. However the hepatic damage was 110t deemed of a serious nature to lead to 
discontinuation of therapy in two out of the three persons in this group. In the entire 
group of persons developing isoniazid-associated adverse effects, treatment was 
discontinued in 2.6% of all persons who wcre started on isoniazid. Much attcntion has 
been given to the hepatic-related adverse effects of isoniazid since these are the ones 
likely to result in a fatal outcome, however other intolerances do occur. In this study 
among persons in whom isoniazid was discontinued just over one-half were due to 
reasons related to hepatic damage occurring either alone (asymptomatic) or in 
combination with other symptoms. Stead et a1. reported that other types of isoniazid 
intolerance such as nausea without any significant change in liver functions, anxiety, 
headache, somnolence, fever, and skin rashes occurred often than hepatitis (14). 
It is generally recommended that patients on isoniazid should be advised to stop 
treatment at the onset of symptoms that are suggestive of incipient hepatitis, such as 
nausea, loss of appetite, and dull mid-abdominal pain (45). In this study among those 
persons in whom treatment was discontinued eight out of the nine patients with an 
elevated transaminase level had the isoniazid stopped on basis of a rise in the hepatic 
enzyme levels alone. This supports evidence from other studies which showed that 
symptoms alone are not a sensitive method to detect liver function abnormalities (29). 
\Vhereas the threshold to initiate isoniazid prophylaxis was low in the army programme, 
therapy was discontinued at much lower levels oftransaminasc elevation in comparison 
to other studies. In a recent Danish study on liver injury during anti-tuberculosis 
treatment, Dossing et al did not discontinue treatment even at transaminase elevations of 
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four times ULN (48). Byrd et al (29) used a transaminase elevation of five times normal 
as a cutoff level to discontinue isoniazid therapy. 
The highest transaminase level associated with isoniazid therapy in tills study was 5.4 
times ULN. Much higher transaminase levels associated with isoniazid therapy have 
been recorded. In the series reported by Dossing et al (48), three cases had an AST level 
exceeding 20 times ULN. However these patients were taking also other antituberculous 
dmgs. Remarkable in this study is the very high transaminase levels of 14 times ULN in 
a patient who reacted to paracetamol winle on isoniazid therapy. The part played by 
concomittant medications in persons taking isoniazid prophylaxis needs fmther 
investigation. It is known for instance that in 29 percents of isoniazid recipients, 
combined isoniazid and rifampicin therapy predisposes to elevated plasma hepatic 
enzymes (35). Phenytoin is hepatotoxic and its toxic effects are potentiated by isoniazid 
(35). Paracetamol is also known to cause liver damage when taken in higher doses, and 
doses higher than 6 grams can lead to irreversible liver damage (49). However the 
patient who reacted to paracetamol in this study was not taking high doses of tlllS drug. 
It is possible that paracetamoi and isoniazid potentiated each other resulting in more 
extensive liver damage as witnessed by a very high transaminase level. A history of 
medicaments is thus important before initiating isoniazid therapy. It is recommended 
from this case that caution with isoniazid be exercised if persons are already taking 
medicaments that by themselves are known to have a hepatotoxic effect. Similarly 
persons with elevated hepatic enzyme levels should be investigated for other possible 
causes of liver injury, such as viral infections. In this study, one of the patients with 
hepatic enzyme elevations had Pfeiffer disease. Epstein~Barr virus can probably cause 
hepatic damage and in the case of this patient, isoniazid could not be entirely 
responsible for the transaminase elevations that were registered. 
Merritt et al. reported in 1959 the first possible isoniazid-associated fatality in a 38 year 
old female who developed massive bleeding from oesophageal varices complicating 
liver destruction following isoniazid administration (40). No patients in the current 
study population died of hepatitis or an isoniazid-related adverse effect. This might be 
attributed to the close clinical and hepatic enzyme monitoring programme for all those 
on isoniazid. The risk of £1tal hepatotoxicity is reduced when patients on isoniazid are 
regularly monitored (11). \Vhile reviewing the risk of fatal hepatitis among recipients of 
isoniazid who had been monitored routinely, Salpeter found that the rate of fatal 
hepatoxicity was equivalent to the rate in the general population of death from acute 
hepatitis and acute liver necrosis from any other cause, that is, 0.001 % (11). The 
unusually high fatal hepatotoxicity rate (0.1% in those 35 years plus) observed in the 
USPHS study was perhaps due to other reasons. Seven of the eight deaths in that study 
happened in one state where the fatality rate for cirrhosis that year was significantly 
higher than in the rest of the United States (11). However fatalities due to isoniazid 
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continue to be reported. Moulding reported 20 isoniazid~induced hepatitis deaths in 
California (50). In 1993, a report from New York described 10 cases of severe hepatitis 
attributed to isoniazid of which 4 resulted in death (51). 
Three persons in this study had a history of past BCG vaccination. To assess these 
persons for isoniazid prophylaxis, risk factors other than a positive induration diameter 
were taken into account. This avoided indiscriminate isoniazid prophylaxis to all 
persons who had a post vaccination BCG-induced tuberculin reactivity. Persons with a 
history of BCG vaccination are known to react to tuberculin with indurations ranging 
from zero to an induration of 19 mm (52). Hence the presence of a positive tuberculin 
reaction is not a factor to determine whether persons are infected with M tuberculosis. 
The United States AdvisOlY Council for the Elimination of Tuberculosis statement 
recolllmends that a diagnosis of tuberculosis and the use of isoniazid prophylaxis should 
be considered if the tuberculin reaction in BCG vaccinated persons is ~ 10 nun in the 
presence of the following circuIllstances: 
a) the vaccinated person is in contact with an infectious case, particularly if the case 
has transmitted tuberculosis to others 
b) birth in a country with a high tuberculosis prevalence 
c) exposure of vaccinated persons to populations with a high tuberculosis prevalence, 
such as, volunteers at homeless shelters (52). 
It is noteworthy that in two persons with a Mantoux induration less than the cut-off 
point of 10 111m (defining the lower induration limit for infection in the army 
programme) were given isoniazid. Consideration in these two cases took into account 
the presence of other risk factors that were likely to support the view that these persons 
were infected illspite of an induration diameter less than 10 mm. 
Out of the 6 persons with an initial elevated transaminase level. 67% developed side 
effects while on isoniazid therapy. Although treatment was not discontinued in any of 
these persons, they should be closely and more frequently followed. 
Much controversy regarding the use of isoniazid has mainly centered on low-risk, young 
adult tuberculin reactors (46) - a group that formed 71.6% of the study popUlation in the 
current series. The results of this study show that there is no difference in the frequency 
of side effects between young adult low-risk tuberculin reactors and those in the same 
group with a known risk factor for tuberculosis activation. This suggests that when 
assessing the suitability of isoniazid prophylaxis in the young adult with a low-risk for 
tuberculosis activation, it should be borne in mind that they arc not at an unduly 
increased risk of developing side effects. 
In conclusion, clinical monitoring and hepatic enzyme monitoring even for younger 
persons on isoniazid prophylaxis will minimise the chances of severe hepatitis. Such 
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monitoring should at least take place during the first 3 months of therapy. This study 
shows that 77% of these adverse effects happened during this period. However side 
effects happened throughout the study period. Although the prevalence of isoniazid-
associated side effects in this study were much lower than in many other studies, 
guidelines should be devised to even minimise these further. The American Thoracic 
Society guidelines for selecting persons into the isoniazid programme could be adapted. 
Of course the other factor that needs addressing is the extent to which cross-reactions 
with nontuberculous mycobacteria contribute to the rate offalse Mantoux positives. 
This will be the subject of the next chapter which will be exploring a strategy of using 
isoniazid in a more rational manner. 
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CHAPTER 
4 
SKIN SENSITIVITY TO MYCOBACTERIA OTHER 
THAN MYCOBACTERIUM TUBERCULOSIS IN 
THE ROYAL NETHERLANDS ARMY 

SKIN SENSITIVITY TO MYCOBACTERIA OTHER THAN 
MYCOBACTERIUM TUBERCULOSIS IN THE ROYAL 
NETHERLANDS ARMY 
Introduction 
Mycobacteria not assigned to the 1\1ycobac/eriwn tuberculosis complex or 1\1. /eprae 
have been referred to variously as "atypical mycobacteria", "mycobacteria other than 
tubercle bacilli - MOTT', "envirorullcntal mycobacteria", "anonymous", "chromo-
genic", "achromogenic" and unOlHuherculous mycobacteria - NTM". In this text the 
term non-tuberculous mycobacteria (NTNI) will be used in referring to these organisms. 
In 1959 Runyon (1) suggested a classification of these bacteria into four groups: photo-
chromogens; scotocluomogens; nonchromogens and, rapid growets. This classification 
was based on culhual characteristics such as morphology, presence of pigment and rate 
of growth. Non-tuberculous mycobacteria are ubiquitous and have been isolated from a 
wide range of environmental sources. Falkinham et al.. in 1980 reported on isolates of 
NTMs that were recovered from 33% ofthe water samples collected from various 
acquatic environments (marine and fresh waters) in the southeastern United States (2). 
Tuffley and Holbeche in 1980 described the isolation of various NTM organisms from 
rainwater tanks used to conserve water in palis of Australia (3). Katila and colleagues 
(4) in Finland found evidence of NTMs in sur!;,ce waters. The high frequency ofNTMs 
in water sources has often accounted for small epidemics. In 1987 Stine and associates 
(5) reported on a pseudoepidemic of non-tuberculous mycobacteria which affected 22 
patients following infection from a contaminated hospital water supply. NTMs have 
been isolated from fish, dust and soils. Brooks and colleagues investigated the relation-
ship between soil characteristics and presence ofNTMs (6). However, Brook's study 
did not show any strong correlation between the different soil characteristics, such as, 
acidity, conductivity, moisture, and the frequency of NT Ms. Other sources of potential 
infection ofNTMs to man include domestic and wild animals and birds. 
\Vith the advent of the AIDS epidemic, infections with some of these mycobacteria, e.g. 
lHycobaclerium avium complex, are increasingly impOliant health problems. For 
instance, in the United States, in addition to Mycobacterium tuberculosis, the non-
tuberculous l\1ycobacteJ'ium avium complex (MAC) is a common cause of clinical 
disease due to mycobacteria mostly in AIDS patients (7). However, most non-
tuberculous mycobacteria are not or are facultatively pathogenic in immunocompetent 
hosts. NTMs can produce pulmonary and cutaneous disease, lymphadenitis and 
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disseminated infection (8, 9, 10). When pathology occurs, there is a wide range of 
diseases. Disseminated disease has been described in both immunocompetent and 
inullunodeficient persons (11, 12). NOllR{uberculous mycobacterial lymphadenitis is one 
of the well recognized clinical entities especially in paediatric practice. \Vright provided 
an extensive review il11996 of non-tuberculous mycobacterial lymphadenitis in New 
South Wales province of Australia covering a period of over 30 years (13). Joshi et al .. 
in 1989 reported on eighty-six children with NTM lymphadenitis in Victoria province of 
Australia (14). In 1995 Wolinsky reported on the results of a prospective study 
spanning 32 years in which NTM lymphadenitis among children seen in Ohio state} 
United States, was described (15). 
In the Netherlands, the role of non-tuberculous mycobacteria as pathogens in human 
disease was first recognized as early as 1935 by Dinger and Ruys (16). In 1943, Bekker 
reported to have isolated from the urine of a patient sufferring from renal tuberculosis an 
acid-fast strain which was apparently differrent from the then known acid-fast bacteria 
(16). In 1967 Van Joost and associates (16) conducted an investigation aimed at 
establishing the occurrence of infections with non-tuberculous mycobacteria disease in 
the Dutch population. In that study it was found that J\1. kal1sasii accounted for more 
than 60 percent of the cases with pulmonary lesions resembling tuberculosis. Cervical 
lymphadenitis was found to be caused by both 111. scrofidaceuIII and 111. battey 
organisms. The nature of the non-tuberculous mycobacteria isolated in relation to the 
lesions they evidently or probably caused is shown in table I. 
In tuberculosis control, the Ubiquitousness ofNTMs is of fundamental significance. For 
example, some workers have suggested that immunologically effective contact with 
NTM has a profound influence on the wayan individual responds to infection by AI. 
tuberculosis or other pathogenic mycobacterial species (16,17). In 1981, Stanford and 
associates postulated that a positive tuberculin test is a result of two mechanisms of cell 
mediated response to mycobacteria (18). These mechanisms were referred to as the 
Listeria-type and the Koch-type responses. It was postulated that depending on the 
species ofNTM, contact with these bacteria would either result in a Listeria-type 
reaction (which enhanced the protective effect ofBCG) or a Koch-type reaction which 
makes BeG ineffechtal. NTMs are also capable of affecting the interpretation of the 
tuberculin skin test (Mantoux) by causing nonspecific tuberculin sensitivity. The most 
classical study that investigated the prevalence of nonspecific hlberculin sensitivity is 
that which was reported in 1955 by Edwards and Palmer (19). The tuberculin skin test 
(Mantoux) is the only means available to identify persons with subclinical M 
tuberculosis infection. A positive reaction is considered indicative of previolls infection 
withM tuberculosis. However, if the size of reactions to PPD in the general population 
are plotted against the frequency, it is found that a large number of persons have small 
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reactions, a relatively small number have intemediatc reactions and then the rest having 
larger reactions. The conclusion from these observations is that there are two sorts of 
reactions to tuberculin - specific (rcflecting previous hlberculosis infection) and 
nonspecific (which are manifested by a smaller response to hlberculin). Nonspecific 
reactions have been attributed to infections with non-tuberculous mycobacteria. Each 
mycobacterial species has a mosaic of protein antigens. Some of these antigens are 
specific for a given species, but many others are shared by atl mycobacteria. The PPD 
uscd in the Mantoux test is a mixture of different mycobacterial antigens which partially 
cross-react to species of non-hlberculous mycobacteria which are common sensitisers of 
the human population (20). Such cross-reactions to PPD among persons infected with 
non-tuberculous mycobacteria hinder the interpretation of a Mantoux test. The extent to 
which NTfvfs are distributed in a given geographical region on the one hand, and the 
extent of the tuberculois problem all the other, will ultimately affect the usefulness of 
the tuberculin test in epidemiological or clinical investigations. 
During a routine skin testing procedure in the 1980s fotlowing military exercises in 
\Vest Germany, it was found that a suspiciously large number of Dutch troops had a 
positive :Mantoux in the range 10 - 15 mm (unpublished report). There was 110 history of 
these persons being in contact with a known tuberculosis source. It was therefore 
unlikely that these results represented a new hlberclilosis infection acquired while on 
deployment in \Vest Germany. Tlus led the Army tuberculosis progranune to look at the 
potential role that NTMs were playing in this group of persons. Indeed many were 
found to have large indurations to M. scrofulaceum sensitin in comparison to PPD RT 
23 reactions. It was concluded that these reactions had been caused by NTM infections. 
On the basis of these findings, it became pertinent to study the frequency ofNTM 
infections in the Army as tIus has important bearings on the interpretation of the 
J\1antollx skin test and the ultimate enrollement of persons into the iSOluazid prophylaxis 
programme. The results of a shIdy that investigated the frequency ofNTM sensitivity in 
the popUlation of Dutch army recruits are presented in this chapter. 
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Table 1. 122 strains of atypicallllycobacteria according to IInderlying disease (adapted 
frolll reference 16). 
Underlying M. Kansasli M. Sero- Other scoto- M. M. Rapid Total 
disease fulaceum chromogens battey avlum Growers 
Pulmonary process 42 2 9 3 
resembling 
tuberculosis 
Silicotuberculosis 11 
Pulmonary and 
arthritic lesion 
Pulmonary and 
genitourinary lesion 
Pleural exudate 
Lymphadenitis 13 10 
Not mentioned 12 
Total 67 14 2 19 3 
Materials and Methods 
The study was conducted between January 1986 and December 1988. In the study 
37755 clinically healthy army recruits without previous BeG vaccination were enrolled. 
All were male recmits with a mean age of22 years. The study participants were drawn 
from all over the country. Each of the recruits was tested with two different intradermal 
injections given simultaneously one on each arm. 
Skin testing 
Injections and readings were done at the Department of Military Health Care (DMGZ), 
Utrecht, by a tuberculin testing team. The first skin test was made with 0.1 mi of PPD 
RT 23 + Tween 80 obtained from Statens Seruminstitut (SSI) in Copenhagen, Denmark. 
The second test was made with 0.1 ml of ).\1ycobacteriul1l sCl'ojillaceum sensitin + 
Tween 80 RS95 also obtained from Statens Seruminslitut (SSI), Delllllark. 
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The administration and reading of the PPD RT 23 and M scrofulaceum sensitin was in 
accordance with the World Health Organization (WHO) protocol for standard WHO 
tuberculin test. All tests were read 72 hours later and the diameter of the induration 
recorded in millimeters. 
In this report a skin test is defined as positive (subject infected with either Atl 
tuberculosis or non~tuberculous mycobacteria) if the induration to either antigens is 
more than 9 mm. Only the results of readings foHowing the administration of 1\1. 
scrofulaceum sensitin will be presented in tIus chapter. 
Results 
Out of the 37755 recmits tested, 31130 (82%) showed complete anergy to the M. 
scrofiilaceu11l sensitin. Induration diameters 10 mm and greater were recorded in 7.76% 
of the study group. However there was considerable fluctuation over the three year 
study period in the frequency of persons reacting with;;;:: 1 0 nUll it~duration. In 1986, tlus 
percentage was 6.9 and the foHowing year witnessed a moderate rise to 9.7%. During 
1988, the percentage had showed a moderate decline to 6.5% (table 2). 
Table 2. Induration diameters to M. scrofulaceum sensitin in period 1986~88 
Year Total no. of Induration ~ 6 mill Induration ~ 10 lUlU 
persons studied 
no. persons % no. persons % 
1986 13353 1556 11.65 925 6.93 
1987 12380 1870 15.11 1206 9.74 
1988 12222 1330 10.88 799 6.54 
Total 37755 4739 12.55 2930 7.76 
Geographical distribution 
The current address of the participants during the time of the study was recorded. 
Therefore it is possible that in some of the subjects this address did not correspond with 
birthplace or areas where participrults have spent a greater part of their lives. The 
frequency of persons with induration diameters> 5 mm were examined according to 
province of residence. The results are in table 3. 
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Table 3, Geographical distribution of sensitivity to M, scrofulaceum sel1sitil1 per 
province. 
Diameter of induration 
Province Total no. tested 
>5111111 >9 mill 
No. % No. % 
Friesland (mral) 1309 155 Il.8 97 7.4 
Groningen (rural) 1364 167 12.2 III 8.1 
Drenthe (rural) 945 105 Il.I 59 6.2 
Overijssel (rural) 2840 340 12.0 211 7.4 
Gelderland 4911 578 Il.8 351 7.2 
(rural) 
Flevoland (rural) 346 54 15.6 36 10.4 
Limburg (urban) 2870 317 Il.I 177 6.2 
Brabant (rural) 7274 834 Il.5 490 6.7 
Noord-Holland 4848 617 12.7 382 7.9 
(urban) 
Zuid-Holland 7643 1137 14.9 744 9.7 
(urban) 
Utrecht (urban) 2230 302 13.5 185 8.3 
Zeeland (rural) 1175 133 11.3 87 7.4 
37755 4739 12.6 2930 7.8 
Total 
\Vithin the Netherlands, provinces can be looked as either rural (mainly farming) and 
urban, or as coastal versus inland. The results did not show any geographical variations 
in frequency of indurations to kl scrofulaceul1l antigen, However, among indurations> 
9111111, the rural province ofFlevoland scored the highest (10.4%) with the lowest 
frequency of indurations being registered in persons from Limburg and Drenthe (6,2%). 
Details are presented in table 3. 
Discussion 
Infections with non-tuberculous mycobacteria sensitises persons to tuberculin 
(20,21,22). These cross-reactions are attributed to shared antigens among mycobacterial 
species. It was during studies conducted to investigate the nature, as well as variations 
in prevelance of the hlberculin sensitivity interpreted as cross-reactions among 
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apparently normal, healthy populations that evidence about the role of non-tuberculous 
mycobacteria in causing this phenomenon came to light (22). The usefulness of the 
tuberculin skin test is a trade-off between the prevalence of the infection with M 
tuberculosis and the relative prevalence of cross-reactions to non-tuberculous 
mycobacteria (21). The prevalence of non-tuberculous mycobacteria sensitivity in a 
given area will therefore determine the usefulness of the Mantoux test as an 
epidemiological or diagnostic tool. 
In this study recruits were tested with M scrofulaceum sensitin. This sensitin was 
chosen because it cross-reacts more broadly with all other non-tuberculous 
mycobacteria (23). In the current study it was found that the prevalence ofNTM 
sensitivity (7.8%) in a group of37755 army recruits seen in a period of three years was 
high. However tIlis percentage is less than that found by Bleiker among Dutch school 
children in Delft (24). In the Delft study, begun in 1966 and repeated every five years, 
the prevalence of non-tuberculous mycobacteria reactions> 9 nun were found to be 
12.9% in 1985. The Delft area is in the Zuid-Holland province and when the frequency 
of non-tuberculous mycobacteria sensitivity in only those recruits from Zuid-Holiand is 
considered, a higher frequency of9.7% is noted. This is second only to Flevoland 
province which at a prevalence of 10.4% represented the highest frequencyofNTM in 
this army study. 
There is a varying frequency of non-tuberculous mycobacteria sensitivity in different 
parts of the world. Different studies have employed varying types of mycobacterial 
sensitins to test for the frequency of non-tuberculous infections in populations. During 
the 1950s and 1960s, Edwards, Palmer and associates in the United States performed 
studies 011 the sensitivity of populations to non-tuberculous mycobacteria (19,25). These 
large USA studies were conducted among army recruits and it was found that a high 
percentage of 33% reacted to A1ycobacteriulll intracellulare (Battey) sensitin. It was 
remarkable that only 4% of these recmits reacted to tuberculin (PPD-S). In Sweden Lind 
et al .. (26) found a high degree of reactions to sensitin among school cllildren. A total of 
25% of these reacted with> 5 mm induration diameters to AI. avium sensitin, whilst 
32% reacted to A1. scrofulaceum sensitin. 
Dascalopoulos and associates studied non-tuberculous mycobacteria sensitivity in Greek 
army recruits. They found rates of over 8% in segments of their study population (27). 
Svandovrea et al.. lIsing a cutoff-point of> 5 mm to define sensitization, found high 
prevalences to AI. scrofulaceum sensitivity (over 20%) in some areas ofChechoslovakia 
(28). In 1995 K wamanga and colleagues in Nairobi, Kenya, tested school cllildren using 
.1.\1. scrofulace1ll11 sensitin (29). In that study, 22.7% of the school children reacted to the 
sensitin with diameters of at least 9 mm. Although these studies have used different 
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sensitins and different cutoff points (>5 mm or > 9 mm), the fact that the sensitivity of 
populations to non-tuberculous mycobacteria is often high remains unobscured. 
Van Joost and associates described in 1967 the distribution of infections with non-
tuberculous mycobacteria within the Netherlands (16). They found that disease due to 
1\1. avium were more common in the provinces of Limburg and in N0l1h Holland. The 
province South Holland had the highest incidence of disease due to Ai scrofulaceum as 
well as disease due to Ai battey. The high incidence of Ai. kansasii in the provinces of 
Limburg and North Holland it was speculated, was related to the prominence of these 
areas in the coal and steel industry. In this study no clear geographical patterns to M 
scrofulaceum sensitin sensitivity within the country were noted. However, it should be 
pointed out that some provinces contributed fewer persons to the study. This is the case 
with the provinces of Flevoland and Drenthe. On the other hand, some provinces were 
over-represented ego Brabant with over 7000 persons. Tllis uneveness in distribution of 
numbers is because during the study period more recruits came from the Brabant area 
and fewer were from Flevoland. Although this study attempted to classify the provinces 
according to the dominant form of commercial activity (industrial/mral), this classifica-
tion is rather unsatisfactory. The Netherlands is a small country that is heavily indus-
trialised and a strict distinction between the provinces based on tlus criteria does not 
entirely reflect the actual situation. Persons coming from relatively mral provinces 
might originate from what is rather urban setting. It would therefore be misleading view 
them as representatives of a rural agriculhlral population. 
Shldies elsewhere have demonstrated that the prevalence of non-tuberculous sensitivity 
varies geographically within the same country. Studies done in the United States during 
the 1950s and 1960s showed that non-tuberculous mycobacteria sensitivity showed a 
high frequency in the southeastern states (19,25). Recent studies have also supported the 
predominance of these non-tuberculous mycobacteria in the southeastern United States. 
Falkinham et al.. sampled various aquatic environments in the southeastern United 
States and found a correlation with the frequency of persons reacting to non-hlberculous 
mycobacteria sensitins demonstrated in earlier studies (2). Codias and Reinhardt in 1979 
studying cultures of 1vJycobacterium avillm-intracellulare-scrofulacewll (MAIS) 
isolated in residents of Georgia, United States, also found a cOlTelation with the shldies 
of Edwards and associates indicating that the largest reactors to non-tuberculous 
mycobacteria sensitins resided in coastal regions (30). Dascalopoulos et al.. in Greece 
found a higher frequency of non-hlberculous sensitivity among persons residing along 
seaside areas and those living near big rivers compared to those from mountainous 
regions (27). This Greek study supports the theory that living in the neighbourhood of 
large bodies of water are an imp0l1ant source of infection with non-hlberculous 
mycobacteria. Lind et a!.. (26) attempted in their study of school children to examine 
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reactions in relationship to presence of various pets. They found that the presence of 
birds, dogs and cats in homes was associated with an increased frequency of children 
reacting to the sensitins used. Many studies have demonstrated that pets (animals and 
birds) can be infected by non-tuberculous mycobacteria and could be an important 
reservoir of infection to human populations (31, 32, 33). For example inhalation of dust 
from the litter in bird cages is one way in which human hosts become infected (26). In 
this current Dutch army study the association between domestic pets and sensitivity to 
non-tuberculous mycobacteria was not investigated. Although the shldy examined the 
possible association between non-tuberculous mycobacteria and aquatic environments 
by classifying provinces as inland versus coastal, tIus approach too, for a country such 
as the Netherlands which is traversed by many water sources, does not allow for such a 
distinct classification. 
The frequency of non-hlberculous mycobacteria disease among certain populations has 
been shown to be increasing over the years. Isaac-Renton and associates were able to 
demonstrate that over a 10 year period in British Columbia, Canada, the absolute and 
relative numbers of non-tuberculous mycobacteria increased (34). Bleiker and associates 
(24) also found that non-tuberculous sensitivity among school children in Delft was 
showing an increase over time. In 1975 this prevalence was 9.5% increasing to 13.3% in 
1980. Thereafter this frequency remained relatively stable and by 1991 it was 14.4%. In 
the current army study, the observation period of three years was too short to allow an 
observation in the trend ofnon-hlberculous mycobacteria sensitivity. However over the 
three year period sensitivity to .1.\;1 scrojulaceum sensitin showed great fluctuations. A 
long term follow-up of.1.\;l scrojulaceum sensitivity in the army would have provided a 
clear insight into the trends of non-tuberculous mycobacteria infections in the Dutch 
population. The increase in the frequency of non-tuberculous mycobacteria over the 
years remains remains unclear. Johnston et al.. in 1965 suggested that most NTM came 
from the soil (35). Consequently, they argued, there would be no reason for a decline in 
the infection or reinfection rate with these mycobacteria in a specific geograpluc area, 
even when there was a dramatic reduction in new primary infections. 
This study have shown that non-hlberculous mycobacteria sensitivity may interfere with 
the interpretation of the Mantoux skin test. The :Mantoux skin test might be of limited 
value in regions such as the Netherlands with a high prevalence of non-tuberculous 
mycobacteria sensitivity and a low prevalence of tuberculin sensitivity. Separating 
reactions to the Mantoux test due to Ai tuberculosis infection from those due to non-
tuberculous mycobacteria is therefore of major clinical and epidemiological importance. 
Persons with positive rvrantolIx skin reaction are prescribed isoniazid chemoprophylaxis, 
wluch is not infrequently free of serious side-effects (see chapter three). Being able to 
identify persons who are achmlly infected with tuberculosis on the basis of skin tests 
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alone would greatly reduce the UlUlccessary prescription of isoniazid to those infected 
with non-tuberculous mycobacteria but who due to cross reactions, react with a positive 
skin test to the Mantoux test. The following chapter (chapet five) contributes to improve 
existing models to classify different indurations so that only persons infected with AI. 
tuberculosis are enrolled into the isoniazid prophylaxis programme. 
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INH-PROPHYLAXIS IN THE ROYAL 
NETHERLANDS ARMY 

CONSEQUENCE OF THE PREVALENCE OF NON-
SPECIFIC TUBERCULINE SENSITIVITY FOR INH-
PROPHYLAXIS IN THE ROYAL NETHERLANDS ARMY 
Introduction 
The WHO-standard Mantoux test with I TV PPD RT 23 + Tween 80 (1,2) forms part of 
the medical examination of all RNLA conscripts. The percentage of recruits that react 
with indurations of 10 nun and more to PPD RT 23 has gradually decreased from 19.2% 
in 1955 to 0.48% in 1991 (3). As chest x-ray examination on entering the Army in active 
service was abandoned in 1987, the tuberculin test became the only tool to check for 
infection withMycobacteriuln tuberculosis in anllY recruits. 
Persons who have not previously had BeG-vaccination but after Tuberculin tests 
develop indurations greater than 10 nun are considered to be infected with M 
tuberculosis. Such persons are given isoniazid (INH) chemoprophylaxis 300 mg/day for 
six months irrespective of contact or family history. 
As side effects to INH chemoprophylaxis are likely in some cases (4-6) the specificity of 
the induration is very important - especially the development of isoniazid-associated 
hepatitis. Kopanoifet al. estimated this condition to occur at a case rate of3 per 1,000 
persons in the age group 20 to 34 years and I per 1,000 persons in persons less than 20 
years of age (4). It is known that infections with nontuberculous mycobacteria (NTM) 
may cause tuberculin sensitivity through cross reactivity. In the Netherlands an increase 
in the percentage ofNTM infections has been shown (7) and the existence of clinical 
infections with Mycobacterium scro/utaceum documented (8-10). 
Recruits infected with NTM could show indurations (10 mm in standard tuberculin test 
and accordingly would be given, needlessly, INH chemoprophylaxis. To avoid this it is 
desirable to separate infections with M tuberculosis from those due to NTM. 
Double Mantoux skin testing 
The use of two skin tests in tuberculosis control to differentiate between skin reactions 
which are a result of infections due to non-tuberculous mycobacteria vis a vis 
tuberculous infections was a well established procedure in veterinary practice since the 
early 1930s (11) - long before shnilar attempts in human medicine. At the time non-
tuberculosus mycobacteria which could confuse the significance of the Mantoux test 
were considered so rare that little attention was paid to the specificity issue of the skin 
test. In veterinary practice veterinarians had long known that infection of cattie with non-
tuberculous mycobacteria was widespread. In particular it was recognized that 
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cattle were infected with M avian and M jolmei organisms which did not matter from 
an economic point of view but which would interfere with the interpreatation of the 
tuberculin skin test when screening herds for evidence of infection with M bovis. 
Differentiation between the tuberculous and non-tuberculous mycobacteria was achieved 
through a so-called "Single Intradennal Comparative test" (12). Tins procedure involved 
the use of two tuberculins, mammalian and avian, injected sirnulataneously a few inches 
apart in the animals neck in an attempt to sort out cattle with non-tuberculous 
mycobacterial infections from bovine tuberculosis. 
In human medicine no attempts were made to address the specificity of the tuberculin 
skin test in terms of the possible effect ofunderiying non-tuberculous mycobacteria 
infections in the popUlations in spite of studies conducted in the 1930s by Mariette and 
Fenger which pointed to the fact that sensitivity to avian tuberculin in Minnesota, United 
States, was high (13). As already pointed out above, medical opilnon in those days 
considered the issue of no major practical significance in human medicine although 
veterinarians of considerable experience in these issues were urging their collageues in 
human medicine to investigate the subject. A most notable appeal having been made by 
Green of the Weybridge Laboratories, England. In Ins opening paper in the Proceedings 
of the Royal Society of Medicine (1951) Green wrote (12): 
"Whether the point, or indeed the whole question of "specificity" of 
tuberculins is or is /lot oj importance in medical usage it would seem at 
least of scientific interest to explore the possibility oj using 
specijicprotein derivatives to identify a Mantoux positive as arising 
from a homjllts infeclion or from all injection with olle or other oj the 
recently described Hskin tuberculosis" types, slich as the Bairnsadale 
bacillus Mycobacterium ulceralls. " 
Although major opinion in human medicine at the time considered the issue of tuberculin 
"specificity" unimportant, two skin test procedures employing different skin antigens 
were already in practice - but for a different reason. In the 1930s studies which cast 
doubts on the specificity of tuberculin began emerging in the US. It was found that 
pulmonary calcifications - whose presence at the time were considered the sine qua 1l01l 
of tuberculosis - were present in a large number of persons who reacted negatively to the 
tuberculin skin test (13). It became clear to some that tuberculosis alone could not attest 
for all the calcifications which were being observed, hence a focus on non-tuberculous 
origins of the calcificatory chest X-ray lesions. 
In 1942 Aronson et al. used tuberculin and coccidioidin skin tests in Indians in the 
Southwest of the United States to show that coccidioidomycosis was responsible in the 
localities studied for a considerable amount of calcifications which were being seen on 
chest x-rays (14). In their classical comprehensive study began in the fall of 1943, 
Goddard et al. (15) in the US investigated the phenomenon with the help of tuberculin 
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and histoplasmin skin tests. Their study showed that 82 percent of student nurses studied 
and with calcifications reacted to histoplasmin and 27 percent to tuberculin. It was 
therefore concluded that calcifications on chest x-ray seen in some patients with negative 
tuberculin skin reactions are due possibly to a mild subclinical infection with 
Histoplasma capsulatum or a closely related organism. Having made this discovery 
another more subtle problem of specificity with the tuberculin skin test was to arise. This 
was the phenomenon of cross reactions between M. tuberculosis and related 
mycobacterial species (nontuberculous mycobacteria). It had been suspected for some 
time that the so-called c<strong-dose" tuberculin sensitivity were not a result of 
tuberculous infection and that many ofthe small reactions to the standard 5-TU test 
might also be due to other factors. Defining the cause of these cross reactions pre-
occupied tuberculosis research in the 1950s. In 1955 tuberculosis researchers at the 
World Health Organization and two years later Edwards and Krohn were able to 
demonstrate that avian tuberculins appeared to be effective in identifYing persons whose 
reactions to human tuberculin were considered to be cross reactions (13). However 
Edwards and Edwards pointed out in 1960 that infection with the avian tubercle bacilli 
cannot be incrimated as the sole or perhaps even the most frequent cause of cross 
reactions to human tuberculin for the reason that antigens prepared from a variety of 
other mycobacteria are equally effective in identifYing persons with that kind of infection. 
Rigorous comparative skin testing by Edwards and Krohn (16) using different 
mycobacterial antigens in residents ofIndia and the Philippines concluded that: 
"the low- grade tuberculin sensitivity conSisting of small indurations 
rallgillg/rom3 to 12 mill diallleter to 5 TU [authors emphasis] to 
purified human tuberculin seem to reflect a response to Gn antigenic 
jaclor common to various types of acid-fast organisms and not a 
specific factor in human tuberculin, whereas the higher degrees of 
sensitivity with illduration diameters at least 12 mm [authors 
emphasis] to purified tuberculin appear to represent a specific response 
to tuberculous injection" 
In essence the Edward and Krohn (16) study had demonstrated that if infection with 
other nontuberculous mycobacteria results in low grade sensitivity, then comparative 
tests with appropriate antigens should provide an opportunity to distinguish M 
tuberculosis infection from cross reactions. Experimental work by Edwards and her 
associates, Bjerkedal, and Jolmson and Smith provided evidence that infection with a 
single mycobacterial species provided a degree oftuberculin sensitivity which is 
definitely greater to the homologous antigen than to the heterologous mycobacterial 
antigens (17). Edwards and Edwards reported on a United States Navy comparative skin 
testing study which involved 46,000 Navy recruits each receiving both PPD-S 
(manunalian) and antigens from the Battey mycobacterium (PPD-B). To arrive at a 
93 
practical way of distinguishing the different possibilities when interpreting results, they 
categorized the recruits into three groups according to induration diameters following 
administration of the the two antigens: 
• those whose reactions to PPD-B was larger than to PPD-S. These persons were 
designated as having cross reactions to PPD-S and not infected with M Iltbercl/losis. 
• those whose reactions to the two antigens were the same size or within 1 nun of each 
other. No speculations were made regarding tlus group, perhaps illustrating that a 
golden standard in addressing the specificity of tuberculin was far from being found 
even when employing dual skin tests. 
• those whose reaction to PPD-S was larger than to PPD-B. These were considered as 
having true tuberculous infection. 
Sensitivity to PPD-B is a reflection of infection with any of a number of species of 
non tuberculous mycobacteria. The choice as to which nontuberculous mycobacteria 
antigen ought to be used in a double Mantoux skin test is ultimately dependent upon the 
strains of nontuberculous mycobacteria prevalent in a particular geographical area. Even 
in the United States where much of the earlier work on nontuberculous mycobacteria 
was done, there was considerable variation in the distribution of these bacteria in the 
population. In the Netherlands a double Mantoux skin test was employed in an 
investigation of6532 school pupils (II). In that study, PPD RT 23 + Tween 80 was used 
to elicit evidence of infection withM tuberculosis, while evidence of infection with 
nontuberculous mycobacteria was demonstrated in about half the study subjects using 
PPD avium and the other half with PPD scrofulaceum. Subsequent surveys investigating 
sensitivity to NTM organisms within the Netherlands showed that tuberculins prepared 
from M scro/I/lacel/m appeared to offer the best means ofidentitying persons whose 
reactions to human tuberculin were considered to he cross reactions. Therefore in this 
current study, NTM sensitivity has been studied using M sc}'ojulaceu!11 sensitins. 
In the present study of M II/bercl/losis and NTM sensitivity in the Royal Netherlands 
Army recruits a double Mantoux test is introduced. The current methods to separate 
infections with M II/bercl/losis from that with NTM are based on classifYing persons 
using their reactions. Those with stronger reactions to tuberculin prepared from M 
tuberculosis than to sensitin prepared from NTM can be classified as infected with M 
tuberculosis and vise-versa (18,19). Attempts have been made to improve on existing 
models for classifYing the different indurations to increase the likelihood that only 
persons infected with M luberculosis are prescribed INH chemoprophylaxis. 
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Populations and Methods 
Study Population 
The first part of the study, conducted from 1986 - 1988 comprised 37755 army recruits 
without previous BeG vaccination. Two skin tests - one test on each forearm - were 
applied simultaneously. One test was made with I TU PPD RT 23 + Tween 80 followed 
by a second test employingM scro/Illacelllll sensitin + Tween 80. Both tests were read 
after 72 hours. 
The second part of the study was conducted ITom 1989 - 1993 and consisted of 199937 
recruits without previous BCG vaccination. In this group all received I TU PPD RT 23 
and the reading was done after 72 hours. In those who showed an induration in the range 
of 10 - 15 rum a second skin test withM scrofulaceum sensitin was given on the second 
forearm and results read after 72 hours. 
The test was performed and read according to the WHO protocol for standard WHO 
tuberculin test (20). Both study populations consisted of clinically healthy army recruits, 
born in the Netherlands, with a mean age of22 years. For this study the population was 
not tested for infection with the human immunodefieciency virus (HIV) as this is not 
routinely indicated. 
Methods 
The criteria for infection with either M luberclilosis or NTM was set at an induration of 
at least 10 mm (21). To distiguish between persons infected with M Iliberclilosis and 
those infected with NTM, a model based on the one proposed by the International 
Tuberculosis Surveillance Centre (ITSC) was used (19). Briefly the ITSC model shows 
four distinct areas: 
1. an area that represents the noninfected; 
2. a region showing those infected with M tuberculosis with an induration diameter to 
PPD 2:17 mm); 
3. in between these two, a diagonal line separates those infected with NTM from those 
infected with M tuberculosis but reacting with an induration diameter < 17 mm; 
4. further, those whose indurations lie on this diagonal line are equally divided into 
those with M Iliberclilosis infection and those with NTM. 
In this study an additional criterion was made in such a way that positive indurations to 
M scro/lilaceulIl sensitin have to surpass indurations to PPD RT 23 by at least 3 mm to 
be classified as NTM infections and vice-versa. The diagramatic presentation of this 
model is shown in Figure I. Area (A) represents non-infected persons; area (D) are 
persons directly classified as infected with M luberculosis; area (B) represents the M 
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tliberclilosis infected based on the 3 nun criteria. Area (C') are those infected with NTM, 
while area (C") represents those infected with NTM who were classified as giving a false 
positive induration to PPD RT 23. 
Results 
During the period 1986 - 1988, 37,755 recruits were tested using two simultaneously 
applied skin tests with PPD RT 23 and M scro/Illacelim sensitin. The distribution of 
both PPD RT 23 and M scro/Illacelim sensitin is shown in Figure 2. Distribution to PPD 
RT 23 shows neither mode nor antimode, whilst the distribution to M scro/Illacelim 
sensitin shows a bimodal pattern. The antimode is found at 5 mm with the second mode 
at 9 mm. A total of30 626 (81%) persons had zero reaction to either PPD RT 23 or M 
scro/Illacelim sensitin; zero reactions to PPD RT 23 were more frequent with 97% (36 
643/37755) compared to 82% (31 130/37755) for M scro/Illacelim sensitin. Induration 
diameters of 1 - 9 mm occured in 2.6% (967/37 755) with PPD RT 23 and in 9.7% 
(3688/37755) with M scro/Illacelllll sensitin. Indurations;'10 mm to M scro/Illacelim 
sensitin fluctuated over the three years - averaging prevalence of7.76%. Throughout the 
study Le.1986 - 1993, induration diameters dO mm to PPD RT 23 were registered in 
about of 0.45% persons; this remained fairly constant throughout the years. 
Table 1 shows the percentage of persons reacting with induration diameters dO mm to 
PPD RT 23 in the period 1986 - 1993 and to M scro/ulacellm sensitin in the years 1986-
1988. The mean diameter for those reacting to M scro/Illacelim sensitin with an 
induration;, 10 mm is 13.5 mm (SD 2: 3.07), compared with 15.4 mm (SD;, 3.85) to 
PPD RT 23. 
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Table 1. Percen/age of recruits reacting /0 PPD RT 23 and M. scrofulaceum sensitill. 
Year Persons tested PPD RT23 M. scrofulaceum 
:?:.10 mill (%) sensitin:?:.l0 miU (%) 
1986 13353 0.47 5.1 
1987 12380 0.41 7.9 
1988 12022 0.48 5.4 
1989 43801 0.46 
1990 41040 0.44 
1991 39956 0.49 
1992 39555 0.39 
1993 35585 0.48 
The exclusion percentage using the criteria of 3 mm (Figure 1) 
M.scrofulaceum senstin 
10mm >lOmm 
I A C' lOmm , 
~ I 
~ l 
15mm _ 
B e" 
D 
>15m~ 
Figure 1. GrapMcal presentaUon of model classifj1bzg dually skin tested recruits: 1986-
1988. 
Using the 3 lllm criterion among persons with indurations to PPD RT in the range 10-15 
mill, 46% of the recruits investigated during 1986-198& were classified as infected with 
NTM {C" !(B+C")). In tlils same period 20% of the total group of persons who reacted 
with a diameter <":10 mm to PPD RT 23 {C"!(B+C"+D)) were excluded. 
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Table 2. Induration diameters to PPD RT 23 between JOmlJl - 15 111m and percentage 
afpresumedfalse positives, 1986 - 1993. 
Year persons No. with induration Presumed false 
tested diameter;;::: 10 111111 and positive (%) 
~ 15 mill 
1986 13353 23 10 (43) 
1987 12380 21 8 (38) 
1988 12022 21 12 (57) 
1989 43801 59 27 (46) 
1990 41040 58 24 (41) 
1991 39956 46 14 (30) 
1992 39555 55 39 (71) 
1993 35585 72 38 (53) 
Total 237692 355 172 (48) 
Referring to the positive exclusion percentages found in 1986-1988, a second 
investigation was done from 1989-1993. Only those with induration diameters between 
10-15 mm to PPD RT 23, a total 0[290 recruits, were tested with M. scrofulaceum 
sensitin. The 3mm criteria was then applied and a distinction made as to whether the 
reaction represented infection with Ai. tuberculosis or infection with NTM. Those 
classified as infected with NTM were then excluded from INH chemoprophylaxis. Table 
2 shows the percentages of persons who reacted to PPD RT 23 with diameters ;;:::10 mm 
and::; 15 mm who were excluded from INH chemoprophylaxis using the criteria 
described above. 
The percentage that was excluded (exclusion percentage) from INH chemoprophylaxis 
fluctuated over the study years, with a strong peak in 1992. The average exclusion 
percentage over the seven-year period was 48% and 16% for indurations to PPD RT 23 
in the range 10 - 15 mm and ;;:::10 nun respectively. 
Discussion 
Between 1986 and 1988 the sensitivity to PPD RT 23 and !'vI. scrafiilaceum sensilin 
among recruits in the Royal Netherlands Army was investigated. The prevalence of 
indurations ~10 111m to PPD RT 23 in these three years was low (0.45%) compared to a 
high prevalence of 7.76% to 1\1. scrofulaceum sensitin. A similar high prevalence of 
NTM sensitivity was found among Dutch school children in the city of Delft during a 
1964 study (11). This high prevalence to 1\1. sCl'ofulaceum sensitin in the current study 
fluctuated over the three-year period, with no clear pattern of non tuberculous 
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mycobacterial (NTM) infections. Response to 101. scro/Illacellm sensitin in this study was 
not necessarily an indication of infection with 101. scro/Illacellm but a reflection ofthe 
prevalence ofNTM in the study population. Therefore the fluctuating pattern to 101. 
sero/lIlaeellm sensitin could be the result of shifts in sensitivity to different NTM. The 
distribution of indurations to PPD RT 23 in the histogram (Fig 2) shows no clear-cut 
unimodal distribution. This is in contrast to the normal distribution seen in other 
populations in whom tuberculin test results in a low rate offalse positives. In such 
populations th.tuberculin test is highly specific (21). On the other hand, in populations 
such as in'the present study with a low prevalence to tuberculosis and a relatively high 
NTM prevalence, the utility ofthe tuberculin test might be limited. 
100% • 
1.50% 
1.25% 
1.00% 
0.75% 
0.50% 
0.25% 
0.00% 
Figure 2. Reactivity to PDD RT 23 alld 101. seroli/Illacellm 
• PPDRT23 
EJ 
M.serojitlaeeulIl 
In the Royal Netherlands Army a cut-off point of;o, 10 mm in response to PPD is used to 
define a positive test among non-BeG vaccinated persons; all those with a positive test 
to PPD are then prescribed isoniazid chemoprophylaxis for six months. However, since 
mycobacterium species share many common antigens, healthy persons infected with 
NTM might respond to PPD RT with a positive induration. Attempts should therefore be 
made at differentiating infections due to 101. Illberel/losis and those due to NTM 
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among persons reacting with a positive induration to PPD RT, so that isoniazid 
chemoprophylaxis can be limited to those where it is indicated, 
In regions where the distribution ofPPD in the population neither shows an antimode 
nor a mode, both may be obscured by a high ITequency of reactions to NTM, When two 
skin tests are used to each subject (one with tuberculin and the other with sensitin 
prepared ITom NTM) this might separate infections due to M Il/bercl/losis from those 
due to NTM (22), By introducing a model based on this double Mantoux, this present 
study has attempted to separate responses due to M II/bercl/losis infection ITom 
responses to NTM, The exclusion rate was the percentage of persons who reacted with 
an induration diameter between 10 mm and 15 mm to PPD RT 23 but with a stronger 
response on second testing with M scrofulaceum sensitin. Response to M scrofulaceum 
sensitin had to exceed that due to PPD RT by at least 3 mm, TIlls 3 mm criteria was first 
proposed as reasonable by Carruthers in 1970 (23), In that study Carruthers studied the 
difference in size between comparative Mantoux reactions which could be considered 
outside the limits of observer variation. The study found that it was reasonable to accept 
differences of 3 mm or more between simultaneous comparative Mantoux test readings 
as indicating differences in reactions to sensitins used. More recently a dual skin testing 
procedure using a 3 mm criterion to distinguish between persons with M tuberculosis 
infection and those infected with Mycobacleril/m Avil/l11 Complex (MAC) has been 
employed by von Reyn et al. (24), They designated skin reactions into M avilllll-
dominant or M tuberculosis-dominant, using a 3 mm criteria. 
In the current study, ITom 1986 to 1988 the percentage of persons reacting to PPD RT 
with a positive induration between 10 mm to 15 mm and classified as false positive was 
45%, The exclusion rate for all persons with indurations ;>0 mm was 20% during that 
study period, During the second part of the study a second test withM scro/lllacellm 
sensitin was given only to those reacting with an induration diameter of between 10 mm 
to 15 nun. The exclusion rates fluctuated over the years. On average, the exclusion rate 
for those reacting with indurations 10 mm to 15 nun was 48% throughout the study 
period, This means that almost half of the persons with indurations to PPD in the range 
10 nun to 15 mm are showing sensitivity as a result of infection with NTM. In the group 
of persons with indurations to PPD ~ 10 mill tlus percentage is 16%. These persons are 
therefore excluded from lNH chemoprophylaxis, and the potential side effects due to 
lNH are eliminated in this group, During this second phase of the study the skin tests 
were not given simultaneously, which could have introduced a potential flaw in the 
methodology. A second skin test even with a different sensitin may give a response 
which is a non specific reflection of all other mycobacterium sensitisation. To overcome 
this effect both PPD RT and NTM sensitins could be given at the repeat skin testing in 
the group of persons reacting with induration diameters 10 mm to 15 mm, The 
assumption here being that persons with induration diameters greater than 15 mm to 
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PPD RT are statistically more likely to be infected with M tuberclIlosis. This assumption 
is based on earlier observations that indurations exceeding 15 mm are statistically more 
likely to be caused by an infection with M tuberclI/osis (17). 
The cross reactivity between M tuberclI/osis and NTM also has important implications 
for using the tuberculin test as an epidemiological tool in calculating the risk of 
tuberculosis infection. The yearly tuberculin index could be overestimated in situations 
where the rate ofNTM infections in the population are high. 
This study proposes a long term standardisation of the double Mantoux test outside the 
Royal Netherlands Army, in particular in contact surveys, to avoid the unnecessary use 
of INH chemoprophylaxis. To evaluate this approach an investigati()n has to be 
undertaken to ensure that persons excluded fromlNH chemoprophylaxis using tills 
criteria do not develop tuberculosis. Such a study is yet to be undertaken by the Army. 
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HOTEL-ACQUIRED MDR TUBERCULOSIS 
INFECTION IN 10 DUTCH SERVICEMEN 

HOTEL-ACQUIRED MDR TUBERCULOSIS 
INFECTION IN 10 DUTCH SERVICEMEN 
Introduction 
Infection with hlberculosis following contact with a case of tuberculosis during travel is 
well documented, and such contact has even been suggested to happen within the 
comforts of modern commercial aircrafts (Driver et al., 1994; Kenyon et al., 1996; 
Miller et al. 1996). These findings might offer little solace to persons from low endemic 
countries who perhaps perceive that their risk of acquiring tuberculosis is infinitesimally 
minimal. In the Royal Netherlands Forces, post-deployment screening for tuberculosis 
has taken on an even more important dimension in the last years given the global 
increase in the number oftuberculosis cases. \Vith the emergence of multipledmg-
resistant tuberculosis (MDR-TB) in several countries, tlus risk, though small as it may 
seem, takes on an ominious twist. The account that follows in tius article will re-
emphasise the importance of travel as a possible risk-factor for tuberculosis infection 
and that countries such as The Netherlands with a successful tuberculosis control 
programme cannot entirely be free from this disease as long as the TB problem exists 
elsewhere. The globe has shrunk and we are increasingly getting intercOlmected as 
millions of people can now traverse long distances around the globe in a few hours. 
Travel amplifies the chance of bringing and acquiring infections from one point of the 
globe to another. 
In 1991 a Royal Netherlands Air Force unit was based in. Turkey as part of a multi-
national force during "Operation Desert Storm", The Ulut stayed in Turkey for three 
months, returning home end of March. As part of routine medical examination after 
overseas deployment, the servicemen were screened for tuberculosis infection. 
Methods and Results 
In June 1991, a total of397 servicemen who had been based in Turkey were contacted 
and requested to come for a tuberculin test (Mantoux) and or a chest X-ray. Chest x-
rays were performed in 127 persons and a Mantoux skin test administered to 270. The 
Mantoux skin testing identified 10 persons with induration diameters greater than 10 
mm, and hence considered to have a positive Mantoux test (some of their characteristics 
are shown in the tabel). All persons were started on iSOluazid prophylaxis therapy. 
Further analysis of these persons revealed that they were part of a group of 69 who had 
been accomodated in the same hotel at Diyarbakir, Turkey. The rest of the group had 
stayed in other hotels and none of these had a positive Mantoux. According to the 
servicemen, these other hotels offered better living quarters compared to the hotel which 
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accomodated those with positive Mantoux tests. Interestingly, these persons reported 
that there was a hotel guest, probably a local, who constantly coughed although there 
were no reports suggesting close contact with the said person. There was also 110 
information on whether this particular hotel guest had tuberculosis. 
Table 1. Characteristics of servicemen with a positive Alantoux skin test 
Pat. No 
I' 
2 
3 
4 
5" 
6 
7 
8 
9 
10 
• 
Age 
24 
19 
31 
33 
33 
29 
26 
37 
34 
31 
Sex 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
Mantoux 
(nun) before 
Turkey 
0 
0 
0 
0 
4 
0 
0 
0 
0 
4 
BeG 
(Y.slNo) 
N 
N 
N 
N 
Y 
N 
N 
N 
N 
N 
This patient developed MDR tuberculosis 
Year last 
known 
Mantoux 
1987 
1990 
1981 
1977 
1970 
1980 
1983 
1971 
1977 
1991 
Mantoux 
induration 
Post Turkey 
16 
12 
15 
20 
20 
12 
23 
12 
17 
16 
•• This servicemen had a BCG in childhood. There is no policy ofBCG 
vaccination within the Royal Netherlands Anny. 
Four months later, one of the 10 (a 24 year old male) developed tuberculosis with 
positive cultures for M tuberculosis. Dmg susceptibility testing done at the Institute of 
Public Health and Environment (RlVM) showed resistance to rifampicin, isoniazid and 
streptomycin. The tubercle bacilli were sensitive to ethambutol, pyrazinamide and 
ofloxacin. His treatment consisted of ethambutol (1200 mg), isoniazid (300 mg), 
pyrazinamide (2000 mg) and ofloxacill (800 mg). Tills patient was successfully treated 
for one year and subsequent follow-up has shown no evidence of relapse. In the rest of 
the group on INH prophylaxis, treatment was discontinued basing the decision 011 the 
likelihood that these persons had been exposed to the same source of infection. 
DNA fingerprinting (Restricted Fragment Length Polymorphism) was performed at the 
RIVM and results indicated that tillS strain of 1\1. tuberculosis was closely associated 
with two strains that had been identified among persons of Turkish origin residing in the 
Netherlands. 
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The remaining 9 persons with positive Mantoux test have been followed routinely with 
none developing tuberculosis by January 1997. These persons were seen once every 
three months at the Pulmonary Unit of the Central Military Hospital and chest X-rays 
done at six months intervals for two years. In January 1997 all persons were contacted 
by telephone and interviewed for presence of any pulmonary symptoms. All persons 
reported to be well. 
Discussion 
Multipledrug-resistant Mycobacterium tuberculosis disease (MDR-TB) defined as 
resistance to at least isoniazid and rifampicin has emerged as a major public-health 
threat. Rifampicin and isoniazid are key components of therapeutic regimens that are 
used in the treatment of tuberculosis. In the late 1980s and early 1990s MDR-TB 
outbreaks in the United States helped to re-focus public-health measures against 
tuberculosis. Many of the outbreaks however, have been 'reported among persons co-
infected with the human immunodeficiency virus (HJV). The problem ofMDR-TB is 
not only confined to Olle particular country. A recent \VHOIIUATLD report provides an 
idea into the burden ofMDR-TB in different geographicalloealilies (Bustreo et aI., 
1996). High prevalence rates of greater than 30% MDR-TB were reported in Nepal 
(48%), parts ofindia (33.8%), and New York City, USA (30.1%). Most surveillanee-
based or hospital-based :MDR-TB rates for European countries have shown prevalence 
rates lower than 2%. In The Netherlands this rate was 0.8% in 1993. In a hospital-based 
study conducted in 1992 in Turkey, the prevalence ofmultipledmg-resistance was at 
9.2%, a rate much higher than that reported for Western Europe (Tahaolu et aI., 1994). 
The investigation presented in this article represents the first report of :MDR-TB among 
Dutch servicemen that appears to have a direct bearing to overseas deployment. The last 
few years have witnessed an increasing number of deployments of servicemen to out-of-
area theaters. \Vith such increasing travel it is inevitable that some persons will acquire 
disease directly related to deploymcnt in these areas. In fact this increase in travel is not 
only confined to the military population. 
In this investigation there is circumstantial evidence to show that the 10 servicemen 
seemingly acquired infection with MDR tuberculosis while staying at a Turkish hotel. 
Fingerprinting results identified the strain ofAl tllberclI/osis that developed in patient 
no. 1 as being related to strains isolated in persons closely linked with Turkey. This 
report also raises a number of issues that have a direct bearing on the future direction of 
tubcrculosis control within the army. Firstly, the pre-deployment Mantoux results in the 
majority of persons with a positive value were obtained many years before deployment 
to Turkey. Patient number 5 had under-gone BeG vaccination. It might also be argued 
that the positive result in this patient foHowing tuberculin testing is a boosted 
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immunologic response from BeG vaccination in spite of the 4 nun that was registered 
20 years earlier. We can therefore not state with 100% certainity that these persons had 
converted to a positive Mantoux result following the Turkey contact. It might have been 
useful if a Mantoux test had been done just prior to deployment. Future deployments 
will have to reckon with this important prerequisite if concrete information on the risk 
of acquiring tuberculosis in overseas theaters is to be assessed. Likewise, travel clinics 
should also consider pre-travel skin testing of persons without a recent "Mantoux result 
before such persons embark on ajourney to tuberculosis endemic areas. Post-travel 
screening will therefore be important to establish incidences of tuberculosis infection 
during travel. 
Patient no. 1 was started on treatment with at least three agents to which the organism 
was found to be susceptible. Although this patient was not placed on Directly Observed 
Therapy (DOT), he remained compliant until cure was effected one year after initiation 
of treatment. \Ve would however recommend that in managing MDR-TB, directly 
observed therapy should be the rule. DOTS is already becoming increasingly favoured 
within The Netherlands and a number of very successful and innovative DOTS 
strategies have been described in the cities of Rotterdam and Amsterdam (van Galen 
and Breemer, 1996; Horsman and Lopes Dias, 1996). 
Following the discovery of the MDR-TB case, isoniazid chemoprophylaxis was 
discontinued in the nine persons with a positive Mantoux reading. There is no suitable 
chemoprophylactic regimen that these persons (presumed to be infected with .MDR-TB) 
could be given. This therefore begs the question as to how long such persons need to be 
followed-up. The use of DNA fingerprinting in this case and comparing it with strains 
that were from persons closely associated with Turkey represents a new and fascinating 
approach in epidemiology. However, since the routine use of such molecular biology 
techniques is not well developed in many countries, it makes it difficult even at this time 
of exciting molecular biology advances, to compare the different strains isolated and try 
to compare them with strains from other countries. Probably more work will be done in 
this direction thus enabling molecular epidemiologist to exactly pin-down the source of 
a patients disease. 
That tuberculosis developed among a group of servicemen who were accomodated in a 
hotel illustrates just how Ubiquitous this organism can be. For the traveller who takes 
solace in staying in luxuriolls quarters this report may sound alarmist. Although the risk 
of acquiring tuberculosis within The Netherlands is minimal in comparison to other 
areas, the truth should not evade us. The truth is that with increasing travel and 
deployments (for military personnel), persons from tuberculosis non-endemic areas will 
still run a real risk of acquiring tuberculosis infection. All that travellers require is 
exposure to a source of infection which in this case is suspected to have been someone 
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in the hotel. MDR tuberculosis is rare in The Netherlands but this case shows that travel 
brings persons in contact with diseases that might be rare in their home countries.To 
control and contain (MDR) hlberculosis therefore requires concerted global efforts since 
travel that brings persons in contact with environments where the disease might be a 
problem will not slow but increase in the coming years. 
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III 
General Discussion and Summary 
Tuberculosis control in the Royal Netherlands Anny has always been a prominent 
element of the Army Health Services ever since the end of World war II. The basic 
principles of tuberculosis control over the decades have centered around interrupting the 
chain oftrans-mission in Army populations often living and working in congregate 
settings. Tracing and treating persons infected with tuberculosis but with no active 
disease has not been a straight forward issue. This thesis traces the evolution of these 
basic control methods within the Royal Netherlands Army and highlights important 
bottle-necks inherent in applying the different control techniques. Particular emphasis is 
placed on MMR and the shortcomings of the tuberculin test. Novel methodologies 
aimed at increasing the efficiency and specificity of this test are presented. 
Chapter two describes the Army tuberculosis program since its inception and how it has 
evolved over the last 5 decades. Although the basic principles of tuberculosis control 
have by and large remained unchanged since Robert Koch described Ai tuberculosis as 
the causative organism of tuberculosis, the diagnosis and treatment of the condition 
have made impressive strides. Initially reliance was placed almost exclusively on 
physical examination to make a diagnosis, but this was later supplemented with XRray 
of the chest. Rontgenography was adapted in the Royal Netherlands Army as a 
tuberculosis screening tool in 1933. In that year, 1001 recruits reporting for nulitary 
duty underwent a chest X-ray. The Army had clearly found a tool that offerred 
tremendous advantages as time and manpower lost to the disease could be decreased 
and spreading of hlberculosis within the service could be limited by identifying 
infectious cases, which otherwise could escape identification during physical 
examination alone and thus human suffering could be prevented. Subsequent 
improvements in XRray techniques were also adapted through the years. During 1945, 
photofluorographic equipment, "\Vatsons", became operational and it was possible for 
the first time to screen faster and more efficiently. Screening was thus extended to even 
larger groups using this new technique of Mass Miniature Radiography (MMR). 
Remarkable was the shortening of the screelung interval among Army reclUits entering 
the Army and screening procedures to undergo an XRray. For instance this shortened in 
1960 by 56% over the 1951 average of 6.8 days. By 1967 better technology made it 
possible to XRray all reclUits on their first day at an induction centre. 
The X-ray policy as a screening tool was continuously evaluated to see if the returns 
from the application of this tool justified the cost. In 1989, there was evidence 
indicating that compulRsory chest XRray screening added little to the identification of 
tuberculosis infected persons. 
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Other tools were more attractive as a means of identifying these persons. The tool that 
was relied on was the 1I.1antoux skin test. This test came into usage in the Army in 1955. 
Between 1955 and 1956, a study was conducted among Army recruits to ftnd out if 
there was a regional differrence in sensitivity to tuberculin. The ShIdy found that the 
tuberculin sensitivity ranged from 14 to 30% with the lowest percentage being observed 
in the nOlihern provinces of the Netherlands in comparison to the southern provinces. 
This phenomenon has faded out over the years. By the decreasing infection~index the 
percentages in north and south became equal by 1975. Apali from demonstrating such 
important regional differences, the tuberculin skin testing program of the Army main~ 
tained a tuberculosis registry in which the alUmal prevalence of hlberculin sensitivity 
alllong recmits were entered. Tilis registry has provided over the years a unique set of 
data that gives an insight into the temporal trends of hlberculosis infection among young 
Dutch males. During the period 1956 to 1969, the percentage of recruits reacting with a 
positive Mantoux declined from 19.2% to 4.4%. By 1995, tuberculin sensitivity among 
recruits had drastically declined to a prevalence of 0.42%. 
This decline occurred in absence ofa BCG vaccination policy in the Army. BeG has 
never been used on a wide scale even among the general Dutch population. However 
with increasing mobility of the population in modern times, the Army~ just like in the 
general population- is witnessing an increase in the number of recruits from countries 
where a policy ofBCG vaccination is widely practiced. In 1995, of the 306 recruits with 
a BCG vaccination, 74% were foreign born. Mantoux skin testing among such persons 
is unlikely to be a useful tool in identifying hlberculosis infections. Therefore, a 
Nlantoux skin test in this group of persons will be of limited value. Apmi from 
providing useful information on prevalence of tuberculosis infection among Army 
recruits, the Mantoux skin testing has been extensively used as a means of selecting 
canditates for isottiazid prophylaxis therapy (lPT). 
Isoniazid prophylaxis in the Army was initiated in 1960. Recruits reacting to a Mantoux 
skin test with an induration of at least 10 mm are recommended for IPT. However, the 
decision to give IPT is based on assessed risks and benefits of isoniazid treatment. One 
clear advantage from isoniazid prophylaxis is that it decreases the likelihood of infected 
tuberculosis persons from developing active disease. The efficacy of isoniazid 
prophylaxis in preventing tuberculosis reactivation has been shown to range from 60~ 
80% (I). On the other hand IPT is not free of side effects. Chapter three presents results 
of the RNLAs experience with using isoniazid chemoprophylaxis between 1984 to 1995 
among 739 persons. The study showed that isoniazid-associated adverse events were 
present in 10.6 percent of the ShIdy population. Of all adverse events associated with 
isoniazid, liver damage, which occassionatly is severe and fulminant is the most dreaded 
complication. Among the 739 persons in this study, liver transaminase levels were 
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assessed during therapy. Elevated transaminase levels were observed in 5.4% of the 
study population with evidence of hepatic damage in 1.4 percent of these. The majority 
of transaminase level elevations were less than 2x upper limit of normal. The frequency 
of transaminase level elevation in this study was much lower than that reported by 
authors from elsewhere (2,3). For instance a United States Air Force study found a 
percentage of22 percent among those on IPT (2). The difference between the Dutch 
Army series and the US Air Force Study is possibly related to the age of patients and the 
duration ofIPT, six month versus one year. In this Dutch study over 96 percent of the 
study subjects had a mean of 22 years while the US Air Force study had subjects with a 
mean age of 30 years. Age is an impOliant factor in the decision of initiating isoniazid 
prophylaxis. Usually in persons older than 35 years, isoniazid chemoprophylaxis is not 
recommended unless the patient is at a very high risk of developing active tuberculosis. 
This recommendation is based on the finding that isoniazid hepatotoxicity is three times 
greater among patients aged 235 years than those aged <35 years (4). This RNLA study 
did not register any form of fulminant hepatitis and no fatalities were seen. Perhaps this 
had to do with regular clinical and hepatic enzyme monitoring that these patients 
underwent. In this study discontinuation of therapy happened in 19 persons and this 
represented 24% of all those persons who developed adverse reactions attributed to 
isoniazid therapy. Eight of the persons in the group in which therapy was discontinued 
were among those with asymptomatic elevated transaminase levels. Side effects to 
isoniazid occurred throughout the study period with 77%ofthese events happening in 
the first three months. Although the frequency of isoniazid associated side effects in this 
study were much lower than in many other studies, guidelines should be devised to even 
minimise these further. This study recommends that regular clinical and hepatic enzyme 
monitoring should at least take place during the first three months of therapy. 
Currently .Mantoux skin testing with purified protein derivative is the only practical test 
in discriminating between those with AI. tuberculosis from those without and hence 
determining who qualifies for enrolment into the IPT programme. However the 
interpretation of this test is not always a straight forward I'positive" or <lnegative". The 
interpretation of the Mantoux test depends on a number of clinical circumstances of 
patients. For instance the Centres for Disease Control (CDC) in the United States 
recommends that a 5 nUll cutoff point be considered for persons with mv infection or 
those who have had close contact with someone with infectious tuberculosis and a 10 
mm cutoff point for foreign-born persons (5). An induration of at least 15 mm in 
persons with no risk factors for tuberculosis is considered as positive. Another imp0l1ant 
aspect that must be taken into account while interpreting the Mantoux test results is the 
role of nontuberculous mycobacteria (NTM). The PPD used in the Mantoux skin test is 
a mixture of different mycobacterial antigens, which patiially cross-react to species of 
nontuberculous mycobacteria. These mycobacteria are present in a wide range of 
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environmental sources making these organisms a common sensitiser of human 
populations. Therefore in populations with a low prevalence of tuberculosis infection 
and a high non tuberculous mycobacteria prevalence, the usefulness of the tuberculin test 
will be limited. The prevalence of nontuberculous mycobacteria among RNLA recruits 
was therefore studied in a period of three years, 1986-1988, among a total of 37,755 
persons with the M scrofulaceum sensitin. The use of this sensitin as a test antigen was 
because it cross-reacts more broadly with all other nontuberculous mycobacteria (6). 
The results of this investigation are presented in chapter four. 
The prevalence of nontuberculous mycobacteria sensitivity among the entire recruit 
population observed in the three study years was 7.8 percent. A Dutch study conducted 
among school children in the Delft area of the Netherlands showed an even higher 
prevalence of about 13 percent (7). This Dutch Army study clearly demonstrates that 
there is n high prevalence of sensitivity to nontuberculous mycobacteria in recruit 
populations. The practical importance of this is that the delineation of reactions due to 
nontuberculous mycobacteria from those attributed to M tuberculosis infection is 
necessary if isoniazid prophylaxis is to be given to those who are truly infected with 
tuberculosis and not to those who as a result ofNTM infections react positively to a 
Mantoux skin test employing PPD Rt Tween 23. 
Chapter five presents the results of a study whose objective was to improve upon the 
PPD skin testing procedure so as to provide a better distinction between reactions due to 
1\1. tuberculosis from those that result from NTM infections. During the first part of the 
study, from 1986-1988, army recruits were tested simultaneously with PPD RT 23 and 
lH scrofulaceum sensitin. During the second part of the study, from 1989 to 1993, 
recruits reacting to PPD RT 23, with an induration in the range of to-IS mm, underwent 
a second skin test with At/. scrofulaceum sensitin. The total study popUlation consisted of 
237,692 non-BCG-vaccinated recruits. The results showed that from 1986-1993 an 
average of 0.45% persons reacted with indurations ~IO mm to PPD RT 23. An average 
of7.7% army recruits reacted with indurations of;:::.:10 nml to Ai. scrofitlaceum sensitin 
during the first part of the study. Using a modified ITSC (International Tuberculosis 
Surveillance Centre) model, 48% of the persons reacting to PPD RT 23 with indurations 
in the range 10 !lUll and 15 111111 were classified as false positive. False-positive persons 
were then excluded from INH chemoprophylaxis. This study recommends that in areas 
with a high prevalence of nontuberculous mycobacteria infection the use of a double 
Mantoux skin testing might be useful in differentiating between indurations due to 
tubercle bacilli and those due to infection with nOlltuberculous mycobacteria. Tlus will 
limit the prescription of isoniazid to persons who are truly infected with the tubercle 
bacilii and therefore will benefit from it. This study also proposes a standardization of 
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the double Mantoux test as a tool in avoiding the unnecessary use ofINH 
chemoprophylaxis. 
The RNLA has not been oblivious of the public health problem of tuberculosis among 
her ranks and files. Through the years, the army has used all avaiJable hlberculosis 
control tools to provide better care for all servicemen. Although the prevalence of 
tuberculosis infection in the Army is extremely low it is unlikely that hlberculosis will 
become a historical curiosity within the Service. Many countries still have a very 
serious tuberculosis problem with disease prevalence rates above 200 cases per 100,000 
persons. The consequences of this high prevalence rates from such regions ensure that 
the eradication of tuberculosis in the near future arc unlikely. The army deployments 
around the globe, especially in peace-keeping missions, will certainly come into contact 
with tuberculosis in areas where it remains a major public health problem. 
In chapter six, an account of exposure to tuberculosis during a military deployment 
abroad is provided. The incident underscores the value of a hlberculosis screening 
programme for persOlll1el deployed to areas with a significant tuberculosis problem. In 
1991, a tuberculin skin testing exercise was carried out in a Dutch Military Unit 
returning from a three months deployment in Turkey. It was found that ten of those 
tested had acquired tuberculosis infection during deployment. Further investigation 
found that all 10 were among a group of 69 who had stayed at the same hotel. One 
person developed multiple drug-resistant (NIDR) tuberculosis five months later. It was 
likely that the other persons were infected with MDR-TB as well. This report under-
scores the fact that tuberculosis transmission can occur in the course of deployments. 
The chapter also highlights the fact that although it is possible to skin test individuals 
and provide isoniazid to those with tubercle infection, the emergence of MDR TB is a 
challenge that will not only limit itself to highly affected geographical areas. 
The control of tuberculosis in the RNLA has always been adapted in such a way that it 
conformed to new developments and insights in the field of tuberculosis epidemiology 
within the Netherlands and from elsewhere. In spite of the fact that the Netherlands is 
considered as a low endemic country for tuberculosis, attention for the disease in the 
RNLA has not been slackened. On the contrary. More and more attention has been paid 
to the disease. The reason for this being that in recent years the Army has been involved 
in a number of overeseas operations with servicemen deployed to high tuberculosis 
endemic countries. Besides the shift from a conscription to a professional Army has 
resulted in a considerable change in the demographic and soieal composition of the 
service. Consequences of this being that the tuberculin prevalence figures that were 
calculated based on young Netherlands-born males is no longer a reflection of the 
current tuberculosis prevalence status of the new professional Army. The possible 
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deletrious effects ofMDR tuberculosis as discussed in chapter six have also sharpened 
the control efforts, 
Mantoux skin testing is the pillar of the RNLA tuberculosis control programme and 
during group screening it continues to identify persons infected with tuberculosis. In 
addition the results of the Mantoux skin testing provides the necessary data required in 
estimating the now complex issue of the tuberculosis prevalence in the Netherlands. 
The double Mantoux skin testing outlined in tills thesis offers a better discrimination 
between infections due to the tubercle bacilli and those due to NTMs and is now an 
integral pmi of the army tuberculosis control progralllllle, Tllis methodology has led to 
an almost 50% reduction in persons requiring isoniazid among those with indurations 
between 10-15 mm, This procedure has also been adapted by some civilian organisa-
tions to screen tuberculosis low risk persons. This can be viewed as a positive spin-off 
benefit to general public from the army tuberculosis programme. 
Meanwhile the tuberculosis control policy within the RNLA has been aptly defined, In 
summary, the main areas of focus are as follows: 
• a standard Mantoux skin testing is performed for all persons at induction into the 
Army, before and after overseas deployment and for all persons in lllgh risk 
groups. The latter group undergoes an annual skin testing procedure. For all 
indurations between 10-15111111 among non-BeG-vaccinated persons, a double 
Mantoux skin test as described in the thesis is performed. 
• the results of the tuberculin skin testing are processed and stored in a 
computerised data base. This provides information which serves as basis for 
evaluating the Army tuberculosis control efforts. 
With these measures it is hoped that thc current global TB epidemic will be kept at 
arms-length in the Royal Netherlands Army, 
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Samenvatting 
Tuberculose controle heeft in het Nederlandse leger sinds de Tweede Wereldoorlog 
altijd cell belangrijke rol gespeeld in de militaire gezondheidszorg. De uitvoering van 
deze taak is 11a 1945 ondcrgebracht in cen apartc, daartoe uitgemste Dienst, welke latcr 
de naam Dienst Militaire Gezondheidszorg heeft gelacgen. Het basiswprincipe van de 
tuberculose controle is door de jaren hecn gericht gewcest op het ondcrbreken vall de 
transmissieketen in de veelal dicht opeen werkende militaire leefgemeenschap. Naast 
het in eerste instantie opsporen en behandelen van at. dan niet sputum-positieve 
tuberculosegevallen, is in tweede instantie de identificatie en behandeling van gc'infec-
teerde personen met cen niet actieve tuberculose cen steeds belangrijker doelstelling 
geworden. Dit proefschrift beschrijft de methoden van tuberculose controle die in het 
Nederlandse leger zijn gebruikt en bespreekt belangrijke knelpunten die voortvloeiden 
nit de gebmikte verschillende controle-technieken. In het bijzonder wordt aandacht 
bcsteed aan het tuberculine-onderzoek en de tekortkomingen hiervan. Nieuwe 
methoden, die bedoeld zijn om de effectiviteit en de specificiteit van de gebmikte 
testmethoden te verhagen worden belicht. 
Hoofdstuk 2 beschrijft het tuherculose controleprogal1lllla van het Nederlandse leger 
vanaf de invoering crvan in 1936 en hoe dit na 1945 is veranderd. Hoewel de basis-
principes van de tuberculose contrale grotendeels onveranderd zijn gebleven sinds 
Robert Koch M. Tuberculosis ais de veroorzaker van tuberculose beschreef, hebben 
opsporingsmethoden, diagnostiek en behandeling van tuberculose cen indrukwekkende 
vQomitgang geboekt. In het begin berustte de opsporing van tuberculose uitsluitend op 
de bevinrlingen bij lichame-lijk onderzoek. Dit werd-Iater aangevuld met een rontgen-
. diagnostiek, eerst d.m.v. rontgen-doorlichting en later de (indirecte)rontgenfotografie 
van de thorax. De (massa)-rontgen-doorlichting als middel van screening werd voor het 
eerst in 1933 gClntroduceerd in het Nederlandse leger. In de jaren 1936 tot 1939 
ondergingen 90.000 recmtcn bij hun entree in het leger een rontgenborstonderzoek. Het 
leger had eindelijk een screenings-methode gevonden die veel voordelen opleverde 
zoals een vroegere diagnostiek van longaandoeningen, waardoor er een vroege 
behandeling van opgespoorde ziekten mogelijk werd, er daardoor een daling van het 
aantal ziektegevallen volgde en ziektcverzuim werd temggedrongen. De verspreiding 
van tuberculose bitmen het leger kon op deze wijze worden beperkt. Hierdoor kon veel 
menselijk lijden worden voorkomen ofbekort. In 1945 werd de rontgenschermbeeld-
fotografie geYntrodueeerd. Met gebruik making van de transportabele UWatsons" werd 
deze techniek geoperationaliseerd en werd het voor het eerst mogelijk snel en efficient 
te screenen. De screening van nog grotere groepen militairen in een kortere tijd 
behoorde nu tot de mogelijkheden met de techniek van de Mass Miniature Radiography 
(MMR). Opmerkelijk was de bekorting van het screenings interval tussen de dag van 
opkomst onder de wapenen van de Illilitair en de uitvoering van het rontgenborst-
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onderzoek. Zo was deze periode in 1960 meer dan gehal-veerd tot drie dagen t.o.v. het 
gemiddelde interval van 6.8 dagen in 1951. Tenslotte werd het in 1967 door verbeterde 
technologie en operationele voorzieningen mogelijk om aile recruten op de eerste dag 
van hun binnenkomst in het leger te onderwerpen aan een rontgenborstonderzoek en 
zodoende te screenen op tuberculose. 
Deze methode van rontgenborstonderzoek als middel van screening op tuberculose werd 
daarna regelmatig geevalucerd en getoetst op zijn kosten-baten verhouding. Zo werd, 
mede door toedoen van cen algehele daling van tuberculose in Nederland, tenslotte in 
1989 geoordeeld dat het routinematige rontgenborstonderzoek bij recmten een zodanig 
geringe opbrengst aan tuberculosegevallen opleverde dat deze niet meer kosteneffectief 
was. Bovendien werd een onnodige blootstelling aan rontgenstraling meer en meer 
onaanvaardbaar geacht. 
Voor het opsporen van een actieve, besmettelijke vonn van tuberculose, welke 
overigens na 1980 nog maar zelden bij recmten tijdens hun opkomst werd aan-
getroffen, was men dus in eerste instantie weer aangewezen op fysisch-diagnostisch 
onderzoek. Evenwel was voor het identificeren van niet infectieuze tuberculosegevallen 
en tuberculosebesmettingen binnen het leger imniddels het tuberculine-onderzoek 
geYntroduceerd. Deze onderzoeksmethode bleek uitstekend geschikt en meer op zijn 
plaats om personen met tuberculose vroegtijdig op te sporen. 
De tuberculineproefbij voorkeur werd de Mantoux-huidtest. Deze test werd in het leger 
in 1955 in gebruik genomen. Tussen 1955 en 1960 werd een studie uitgevoerd onder 
recmten am vast te stell en of er regionale verschillen in tuberculine-huidgevoeligheid 
bestonden. De studie toonde aan dat de tuberculine-huidgevoeligheid varieerde en 
toenam van 14% in de meer noordeJijk gelegen provincies naar 30% in de meer zuide-
lijk en westelijk gelegen provincies. Deze waarneming werd verklaard doordat in het 
Bearden en het noordoosten van het land de rundertuberculose voor het eerst werd 
bestreden. Door het verdwijnen van nmdertuberculose en de natuurlijke daling van de 
besmcttings-prevalentie werden tenslotte in 1975 de percentages in de noordelijke, 
zuidelijke en westelijke provincies min of meer gelijk. Naast het aantonen van deze 
beiangrijke regionale verschillen en de veranderingen ervall in de tijd werd de 
systematische registratie van de tuberculineonderzoeksresultaten binnen het leger 
gebruikt voor het bepalen van de jaarlijkse prevalentie van de tuberculine-huidge-
voeligheid onder de recrutenpopulatie bij biImenkomst in het legeI'. Deze registratie 
heeft door de jaren heen een unieke set aan gegevens opgeleverd welke inzicht 
verschafte in de jaarlijkse trend van hlberculose-besmettingen onder jonge Ncderlandse 
matmen. Deze gegevens werden tevens gebruikt voor het berekenen van het jaarlijkse 
infectierisico in Nederland. 
Gedurende de periode van 1956 tot 1969 daalde het percentage positieve mantoux-
reacties onder de recruten van 19.2 % tot 4.4 %. Tot 1985 daalde de tuberculine-
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huidgevoeligheid onder recruten voortdurend tot een prevalentie van om en nabij de 
0.42 % werd bereikt. Hierna zette de dating zich niet verder voort. 
Het verdient vennelding dat deze daling optrad in afwezigheid van een BCG-
vaccinatiebeleid in het Nederlandse leger. Slechts 5% van de jonge recmten bleek in 
1955 bij opkomst gevaccineerd te zijn met BCG. In Nederland is de BCG-vaccinatie 
onder de algemene bevolking noah op grate schaal toegepast. Slechts "bedreigde" 
groepen zoals medisch personeel enlangdurig in het buitenland verblijvende personen 
werden op aanraden van de Gezondheidsraad gevaccineerd. Ook binnen het leger 
volgde men deze aanbeveling en werden bijvoorbeeld rond 1966 de VN-eenheden, de 
Suriname Cie en het geneeskundig personeeimet BCG gevaccineerd. Het grote nadeel 
van de BCG-vaccinatie was dat bij gevaccineerde personen de Mantoux-reactie niet 
meer bruikbaar was voor het opsporen van besmettingen met M.tuberculose. Mede 
hierdoor werd in die tijd de DCG-vaccinatie ook bij de zogenaamde bedreigde groepen 
steeds mindel' toegepast. In 1990 werd onder de merendeel autochtone recmtenpopulatie 
nog maar zelden eell met BCG gevaccineerde persoon aangetroffen. Echter door een 
toenemcnde migratie van de wereldbevolking in de huidige tijd constateert men in het 
leger een toename van het aantal recruten dat atkomstig blijkt te zijn uit landell waar 
een BCG-vaccinatie bij de bevolking nog steeds op grate schaal wordt toegepast. In 
1995 bleek dat van 306 recruten met een BCG-vaccinatie er 74 % van buitenlandse 
atkomst te zijn. Het tuberculineonderzoek bij deze personen heeft zoals eerder gezegd 
een zeer beperkte waarde in de opsporing van tuberculosebesmettillgen. Een screening 
m.b.v. rontgcnborstonderzoek werd dan oak standaard toegevoegd bij deze met BeG-
gevaccineerde recruten. Naast het verzamelen van bruikbare informatie tcn behoeve van 
de tuberculose~besmettingsprevalentie in het Nederlandse leger en de algemene 
Nederlandse bevolking, worden de resultaten van de Mantoux-huidtest gebruikt bij de 
selectie van kandidaten die in aanmerking komen voor preventievc therapie (INH). 
INH als preventieve therapie werd in 1960 in het Nederlandse leger gei'ntroduceerd. 
Recruten die op de Mantoux-huidtest reageerden met een illduratie van tenminste 10 
111m kwamen in aanmerking voor INH. Echter, de beslissing am prevcntieve therapie te 
starten was gebaseerd op de afweging van de voor en nadelen van de INH-behandeling. 
Het belangrijkste voordcel dat voortvloeit uit hct geven van de INH als preventieve 
therapie is het dalen van het risico dat zich later cen actieve tuberculose ontwikkelt. Dc 
effectiviteit van INH-profylaxe in het voorkomen van eell tuberculose (re)activatie 
wordt in de literatuur aangegeven in de orde van 60 - 80% (1). Echter de INH-therapie 
is niet gcheel vrij van bijwerkingen. 
In hoofdshlk 3 worden de resultatcll besprokcll van de ervaringcn met INH-profylaxe bij 
cen groep van 739 recmten in de periode van 1984 tot 1995. De studie 1aat zien dat 10,6 
% van deze studie-populatie bijwerkingen vertoont die aan de INH-profylaxe gerelat-
eerd zijn. Van aIle bekende bijwerkingen, die geassocieerd zijn met INH, is de chemisch 
gei'nduceerde hepatitis de meest gevreesde complicatie. Dezc kan ernstig zijn en fulmin-
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ant vedopen. Bij aile 739 deelnemers aan deze studie zijn gedurende de therapie-
periode de transaminasewaarden in het bloed gevolgd. Verhoogde transaminasewaarden 
werd bij 5.4 % van de studie-populatie geobserveerd waarbij in 1.4 % aanwijzingen 
bestonden op leverbeschadiging. De meerderheid van de verhoogde transaminase-
waarden was minder dan twee keer de nonnaalwaarde. De frequentie van de verhoogde 
transaminasewaarden in deze sHldie was veellager dan die welke gerapporteerd zijn 
door andere auteurs in de Iiteratuur (2,3). Zo yond een studie van de US-Air Force bij 
1000 persanen een percentage van 22 % als camplicatie bij hen met INH-profylaxe. Het 
verschil in resultaat tussen het Nederlandse onderzoek en dat van de Amerikaanse 
onderzoeksgroep is mogelijk te wijten aan de leeftijd van de onderzoeks-groep en de 
duur van de INH-behandeling, 6 maanden Nederland versus 12 maanden in de VS. In de 
Nederlandse studie had 96 % van de deelnemers een gemiddelde Ieeftijd van 22 jaar 
terwiji die bij de Amerikaanse studie 30 jaar bedroeg. Leeftijd is een belangrijke factor 
bij de afi.veging van het geven van INH-profYlaxe. Bij oudere personen is men zeer 
teroghaudend met het vaarsehrijven van INH-profylaxe. INH-profylaxe wardt dan oak 
niet aanbevolen voor personen ouder dan 35 jaar, tenzij de patient een hoog risico loopt 
t.a.v. het ontwikkelen van actieve tuberculose. Deze aanbeveling is gebaseerd op de 
bevindingen dat de hepata-taxiciteit t.g.v. INH drie maal groter blijkt te zijn bij 
personen ouder dan 35 jaar t.o.v. de jongere lceftijdsgroep (4). In het hier beschreven 
eigen onderzoek bij Ncderlandse recruten werden geen gevallen van emstig verlopende 
hepatitiden geregistreerd. Wellicht dat dit mede het gevaig is van een frequente 
monitoring La.v. het kHnische beeld als weI de lever-enzymen bij hen die een INH-
profylaxe volgden. In deze studie werd bij 19 personen de preventieve therapie 
onderbroken. Dit betekent een percentage van 24 van het totaal aan personen die 
bijwerkingen hebben antwikkeld als gevaig van de INH-profylaxe. Bij 8 persanen 
waren sterk verhoogde transaminasespiegels de reden dat de therapie vroegtijdig werd 
onderbroken. Bijwerkingen als gevolg van de INH-therapie kwamen in 77 % van de 
gevallen in de eerste drie maanden van de therapie-periode voor. Hoewel de frequentie 
van het voorkomcn van bijwerkingen in deze studie veellagcr was dan in vergelijking 
met veel analogc studies, is het toch aan te bevelen richtlijnen op te stellen am het 
optredcn van deze bijwerkingen verder te voorkomen. Deze studie onderstreept nog 
eens de wcnselijkheid 0111 in de eerste 3 maanden van de therapie een geregeld klinisch 
onderzoek en bepating van de leverenzymen te latcn plaatsvinden. 
Het Mantoux-onderzoek met PPD-Humanum is op dit moment de enige praktisch 
uitvoerbare test die een besmetting met M. Tuberculosis kan aantonen en bepaalt in 
belangrijke mate wie in aarunerking komt voor INH-profYlaxc. De interpretatie van 
deze test is echter niet aLtijd eenduidig "positief' of"negaticf'. Deze interpretatie hangt 
namelijk af van een aantal klinische omstandigheden bij de onderzochte persoon. Zo 
kent bijvaorbeeld het Centres for Disease Control (CDC) in de Verenigde Staten de 
aanbeveling van een 5 111111 "cut off· point" bij HIV -positieve personen en eveneens 5 
nml bij hen die in nauw contact zijn geweest met een besmettelijke tuberculosepatient. 
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Va or uit het buitenland a/kol11stige personen (a!lochtonen) wordt door het CDC een 10 
111111 "cut off-point" aanbevolen (5). Tenslotte wordt door hen cen induratie van 
tClmlinste 15 nun beschouwd als positiefbij personen zander venneende risicofactoren. 
Een ander belangrijk aspect waarlllee rekclling gehouden moet worden bij de 
interprctatie van de Mantoux-test is de rol van de aspecifieke mycobacterien (myeo-
bacterien anders dan de M.tub.hum.). De PPD gebntikt bij de Mantoux-test is een 
mcngsei van verschillende mycobacteriele antigenen van PPD-humanum die gedeelte-
lijk kruis-reacties vertonen met de antigenen van diverse mycobacterien anders dan 
M.tub.hulU. Deze mycobacterien kamcn wijd verspreid voor in de natuuriijke omgeving 
en zijn dien ten gevolge debet aan cen uitgebreide sensibilisatie onder de algehele 
bevolking. Daarom geldt bij bevolkingsgroepen met een lage tuberculose-prevalentie en 
een relatiefhoge prevalentie van aspecifieke mycobacteriele besmettingen, dat de 
bmikbaarheid van de huidige tuberculine-test zijn beperkingen kent. De prevalentie van 
aspecifieke mycobacteriele besmettingen onder Nederlandse recruten werd daarom 
bestudeerd over een periode van 3 jaar, 1986 - 1988, bij een totaal van 37.755 personen 
met behulp van het M. Scrofulaceum sensitine. Het gebruik van dit sensitine als test-
alltigeen is vcrkozen omdat het zich bevindt in het midden van het spectrum van de 
lIaspecifiekcll mycobacterien en daarom kruisreacties vertaant met het merendeel van 
hen (6). De resultaten van dit onderzoek zijn beschreven in hoofdstuk 4. 
De prevalentie van de aspecifieke mycobacteriele besmettingen onder de gehele 
populatie recruten over een peri ode van 3 achtereenvolgende jaren was 7,8 %. Een 
Nederlandse studie uitgevoerd bij schoalkindercn in Delft toonde zelfs een nag hogere 
prevalcntie aan van ongeveer 13 % (7). Deze shldie biImen het Nederlandse leger toont 
duidelijk aan dat er een hoge prevalentie bestaat van aspecifieke mycobacteriele 
besmettingen bij recrutenpopuiaties. Het praktische belang van deze constatering is dat 
cr onderscheid gemaakt moet worden tussen reacties die zijn veroorzaakt door 
aspecifieke mycobactcrien of door M. Tuberculosis. Om tot een juiste indicatiestelling 
voor INH-profylaxe te komen dient deze immers slechts te worden gegevell aan hen die 
zijn besl1lct met de "echte" tuberculosebacterien en niet aan hen die door de 
krllisreacties van aspecifieke mycobacterien toch positief reageren op de reguliere 
Mantoux-huidtest (PPD Rt Tween 23). 
Hoofdstuk 5 presenteert de resllitaten van een anderzoek dat tot doel had het verbeteren 
van het huidige tubercuIineonderzoek bij militairen door met meer nauwkeurigheid te 
kunnen onderscheidcn tussen huidreacties veroorzaakt door M. Tuberculosis en die door 
besmctting met aspecifieke mycobacterien. De theoretische achtergrond van dit 
vergelijkend tubcrculine-onderzoek was gebaseerd op het feit dat de tuberculine-
huidgevoeligheid bij een mycobacteriele infectie grater is bij de toediening van een 
homoloog antigecn dan bij cen hetcroloog antigeen. 
Tijdells het eerste deel van de stud ie, van 1986 - 1988, werden recmtcn simultaan getest 
met PPD Rt 23 en PPD-Scrofulaceum. Gedurende het tweede deel van de stud ie, van 
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1989 - 1993, werden de recruten die positiefreageerden op PPD Rt 23, met een 
induratie tussell de 10 en 15 111m, opnicuw gctest met M. Scrofulaceum sensitine (pPD-
Scrofulaceum). De totale studiepopulatie bestond uit 237.692 niet met BCG 
gevaccillccrde recfuten. 
De resultaten laten zien dat in de periode 1986 - 1993 gemiddeld 0,5 % van de onder-
zochte personen positief reageerde op PPD Rt 23 (induratie > 10 mm.). Gedurende het 
eerste dccl van de studie reageerde gemiddeld 7,7 % op M. Scrofulaceum met cen 
induratie grater dan 10 mm. Gebruikmakend (am praktische redenen) van cen 
gemodificeerd ITSC (International Tuberculosis Surveillance Centre) model, blijkt dat 
48% van de personen die positief reageren op PPD Rt 23 lllet induraties hlssen de 10 en 
15 mm, kUllncn worden geklassificeerd als fout-positieve reacties. Bij deze personen 
werd derhalve oak geen INH-profylaxe voorgcschreven. Deze sturlie toont aan dat in 
gebieden met cen rclatief hoge prevalentie van niet tuberculeuze mycobacteriele 
infecties, het gebruik van de dubbel-mantouxtest bruikbaar kall zijn in het maken van 
onderscheid tussell induraties veroorzaakt door de tubercelbacterie en die door infecties 
met atypische mycobacterien. Het gevolg is dat INH meer gericht wordt voorgeschreven 
aan hen die daadwerkelijk met de tubercelbacterie zijn gernfecteerd en dus profijt 
kunnen verwachten van de voorgeschreven preventieve medicatie. Deze studie beveelt 
dan oak aan tot de stalldaardisatie en de standaard uitvoering van de dubbel-mantouxtest 
bij bepaalde groepen recruten als middel om onnodig en ongewenst voorschrijven van 
INH te voorkomen. 
Het leger heeft altijd veel aandacht bcsteed aan het tuberculoseprobleem binnen haar 
gelederen. Door de jaren heen werd gebmik gemaakt van aIle beschikbare tuberculose-
controlemiddelen met al.s doel een optimale zorg voor haar personeel in deze. De tuber-
culose-prevalentie bitmen het leger is momenteel erg laag en een afspiegelil1g van die in 
de NederJalldse samenieving. Toch is het niet waarschijnlijk dat tuberculose in het leger 
een historische curiositeit wordt. Veellanden in de wereld hebbcl1 namelijk nag steeds 
te maken met een ernstig hlberculoseprobleem met soms een incidentie van meer dan 
200 gevallen per 100.000 inwoners. Het gevolg van deze hoge incidentiecijfers in die 
landen is er de oorzaak van dat het uitbannen van tuberculose in de nabije toekomst ook 
in Nederland niet waarschijnlijk geacht mag worden. 
Het uitzenden van legeronderdelen waar ook ter wereld, in het bijzonder tijdens "peace-
keeping" opdrachten, garandeert onherroepelijk het in contact kamen van militairen met 
hlberculose in gebieden waar de tuberculase-incidentie hoog is. 
In hoofdstuk 6 wordt een voorbeeld gegeven van een dergelijke confrontatie van een 
uitgezonden legereenheid met het tuberculoseprobleem. Dit voorval onderstreept nag 
eens de waarde van het vigerende scrceningsprogramma rondom uitzendingen. 
In 1991 werd een tuberculine~onderzoek uitgevoerd bij cen militaire eenheid die terug-
keerde uit Turkije na een verblijf aldaar van 3 maanden. Het onderzoek leverde een 
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tiental pel'sonen op die l'ecentelijk waren besmet met tuberculose. Bij nader onderzoek 
bleek dat aIle besmette personen afkomstig waren uit een gl'oep van 69 militail'en die 
allen in hetzelfde hotel waren ondergebracht. Eon van hen ontwikkelde 5 maanden na 
terugkeer een Multi Drug Resistente (MDR)tuberculose. Aangenomen mag worden dat 
ook de andere 9 personen besmet geraakt zijn door dezelfde bron, een MDR-
tubel'culose. Bevestigd wordt nag eens dat tuberculosetransmissie tijdens de duur van 
een uitzending kan plaatsvinden. Bovcndien blijkt uit dit rclaas, dat ondanks een zorg-
vuldig uitgevoerd tuberculineondel'zoek en de ingestelde preventieve therapie bij de 
positief(besmet) bevonden personen, de dreiging van MDR-tuberculose ook het leger 
aangaat en niet slechts een probleem is voor ingezetenen van landen met een relatief 
hoge prevalentie aan .MDR-tuberculose. 
De tUberculose-opsporing en bestrijding in het Nederlandse leger heeft zich door de 
jaren heen steeds aangepast aan de nieuwste ontwikkelingen en inzichten van de tuber-
culosebestrijding in Nederland en daarbuiten. Ondanks het feit dat Nederland wordt 
besehouwd als eell laag endemiseh gebied voor tubereulose, is de ~andacht voor tuber-
eulose binnen het Nederlandse leger niet verslapt. In tegendeel, de aandacht wordt zelfs 
verscherpt. De reden hiervoor is dat het lcger in toenemende mate wordt geconfronteerd 
met uitzendingen van personeel naar landen met een hoge tuberculose-prevalentie en -
incidentie. Daarnaast heeft de vel'sehuiving van een dienstplichtig legel' naal' cen 
beroepsleger geresulteerd in een aanzienlijke verandering van de socio-demografische 
samenstelling van het militaire pcrsoneel. Het gevolg is dat de vroegere (jaarlijks) 
berekendc tubcreuline-indices (besmettingsprevalenties) en de trend hiervan, welke 
voorheen waren gebaseerd op de onderzocken bij reeruten - jonge Ncderlandse mannen 
met cen gemiddclde leeftijd van 20 jaar - , niet zonder meer maat zijn voor de 
tuberculosestahls van het huidige beroepsleger. Tenslotte heeft ook de confrontatie met 
~1DR-tuberculose de aandacht voor tuberculoseeontrole birulen hetNederlandse leger 
verscherpt. 
De pijler van de tuberculosebestrijding birUlen het leger is op dit moment het 
tuberculine-onderzoek met gebmik van de Mantoux-test. Tijdens individuele en groeps-
screeningen worden nog geregeld met tuberculose besmettc personen geYdentificeerd. 
Bovendien levert het tuberculineonderzoek nog steeds belangrijke informatie om het 
tuberculosebesmettingsrisico en de trend hiervan binnen het huidige Nederlandse leger 
te volgen. Het totaal aan onderzoeksgegevens zal naar verwachting zijn bijdrage blijven 
leveren aan de schatting van het hlberculose-infectierisico in Nederland. 
Het dubbel-Mantollxonderzoek zoals besehreven in dit proefsehrift is een verbeterdc 
onderzoekstcchniek om hlberculose op te sporen en ondcrseheidt tuberculosebesmet-
tingen van besmettingen veroorzaakt door aspecifieke mycobacterien. Illmiddels is deze 
onderzoeksmethode een integraal onderdeel geworden van de tubereulose-opsporing 
binnen het Nederlandse legeI'. Deze methode heeft geleid tot cen bijna 50% reductic van 
het voorschrijven van INH-profylaxe bij hen die positiefreageerden op tuberculine met 
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induraties tussen de 10 en 15 mm. Het merendeel van hen die positief reageren op de 
tuberculine-huidtest bevindt zich namelijk in het induratiegebied van de 10 tot 15 mm. 
Inmiddels wordt deze methodiek ook bij sonlInige civiele organisaties (GGDen) 
gehanteerd, o.a. bij (low-risk)groepsonderzoek in het kader van contactonderzoek. Een 
en ander kan worden gezien als een positieve spin-off van de resultaten bij het 
groepsonderzoek binnen het Nederlandse leger. Inmiddels wordt het tubereulosebeleid 
binnen het leger opnieuw gedefinieerd en valt dit samenvattend te beschrijven als : 
• Een standaard Mantoux-test wordt uitgevoerd bij aile personen die nieuw het leger 
binnenkolllen, voor en na uitzending naar hoog-prevalente tuberculosegebieden en 
bij aile personen die behoren tot een risicogroep. Deze laatste groep ondergaat 
jaarlijks cen Mantoux-onderzoek. Bij aile gevonden induraties tussen de 10 en 15 
mill bij nilllmer met BeG gevaccineerde personen, wordt een dubbcl-Mantoux-
onderzoek uitgevoerd zoals beschreven in dit proefschrift. 
• De resuItaten van het tuberculineondcrzoek worden opgeslagen in cell data-base, 
van waaruit op reguliere basis evaluatie-ollderzoek plaatsvindt om zonodig het 
vigerende beleid bij te stellen. 
Met deze maatregelen hopen wij het Nederlandse leger te behoeden voor de dreigende 
gevaren van de wereldwijd heersende tuberculose-epidemie. 
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Dankwoord 
Zonder de steun van mijn gezin en de stimulans van enthousiaste collegae en goede 
vricndcn van zowel bhUlcn als buiten de militaire orgallisatie zou het mij noait gelukt 
zijn mijn proefschrift tot een goed eiude te brengen. De volgende alinea zijn dan oak 
gewijd aan mijn dankbetuigil1g aan hen die mij in deze ter zijde hebben gestaan. 
Bij de Dienst Militaire Gezondheidszorg (DMGZ), de bakermat van de tuberculose-
bestrijding onder het (voormalig)dienstplichtig- en beroepspersoneel van de Konink-
lijke Landmacht, de Koninklijke Luchtmacht en de Koninklijke Marechaussee, is het 
allemaal begonnen. In 1983 werd ik geplaatst bij de DMGZ en deze Dienst is de 
voedingsbodcm geworden voor mijn huidige en bijzondcre affiniteit tot de 
tuberculose. Het eerste enthollsiasme werd mij bijgebracht door Sweder Schroten die 
als waar-nemend Hoofd DMGZ mij destijds opleidde in het lezen van schennbeeld-
fotc's waarbij de opsporing van tuberculose centraal stond. Bovendien maakte hij mij 
opmerkzaam op de aanwezigheid bij de Dienst van cell schat aan yerzamelde 
tuberculasegegevens en de epidemiolagische waarde hiervan t.h.v. de sturing van het 
tuberculoseheleid binnen de eigen (militaire)organisatie maar ook daar huiten. 
Bedankt Sweder SchIoten. 
Vervolgens wil ik heel graag Dr. Thijs Bleiker, de goeroe van het tuberculineonder-
zoek in Nederland, bedanken. Toen ik in 1983 startle met mijn werkzaamheden bij de 
Dienst Militaire Gezondheidszorg was er bij mij nag geen enkele intentie om te gaan 
promo-veren. De eerste die mij attent maakte op de goede mogelijkheden die er 
bestonden om te promoveren op het tuberculoseonderzoek onder de rekrutenpopulatie 
was Thijs. Hij was toentertijd directeur van de KNCV en tevens voorzitter van de 
tuberculinewerk-groep van TNO waarin oak Defensie participcerde. Deze werkgroep 
leverde een belang-rijke bijdrage aan de tat standkoming van de voor Nederland zo 
belangrijke, jaarlijkse tuberculine-index. Thijs jij bent degene geweest die mij heeft 
gestimuleerd en enthousiast gemaakt voor het doen van het Hdubbel Mantoux-
onderzoek" in 1986, het onderzoek wat in 1998 werd afgesloten en uiteindelijk de 
kern van mijn proefschrift is geworden. 
In het bijzonder wiI ik Robert Bwire bedanken. Robert is arts en werkzaam geweest in 
de tuberculose- en leprabestrijding in Uganda. In 1993 heb ik Robert ontmoet op een 
tuberculasecongres in Mainz (BRD) waama ik hem gevraagd heb te komen werken 
bij de Dienst "t\1i1itaire Gezondheidszorg waarvan ik toen Baofd was. Van deze actie 
heb ik nooit spijt gekregen. 
Robert jij bent sinds die tijd de motor gewccst in het tot stand brengen van mijn praef-
schrift. Jij hielp mij stmctuur te brengen in het plan van aanpak voor het schrijven van 
de thesis. Je schreef voor mij en herschreef de vele concepten voor het proefschrift uit 
in goed leesbaar Engels en voerde het deelonderzoek uit betreffende INH-protylaxe 
bij rekmten. Urcn hebbenjij en ik doorgebracht met nadellken en discussieren over en 
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het formuleren en uitschrijvell van de vele concepten van het "tuberculose 
manuscript". En als de aandacht dreigde te verslappen door de dmkte van mijn 
reguliere werkzaam~heden, was jij degene die mij s'avonds opbelde en mij 
aanspoorde met de worden "Hans, lets go and finish it". 
Graag wil ik oak Joost Gribnau bedanken. Joost, jij bent mij tot grote steun geweest 
bij het uitwerken van het in 1989 afgesloten "dubbel Mantoux~onderzoek", wat 
uiteindelijk heeft geleid tot publikatie van dit onderzoek en het gerenommeerde 
tijdsehrift Tubercle and Lung Diseases. 
Bedanken wil ik oak hen die deel uit ma(a)k(t)en van de versehillende Mantoux-
teams van de DMGZ en TNO. Zij zijn degenen die het tuberculineonderzoek zorg-
vuldig uitvoerden en aldus bijgedragen hebben aan de betrouwbaarheid van de 
onderzoeksgegevens, die hebben geleid tot de onderzoeksresultaten welke worden 
uitgedragen in mijn proefschrift. De TNO~teams werden structureel ingezet naast die 
van de DMGZ en stonden onder de bezielende leiding van Osrenka Misienovic, die 
een goede vriendin is geworden en gebleven. Osrenka jij bent samen Thijs en Robert 
een zeer belangrijke stimulans geweest om te blijven volharden in het uitschrijven van 
mijn proefsehrift. 
Oak de zorg en de hulp van de administratieve kern van de DMGZ heeft belangrijk 
bijgedragen aan de tot standkoming van mijn proefschrift. Lucia Birzwilks, bedankt 
voor de verzorging van de inwendige mens, die anders zwaar verwaarloosd was 
geworden tijdens mijn "tuberculose-sessies" op de Dienst en Vaal' het verzekeren van 
altijd een parkeerplaats op de Knoopkazerne zodat ik niet steeds van vel' weg, 
dragende al mijn tassen met tuberculosegegevens, behoefde aan te komen sjouwen. Jij 
besefte goed dat ik geen 30 jaar meer was! 
\Vim Veemnan, bedankt Vaal' het verzorgd uitdraaien van telkens weer nieuwe 
concepten van de opeenvolgende hoofdstukken van het proefschrift. Jij wist van ieder 
slordig aan-gedragen document een fraai uitziend exemplaar te maken hetgeen enorm 
gestimuleerd heeft in het doorgaan met (her)schrijven van de hoofdstukken. 
Tenslotte dank ik Rob Seheenstra, het huidige Hoofd DMGZ. Rob, tenslotte heb jij als 
baas van de Dienst oogluikend toegelaten dat vele medewerkers zich hebben ingezet 
voor de tot standkoming van mijn proefschrift. 
Voor wat betreft het opsporen en aanleveren van de talrijke artikelen die benodigd 
waren voor het literatuuronderzoek t.b.v. mijn proefschrift, wiI ik bedanken Paulien 
Burema, Dieuwkje Dijkstra van de Interservice Medische Bibliotheek en Rien Veen 
e.a. van de D!\1GZ. Zonder de inspanningen van hen zou mij dat (te)veel eigen tijd 
hebben gekost, tijd die naast mijn normale werkzaamheden schaars en kostbaar was. 
Oak wil ik de beide longartsen, Dr. Hidde Bok en Dr. Peter Sips bedanken. Met 
Hidde heb ikjarenlang de tienduizenden sehennbeeldfoto's ("dubbel-reading") van de 
rekruten-lichtingen gelezen l11et als primaire doel de opsporing van tuberculose. Met 
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Peter hcb ik veel gesprokcn over de indica ties en de samenstelling van de INH-
profylaxe bij de "positief' reagerende rekruten. Beide coUegae zijn altijd bereid 
geweest am gereed gekomen (deel)manuscripten door te lezen en te voorzien van hun 
commentaar. 
Bedanken wil ik ook het Hoofd van de Gezondheidszorg Dienst van de Koninklijke 
Landmacht, de brigade-generaal Evert van Ankum. Tenslotte heeft hij de mogelijk-
heid geboden om mij op vrijdagen te kunnen afzonderen t.b.v. van het werkcll aan 
mijn proefschrift. Bovendicn heeft hij gezorgd voor de financiele ondersteuning door 
de militaire organisatie. 
De firma SmithKlinc Beecham wiI ik bedankcn voor hun financielc bijdrage in het tot 
stand brcngcn van mijn proefsehrifi. 
De DMGZ heef! altijd een goede relatie onderhouden met de KNCV. Hoewel 
natuurlijk het tuberculoseonderzoek bij de rekruten cen belangrijk bindmiddel is 
geweest, hebben tach vooral de persoonlijke rclaties gezorgd voor de bijna familiaire 
band die onderling is ontstaan. In de twaalfjaar dic ik bij de "tuberculosedienst" 
(DMGZ) van het leger heb doorgebracht ben ik nauw verbonden geraakt met de 
KNCV en haar personccl. Deze KNCV wiI ik bedanken voor zowel de administra-
tieve ondersteuning (literatuuronder-zoek) als de materiele ondersteuning (onder-
zoekssubsidie). Bovendicn dank ik Jaap Broekmans, Jaap Veen, Osrenka Mislenovic 
en nog anderen werkzaam binnen de KNCV voor hun cnthousiasme en persoonlijke 
betrokkcllheid t.a.v. mijn promotie-activiteiten. 
Natuurlijk wiI ik mijn promotor Dr. Joop Huisman bedanken. De betrokkenheid van 
hem bij het onderwerp van mijn proefschrift en de (historische )verwantschap die hij 
had en nog steeds heeft met de geneeskundige diensten van de krijgsmachtdclcn, 
hebben er zeker toe bijgedragen dat de samenwerking en de (inhoudelijke)informatie-
uitwisseling zeer vruchtbaar was en aItijd plezierig is verlopen. Het was mede zijn 
keuze om te komen tot een meer bcschouwend proefschrift \vaarin zowel de rijke 
historie als de actnaliteit van de tuberculosebestrijding in het leger gelijkwaardige 
aandacht zoudcn krijgen. Het proefschrift moest, naast een wetenschappelijke 
vcrhalldeling van het Mantoux-onderzoek in het leger, een voor velen prettig leesbaar 
manuscript blijven. 
Met hem bedank ik ook de leden van de promotiecommissie voor hun welwillendheid 
zitting te willen nemen in de commissie en zich te verdiepen in de problematiek van 
de tuberculosebestrijding in het Nederlandse leger. 
Niet omdat het nu eenmaal gcbruikelijk is aan het einde van een dankwoord de 
gezins-belasting te memoreren maar omdat het van harte gemeend is, wiI ik afsluiten 
met mijn VrollW Olivia en mijn kinderen Jan Willem, Jatmeke, Jenny en Tineke te 
bedanken. Zij hebben de laatste twee jaar veelal indirect en soms direct aan den lijvc 
ondervonden dat haar eeht-genoot respectievelijk hun vader niet altijd adequaat 
aanspreekbaar was en dat promoveren blijkbaar gepaard gaat met gelukkig mcestal 
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beheersbare stressreacties bij de promovendus. Zij zijn het geweest die mij in deze 
veelal goed hebbell opgevallgen ell ik dank het "thuisfrollt" dall ook voor hUll liefde 
ell geduld dat ze hebbell opgebracht. 
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Curriculum Vitae 
Dc schrijver van dit proefschrift werd geboren op 12 maart 1949 te Is-Gravenhage. 
Na doorlopen vanmiddelbare school ben ik in 1969 begonnen met de studie 
gcnccskunde aan de VrUe Universiteit in Amsterdam. Taen in 1978 het artsexamcn 
werd behaald hcb ik aansluitend de huisartsenopieiding via het huisartscn instituut van 
de Vrije Universiteit gevolgd. 
In 1979 werd ik geregistreerd als huisarts en in datzelfde jaar werd ik als dienstplichtige 
opgeroepen voor opkomst in werkelijke dienst bij de Koninklijke Landmacht. 
Het "lot" bepaalde dat ik in 198 I koos voor cen militaire at1sen-Ioopbaan, welke startte 
als kapitein-arts bij het Opleidingscentrum Intendance op de Palmkazeme in Bussum. 
In 1983 werd ik geplaatst bij de Dienst Militaire Gezondheidszorg op de 
(oude)Knoopkazerne te Utrecht in de functie van Hoofd afdeling Preventieve 
Gezondhcidszorg. 
Hier began mijll affiniteit en enthousiasme tc onstaan yoor de tuberculosebestrijding in 
het Nederlands leger. 
In 1991 werd ik Hoafd van de Dienst Militaire Gezondhcidszorg in de rang van 
Luitenant -koloncl. 
Tijdens mijn loopbaan binnen de Dienst Militaire Gezondheidszorg heb ik vele 
cursussen en opleidingen gevolgd waaronder de opieiding Aigemene Gezondheidszorg. 
In dic periode hebben de vcrschillcnde onderzoeken van mijn huidige proefschrift zich 
ontwikkeld. 
In 1995 werd ik tenslotte geplaatst op mijn huidige functic als stafmedewerker Medisch 
Beleid bij de Gezondheidszorg Dienst Koninklijke Landmacht. 
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